BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 719148 CC(=O)NCCNCc1c(C)cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C36H37N3O5/c1-24-16-31(43-23-30-8-5-9-32(25(30)2)29-10-11-34-36(18-29)42-15-14-41-34)19-35(33(24)21-38-12-13-39-26(3)40)44-22-28-7-4-6-27(17-28)20-37/h4-11,16-19,38H,12-15,21-23H2,1-3H3,(H,39,40) WGVCGVUSAQIYCB-UHFFFAOYSA-N 363063 N-(2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)ethyl)acetamide::US9850225, Example 1000 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363063&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435108 401958524 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719149 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CN[C@](C)(CO)C(O)=O InChI=1S/C36H36N2O7/c1-23-14-29(44-21-28-8-5-9-30(24(28)2)27-10-11-32-34(16-27)43-13-12-42-32)17-33(31(23)19-38-36(3,22-39)35(40)41)45-20-26-7-4-6-25(15-26)18-37/h4-11,14-17,38-39H,12-13,19-22H2,1-3H3,(H,40,41)/t36-/m1/s1 YMYDEJCKLQRBRC-PSXMRANNSA-N 363064 (R)-2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1001 Programmed cell death 1 ligand 1 Human 2.25 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363064&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435188 401958525 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719150 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CN[C@H](CO)C(O)=O InChI=1S/C35H34N2O7/c1-22-13-28(43-21-27-7-4-8-29(23(27)2)26-9-10-32-34(15-26)42-12-11-41-32)16-33(30(22)18-37-31(19-38)35(39)40)44-20-25-6-3-5-24(14-25)17-36/h3-10,13-16,31,37-38H,11-12,18-21H2,1-2H3,(H,39,40)/t31-/m1/s1 YSYKQJKQKIDWAL-WJOKGBTCSA-N 363065 (R)-2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxypropanoic acid::US9850225, Example 1002 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363065&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 91971328 401958526 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719151 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CNC[C@@H](O)CC(O)=O InChI=1S/C36H36N2O7/c1-23-13-30(44-22-28-7-4-8-31(24(28)2)27-9-10-33-35(15-27)43-12-11-42-33)17-34(32(23)20-38-19-29(39)16-36(40)41)45-21-26-6-3-5-25(14-26)18-37/h3-10,13-15,17,29,38-39H,11-12,16,19-22H2,1-2H3,(H,40,41)/t29-/m0/s1 MYSWVIKSWHIWQI-LJAQVGFWSA-N 363066 (S)-4-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxybutanoic acid::US9850225, Example 1003 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363066&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434670 401958527 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719152 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CN1CCCC[C@H]1C(O)=O InChI=1S/C38H38N2O6/c1-25-17-31(45-24-30-9-6-10-32(26(30)2)29-12-13-35-37(19-29)44-16-15-43-35)20-36(46-23-28-8-5-7-27(18-28)21-39)33(25)22-40-14-4-3-11-34(40)38(41)42/h5-10,12-13,17-20,34H,3-4,11,14-16,22-24H2,1-2H3,(H,41,42)/t34-/m0/s1 YYTSRZOGVYHLFI-UMSFTDKQSA-N 363067 (S)-1-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1004 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363067&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435021 401958528 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719153 CC(=O)NCCNCc1c(C)cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C35H36N4O5/c1-23-13-30(43-22-29-5-4-6-31(24(29)2)28-7-8-33-35(15-28)42-12-11-41-33)16-34(32(23)20-37-9-10-39-25(3)40)44-21-27-14-26(17-36)18-38-19-27/h4-8,13-16,18-19,37H,9-12,20-22H2,1-3H3,(H,39,40) WQMNXWQTMNRYSA-UHFFFAOYSA-N 363068 N-(2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)ethyl)acetamide::US9850225, Example 1005 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363068&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435129 401958529 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719154 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cncc(c2)C#N)c1CNC[C@@H](O)CC(O)=O InChI=1S/C35H35N3O7/c1-22-10-29(44-21-27-4-3-5-30(23(27)2)26-6-7-32-34(12-26)43-9-8-42-32)14-33(31(22)19-38-18-28(39)13-35(40)41)45-20-25-11-24(15-36)16-37-17-25/h3-7,10-12,14,16-17,28,38-39H,8-9,13,18-21H2,1-2H3,(H,40,41)/t28-/m0/s1 KHLPUYDOUFHOET-NDEPHWFRSA-N 363069 (S)-4-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxybutanoic acid::US9850225, Example 1006 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363069&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434611 401958530 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719155 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cncc(c2)C#N)c1CN[C@H](CO)C(O)=O InChI=1S/C34H33N3O7/c1-21-10-27(43-20-26-4-3-5-28(22(26)2)25-6-7-31-33(12-25)42-9-8-41-31)13-32(29(21)17-37-30(18-38)34(39)40)44-19-24-11-23(14-35)15-36-16-24/h3-7,10-13,15-16,30,37-38H,8-9,17-20H2,1-2H3,(H,39,40)/t30-/m1/s1 SEQRPTLPWHRCNV-SSEXGKCCSA-N 363070 (R)-2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxypropanoic acid::US9850225, Example 1007 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363070&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434758 401958531 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719156 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cncc(c2)C#N)c1CN[C@](C)(CO)C(O)=O InChI=1S/C35H35N3O7/c1-22-11-28(44-20-27-5-4-6-29(23(27)2)26-7-8-31-33(13-26)43-10-9-42-31)14-32(30(22)18-38-35(3,21-39)34(40)41)45-19-25-12-24(15-36)16-37-17-25/h4-8,11-14,16-17,38-39H,9-10,18-21H2,1-3H3,(H,40,41)/t35-/m1/s1 RRTVDINQONANBG-PGUFJCEWSA-N 363071 (R)-2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1008 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363071&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434654 401958532 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719157 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cncc(c2)C#N)c1CN1CCCC[C@H]1C(O)=O InChI=1S/C37H37N3O6/c1-24-14-30(45-23-29-6-5-7-31(25(29)2)28-9-10-34-36(16-28)44-13-12-43-34)17-35(46-22-27-15-26(18-38)19-39-20-27)32(24)21-40-11-4-3-8-33(40)37(41)42/h5-7,9-10,14-17,19-20,33H,3-4,8,11-13,21-23H2,1-2H3,(H,41,42)/t33-/m0/s1 HYOBTDBVIZYQLU-XIFFEERXSA-N 363072 (S)-1-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1009 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363072&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434760 401958533 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719158 Cc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cncc(c2)C#N)c1CN[C@@](C)(CO)C(O)=O InChI=1S/C35H35N3O7/c1-22-11-28(44-20-27-5-4-6-29(23(27)2)26-7-8-31-33(13-26)43-10-9-42-31)14-32(30(22)18-38-35(3,21-39)34(40)41)45-19-25-12-24(15-36)16-37-17-25/h4-8,11-14,16-17,38-39H,9-10,18-21H2,1-3H3,(H,40,41)/t35-/m0/s1 RRTVDINQONANBG-DHUJRADRSA-N 363073 (S)-2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-6-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1010 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363073&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435034 401958534 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719159 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H32N2O5/c1-23-28(11-6-12-31(23)26-9-3-2-4-10-26)22-39-30-14-13-27(19-35-20-29(36)16-33(37)38)32(17-30)40-21-25-8-5-7-24(15-25)18-34/h2-15,17,29,35-36H,16,19-22H2,1H3,(H,37,38)/t29-/m0/s1 HZSZSWDVMRKDAC-LJAQVGFWSA-N 363074 (S)-4-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1011 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363074&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435081 401958535 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719160 C[C@H](O)[C@H](NCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C33H32N2O5/c1-22-28(12-7-13-30(22)26-10-4-3-5-11-26)21-39-29-15-14-27(19-35-32(23(2)36)33(37)38)31(17-29)40-20-25-9-6-8-24(16-25)18-34/h3-17,23,32,35-36H,19-21H2,1-2H3,(H,37,38)/t23-,32-/m0/s1 IXNKXXYVSDLNBR-UDNBHOFDSA-N 363075 (2S,3S)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1012 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363075&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435082 401958536 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719161 C[C@@H](O)[C@@H](NCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C33H32N2O5/c1-22-28(12-7-13-30(22)26-10-4-3-5-11-26)21-39-29-15-14-27(19-35-32(23(2)36)33(37)38)31(17-29)40-20-25-9-6-8-24(16-25)18-34/h3-17,23,32,35-36H,19-21H2,1-2H3,(H,37,38)/t23-,32-/m1/s1 IXNKXXYVSDLNBR-JIYROHSKSA-N 363076 (2R,3R)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1013 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363076&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434826 401958537 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719162 Cc1c(COc2ccc(CNC(C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H32N2O5/c1-23-28(12-7-13-30(23)26-10-4-3-5-11-26)21-39-29-15-14-27(19-35-33(2,22-36)32(37)38)31(17-29)40-20-25-9-6-8-24(16-25)18-34/h3-17,35-36H,19-22H2,1-2H3,(H,37,38) ZAZUVDZYHXXZML-UHFFFAOYSA-N 363078 2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1014 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363078&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434692 401958539 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719163 C[C@H](O)[C@@H](NCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C33H32N2O5/c1-22-28(12-7-13-30(22)26-10-4-3-5-11-26)21-39-29-15-14-27(19-35-32(23(2)36)33(37)38)31(17-29)40-20-25-9-6-8-24(16-25)18-34/h3-17,23,32,35-36H,19-21H2,1-2H3,(H,37,38)/t23-,32+/m0/s1 IXNKXXYVSDLNBR-JPQMRUPTSA-N 363079 (2R,3S)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1015 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363079&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434707 401958540 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719164 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C32H30N2O5/c1-22-27(11-6-12-29(22)25-9-3-2-4-10-25)21-38-28-14-13-26(18-34-30(19-35)32(36)37)31(16-28)39-20-24-8-5-7-23(15-24)17-33/h2-16,30,34-35H,18-21H2,1H3,(H,36,37)/t30-/m1/s1 OUEOAVHGVDLFGR-SSEXGKCCSA-N 363080 (R)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1016 Programmed cell death 1 ligand 1 Human 4.55 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363080&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435003 401958541 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719165 Cc1c(COc2ccc(CNC(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C32H30N2O5/c1-22-27(11-6-12-29(22)25-9-3-2-4-10-25)21-38-28-14-13-26(18-34-30(19-35)32(36)37)31(16-28)39-20-24-8-5-7-23(15-24)17-33/h2-16,30,34-35H,18-21H2,1H3,(H,36,37) OUEOAVHGVDLFGR-UHFFFAOYSA-N 363081 2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1017 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363081&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435005 401958542 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719166 Cc1c(COc2ccc(CN[C@@H](CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C32H30N2O5/c1-22-27(11-6-12-29(22)25-9-3-2-4-10-25)21-38-28-14-13-26(18-34-30(19-35)32(36)37)31(16-28)39-20-24-8-5-7-23(15-24)17-33/h2-16,30,34-35H,18-21H2,1H3,(H,36,37)/t30-/m0/s1 OUEOAVHGVDLFGR-PMERELPUSA-N 363082 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1018 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363082&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435096 401958543 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719167 Cc1c(COc2ccc(CN[C@@](C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H32N2O5/c1-23-28(12-7-13-30(23)26-10-4-3-5-11-26)21-39-29-15-14-27(19-35-33(2,22-36)32(37)38)31(17-29)40-20-25-9-6-8-24(16-25)18-34/h3-17,35-36H,19-22H2,1-2H3,(H,37,38)/t33-/m0/s1 ZAZUVDZYHXXZML-XIFFEERXSA-N 363083 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1019 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363083&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434690 401958544 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719168 CC(C)C(CO)(NCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H36N2O5/c1-24(2)35(23-38,34(39)40)37-20-29-15-16-31(18-33(29)42-21-27-10-7-9-26(17-27)19-36)41-22-30-13-8-14-32(25(30)3)28-11-5-4-6-12-28/h4-18,24,37-38H,20-23H2,1-3H3,(H,39,40) HBNSBYSVEOVGCC-UHFFFAOYSA-N 363084 2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-2-(hydroxymethyl)-3-methylbutanoic acid::US9850225, Example 1020 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363084&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434613 401958545 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719169 Cc1c(COc2ccc(CN[C@H](CO)CC(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H32N2O5/c1-23-28(11-6-12-31(23)26-9-3-2-4-10-26)22-39-30-14-13-27(19-35-29(20-36)16-33(37)38)32(17-30)40-21-25-8-5-7-24(15-25)18-34/h2-15,17,29,35-36H,16,19-22H2,1H3,(H,37,38)/t29-/m0/s1 PDRUZUSHNSQRBD-LJAQVGFWSA-N 363085 (S)-3-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-4-hydroxybutanoic acid::US9850225, Example 1021 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363085&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434794 401958546 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719170 Cc1c(COc2ccc(CN[C@@H](CO)CC(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H32N2O5/c1-23-28(11-6-12-31(23)26-9-3-2-4-10-26)22-39-30-14-13-27(19-35-29(20-36)16-33(37)38)32(17-30)40-21-25-8-5-7-24(15-25)18-34/h2-15,17,29,35-36H,16,19-22H2,1H3,(H,37,38)/t29-/m1/s1 PDRUZUSHNSQRBD-GDLZYMKVSA-N 363086 (R)-3-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-4-hydroxybutanoic acid::US9850225, Example 1022 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363086&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435159 401958547 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719171 Cc1c(COc2ccc(CN[C@](C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H32N2O5/c1-23-28(12-7-13-30(23)26-10-4-3-5-11-26)21-39-29-15-14-27(19-35-33(2,22-36)32(37)38)31(17-29)40-20-25-9-6-8-24(16-25)18-34/h3-17,35-36H,19-22H2,1-2H3,(H,37,38)/t33-/m1/s1 ZAZUVDZYHXXZML-MGBGTMOVSA-N 363087 (R)-2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1023 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363087&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434946 401958548 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719172 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1 InChI=1S/C32H34N2O3/c1-24-29(14-9-15-31(24)27-12-7-4-8-13-27)23-36-30-17-16-28(21-33-18-19-34-25(2)35)32(20-30)37-22-26-10-5-3-6-11-26/h3-17,20,33H,18-19,21-23H2,1-2H3,(H,34,35) CBSWFDGWWLXNCF-UHFFFAOYSA-N 363088 N-(2-((2-(benzyloxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1024 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363088&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434952 401958549 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719173 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(C)c1 InChI=1S/C33H36N2O3/c1-24-9-7-10-27(19-24)22-38-33-20-31(16-15-29(33)21-34-17-18-35-26(3)36)37-23-30-13-8-14-32(25(30)2)28-11-5-4-6-12-28/h4-16,19-20,34H,17-18,21-23H2,1-3H3,(H,35,36) KIITXNPIODTMDQ-UHFFFAOYSA-N 363089 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((3-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1025 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363089&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435062 401958550 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719174 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCC(F)(F)F InChI=1S/C27H29F3N2O3/c1-19-23(9-6-10-25(19)21-7-4-3-5-8-21)17-34-24-12-11-22(16-31-13-14-32-20(2)33)26(15-24)35-18-27(28,29)30/h3-12,15,31H,13-14,16-18H2,1-2H3,(H,32,33) REZCPBAYQFFYNN-UHFFFAOYSA-N 363092 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(2,2,2-trifluoroethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1026 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363092&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434865 401958553 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719175 CCCOc1cc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O InChI=1S/C28H34N2O3/c1-4-17-32-28-18-26(14-13-24(28)19-29-15-16-30-22(3)31)33-20-25-11-8-12-27(21(25)2)23-9-6-5-7-10-23/h5-14,18,29H,4,15-17,19-20H2,1-3H3,(H,30,31) QMKASYRDGBRKOK-UHFFFAOYSA-N 363093 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-propoxybenzyl)amino)ethyl)acetamide::US9850225, Example 1027 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363093&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434808 401958554 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719176 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C#N InChI=1S/C33H33N3O3/c1-24-30(12-7-13-32(24)28-10-4-3-5-11-28)23-38-31-15-14-29(21-35-16-17-36-25(2)37)33(19-31)39-22-27-9-6-8-26(18-27)20-34/h3-15,18-19,35H,16-17,21-23H2,1-2H3,(H,36,37) QQMYSWBQHDRSNF-UHFFFAOYSA-N 363095 N-(2-((2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1028 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363095&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434740 401958556 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719177 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)C#N InChI=1S/C33H33N3O3/c1-24-30(9-6-10-32(24)28-7-4-3-5-8-28)23-38-31-16-15-29(21-35-17-18-36-25(2)37)33(19-31)39-22-27-13-11-26(20-34)12-14-27/h3-16,19,35H,17-18,21-23H2,1-2H3,(H,36,37) BYOVUNBXZRCZCM-UHFFFAOYSA-N 363096 N-(2-((2-((4-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1029 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363096&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434830 401958557 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719178 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCCO InChI=1S/C27H32N2O4/c1-20-24(9-6-10-26(20)22-7-4-3-5-8-22)19-33-25-12-11-23(27(17-25)32-16-15-30)18-28-13-14-29-21(2)31/h3-12,17,28,30H,13-16,18-19H2,1-2H3,(H,29,31) BTHNZGJBXUQWKF-UHFFFAOYSA-N 363097 N-(2-((2-(2-hydroxyethoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1030 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363097&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434734 401958558 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719179 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCC(N)=O InChI=1S/C27H31N3O4/c1-19-23(9-6-10-25(19)21-7-4-3-5-8-21)17-33-24-12-11-22(16-29-13-14-30-20(2)31)26(15-24)34-18-27(28)32/h3-12,15,29H,13-14,16-18H2,1-2H3,(H2,28,32)(H,30,31) JGUHUVVWIAWHRG-UHFFFAOYSA-N 363098 2-(2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)acetamide::US9850225, Example 1031 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363098&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434608 401958559 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719180 COC(=O)CCCCOc1cc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O InChI=1S/C31H38N2O5/c1-23-27(12-9-13-29(23)25-10-5-4-6-11-25)22-38-28-16-15-26(21-32-17-18-33-24(2)34)30(20-28)37-19-8-7-14-31(35)36-3/h4-6,9-13,15-16,20,32H,7-8,14,17-19,21-22H2,1-3H3,(H,33,34) TZSJUTPLTKHDLC-UHFFFAOYSA-N 363099 US9850225, Example 1032::methyl 5-(2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)pentanoate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363099&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434851 401958560 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719181 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCCc1ccccc1 InChI=1S/C33H36N2O3/c1-25-30(14-9-15-32(25)28-12-7-4-8-13-28)24-38-31-17-16-29(23-34-19-20-35-26(2)36)33(22-31)37-21-18-27-10-5-3-6-11-27/h3-17,22,34H,18-21,23-24H2,1-2H3,(H,35,36) ZBQBTXIZFWJPPB-UHFFFAOYSA-N 363100 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-phenethoxybenzyl)amino)ethyl)acetamide::US9850225, Example 1033 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363100&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435183 401958561 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719182 COC(=O)c1cccc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)c1 InChI=1S/C34H36N2O5/c1-24-30(13-8-14-32(24)27-10-5-4-6-11-27)23-40-31-16-15-29(21-35-17-18-36-25(2)37)33(20-31)41-22-26-9-7-12-28(19-26)34(38)39-3/h4-16,19-20,35H,17-18,21-23H2,1-3H3,(H,36,37) SXGOPXLZKCGDDB-UHFFFAOYSA-N 363101 US9850225, Example 1034::methyl 3-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)methyl)benzoate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363101&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434957 401958562 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719183 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCCCO InChI=1S/C28H34N2O4/c1-21-25(10-6-11-27(21)23-8-4-3-5-9-23)20-34-26-13-12-24(19-29-14-15-30-22(2)32)28(18-26)33-17-7-16-31/h3-6,8-13,18,29,31H,7,14-17,19-20H2,1-2H3,(H,30,32) XJDIKXBUDJMSBQ-UHFFFAOYSA-N 363102 N-(2-((2-(3-hydroxypropoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1035 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363102&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434789 401958563 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719184 COC(=O)CCCOc1cc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O InChI=1S/C30H36N2O5/c1-22-26(11-7-12-28(22)24-9-5-4-6-10-24)21-37-27-15-14-25(20-31-16-17-32-23(2)33)29(19-27)36-18-8-13-30(34)35-3/h4-7,9-12,14-15,19,31H,8,13,16-18,20-21H2,1-3H3,(H,32,33) ZAIZIBBKNSGNJX-UHFFFAOYSA-N 363103 US9850225, Example 1036::methyl 4-(2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)butanoate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363103&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434905 401958564 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719185 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(CO)c1 InChI=1S/C33H36N2O4/c1-24-30(12-7-13-32(24)28-10-4-3-5-11-28)23-38-31-15-14-29(20-34-16-17-35-25(2)37)33(19-31)39-22-27-9-6-8-26(18-27)21-36/h3-15,18-19,34,36H,16-17,20-23H2,1-2H3,(H,35,37) JRQOEDVWUKJFFQ-UHFFFAOYSA-N 363105 N-(2-((2-((3-(hydroxymethyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1037 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363105&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435006 401958566 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719186 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1CO InChI=1S/C33H36N2O4/c1-24-29(13-8-14-32(24)26-9-4-3-5-10-26)22-38-31-16-15-27(20-34-17-18-35-25(2)37)33(19-31)39-23-30-12-7-6-11-28(30)21-36/h3-16,19,34,36H,17-18,20-23H2,1-2H3,(H,35,37) CMUWBIGFHFUNLP-UHFFFAOYSA-N 363106 N-(2-((2-((2-(hydroxymethyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1038 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363106&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435184 401958567 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719187 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)C(N)=O InChI=1S/C33H35N3O4/c1-23-29(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-16-15-28(20-35-17-18-36-24(2)37)32(19-30)40-21-25-11-13-27(14-12-25)33(34)38/h3-16,19,35H,17-18,20-22H2,1-2H3,(H2,34,38)(H,36,37) FPBQLJOJJYMIKG-UHFFFAOYSA-N 363107 4-((2-((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)methyl)benzamide::US9850225, Example 1039 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363107&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434798 401958568 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719188 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)C(C)=O InChI=1S/C34H36N2O4/c1-24-31(10-7-11-33(24)29-8-5-4-6-9-29)23-39-32-17-16-30(21-35-18-19-36-26(3)38)34(20-32)40-22-27-12-14-28(15-13-27)25(2)37/h4-17,20,35H,18-19,21-23H2,1-3H3,(H,36,38) ULWDVAOWHHSDTR-UHFFFAOYSA-N 363108 N-(2-((2-((4-acetylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1040 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363108&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434888 401958569 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719189 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1S(C)(=O)=O InChI=1S/C33H36N2O5S/c1-24-28(13-9-14-31(24)26-10-5-4-6-11-26)22-39-30-17-16-27(21-34-18-19-35-25(2)36)32(20-30)40-23-29-12-7-8-15-33(29)41(3,37)38/h4-17,20,34H,18-19,21-23H2,1-3H3,(H,35,36) HCTMEJBBZUJPHI-UHFFFAOYSA-N 363109 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((2-(methylsulfonyl)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1041 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363109&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435032 401958570 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719190 COCCCOc1cc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O InChI=1S/C29H36N2O4/c1-22-26(11-7-12-28(22)24-9-5-4-6-10-24)21-35-27-14-13-25(20-30-15-16-31-23(2)32)29(19-27)34-18-8-17-33-3/h4-7,9-14,19,30H,8,15-18,20-21H2,1-3H3,(H,31,32) DPCRKUMNJKLYQY-UHFFFAOYSA-N 363110 N-(2-((2-(3-methoxypropoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1042 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363110&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434831 401958571 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719191 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)C(O)=O InChI=1S/C33H34N2O5/c1-23-29(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-16-15-28(20-34-17-18-35-24(2)36)32(19-30)40-21-25-11-13-27(14-12-25)33(37)38/h3-16,19,34H,17-18,20-22H2,1-2H3,(H,35,36)(H,37,38) ALGGADHWZKMJAV-UHFFFAOYSA-N 363111 4-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)methyl)benzoic acid::US9850225, Example 1043 Programmed cell death 1 ligand 1 Human 239 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363111&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434861 401958572 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719192 CCOc1cc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O InChI=1S/C27H32N2O3/c1-4-31-27-17-25(14-13-23(27)18-28-15-16-29-21(3)30)32-19-24-11-8-12-26(20(24)2)22-9-6-5-7-10-22/h5-14,17,28H,4,15-16,18-19H2,1-3H3,(H,29,30) DTITVLPZKXFOHV-UHFFFAOYSA-N 363112 N-(2-((2-ethoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1044 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363112&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434774 401958573 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719193 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1C InChI=1S/C33H36N2O3/c1-24-10-7-8-13-29(24)22-38-33-20-31(17-16-28(33)21-34-18-19-35-26(3)36)37-23-30-14-9-15-32(25(30)2)27-11-5-4-6-12-27/h4-17,20,34H,18-19,21-23H2,1-3H3,(H,35,36) IHAMOZROEBBLIN-UHFFFAOYSA-N 363113 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((2-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1045 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363113&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435157 401958574 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719194 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)C(C)(C)C InChI=1S/C36H42N2O3/c1-26-31(12-9-13-34(26)29-10-7-6-8-11-29)25-40-33-19-16-30(23-37-20-21-38-27(2)39)35(22-33)41-24-28-14-17-32(18-15-28)36(3,4)5/h6-19,22,37H,20-21,23-25H2,1-5H3,(H,38,39) FTPNWQHQTALBOX-UHFFFAOYSA-N 363114 N-(2-((2-((4-(tert-butyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1046 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363114&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435016 401958575 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719195 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(C)cc1 InChI=1S/C33H36N2O3/c1-24-12-14-27(15-13-24)22-38-33-20-31(17-16-29(33)21-34-18-19-35-26(3)36)37-23-30-10-7-11-32(25(30)2)28-8-5-4-6-9-28/h4-17,20,34H,18-19,21-23H2,1-3H3,(H,35,36) ZDWASYZDPWEZAT-UHFFFAOYSA-N 363115 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((4-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1047 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363115&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434960 401958576 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719196 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1F InChI=1S/C32H33FN2O3/c1-23-27(12-8-13-30(23)25-9-4-3-5-10-25)21-37-29-16-15-26(20-34-17-18-35-24(2)36)32(19-29)38-22-28-11-6-7-14-31(28)33/h3-16,19,34H,17-18,20-22H2,1-2H3,(H,35,36) DTGZYCPLURLVSW-UHFFFAOYSA-N 363116 N-(2-((2-((2-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1048 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363116&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435117 401958577 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719197 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1c(F)cccc1F InChI=1S/C32H32F2N2O3/c1-22-26(10-6-11-28(22)24-8-4-3-5-9-24)20-38-27-15-14-25(19-35-16-17-36-23(2)37)32(18-27)39-21-29-30(33)12-7-13-31(29)34/h3-15,18,35H,16-17,19-21H2,1-2H3,(H,36,37) MVPKQZAUZRLEAU-UHFFFAOYSA-N 363117 N-(2-((2-((2,6-difluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1049 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363117&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435139 401958578 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719198 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(F)c1 InChI=1S/C32H33FN2O3/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-37-30-15-14-27(20-34-16-17-35-24(2)36)32(19-30)38-21-25-8-6-12-29(33)18-25/h3-15,18-19,34H,16-17,20-22H2,1-2H3,(H,35,36) UAPBZBYXQOYBEA-UHFFFAOYSA-N 363118 N-(2-((2-((3-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1050 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363118&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435076 401958579 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719199 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C(F)(F)F InChI=1S/C33H33F3N2O3/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-40-30-15-14-27(20-37-16-17-38-24(2)39)32(19-30)41-21-25-8-6-12-29(18-25)33(34,35)36/h3-15,18-19,37H,16-17,20-22H2,1-2H3,(H,38,39) IQWRNVMSTQMKEW-UHFFFAOYSA-N 363119 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((3-(trifluoromethyl)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1051::US9850225, Example 1079 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363119&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435103 401958580 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719200 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)C(F)(F)F InChI=1S/C33H33F3N2O3/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-40-30-16-13-27(20-37-17-18-38-24(2)39)32(19-30)41-21-25-11-14-29(15-12-25)33(34,35)36/h3-16,19,37H,17-18,20-22H2,1-2H3,(H,38,39) GJSUIEHFNPKVDT-UHFFFAOYSA-N 363120 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((4-(trifluoromethyl)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1052 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363120&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434852 401958581 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719201 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1Cl InChI=1S/C32H33ClN2O3/c1-23-27(12-8-13-30(23)25-9-4-3-5-10-25)21-37-29-16-15-26(20-34-17-18-35-24(2)36)32(19-29)38-22-28-11-6-7-14-31(28)33/h3-16,19,34H,17-18,20-22H2,1-2H3,(H,35,36) BSQHZPOLXQGUCX-UHFFFAOYSA-N 363121 N-(2-((2-((2-chlorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1053 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363121&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434637 401958582 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719202 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(Cl)c1 InChI=1S/C32H33ClN2O3/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-37-30-15-14-27(20-34-16-17-35-24(2)36)32(19-30)38-21-25-8-6-12-29(33)18-25/h3-15,18-19,34H,16-17,20-22H2,1-2H3,(H,35,36) WSYZPNQQFNEOAC-UHFFFAOYSA-N 363122 N-(2-((2-((3-chlorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1054 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363122&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435119 401958583 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719203 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1C#N InChI=1S/C33H33N3O3/c1-24-29(13-8-14-32(24)26-9-4-3-5-10-26)22-38-31-16-15-28(21-35-17-18-36-25(2)37)33(19-31)39-23-30-12-7-6-11-27(30)20-34/h3-16,19,35H,17-18,21-23H2,1-2H3,(H,36,37) WZGBRFFQGIQDOQ-UHFFFAOYSA-N 363123 N-(2-((2-((2-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1055 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363123&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435164 401958584 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719204 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc2ccccc2c1 InChI=1S/C36H36N2O3/c1-26-33(13-8-14-35(26)30-10-4-3-5-11-30)25-40-34-18-17-32(23-37-19-20-38-27(2)39)36(22-34)41-24-28-15-16-29-9-6-7-12-31(29)21-28/h3-18,21-22,37H,19-20,23-25H2,1-2H3,(H,38,39) DQGGHYUHIDWYOV-UHFFFAOYSA-N 363124 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(naphthalen-2-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1056 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363124&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434626 401958585 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719205 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1[N+]([O-])=O InChI=1S/C32H33N3O5/c1-23-27(12-8-13-30(23)25-9-4-3-5-10-25)21-39-29-16-15-26(20-33-17-18-34-24(2)36)32(19-29)40-22-28-11-6-7-14-31(28)35(37)38/h3-16,19,33H,17-18,20-22H2,1-2H3,(H,34,36) YSQGUVJPJSZUFW-UHFFFAOYSA-N 363125 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((2-nitrobenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1057 Programmed cell death 1 ligand 1 Human 986 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363125&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434819 401958586 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719206 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)[N+]([O-])=O InChI=1S/C32H33N3O5/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-16-13-27(20-33-17-18-34-24(2)36)32(19-30)40-21-25-11-14-29(15-12-25)35(37)38/h3-16,19,33H,17-18,20-22H2,1-2H3,(H,34,36) QANFZKQLVRFPQT-UHFFFAOYSA-N 363126 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((4-nitrobenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1058 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363126&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434658 401958587 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719207 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(F)c(F)c1 InChI=1S/C32H32F2N2O3/c1-22-27(9-6-10-29(22)25-7-4-3-5-8-25)21-38-28-13-12-26(19-35-15-16-36-23(2)37)32(18-28)39-20-24-11-14-30(33)31(34)17-24/h3-14,17-18,35H,15-16,19-21H2,1-2H3,(H,36,37) MYSAHLUEKZXQMR-UHFFFAOYSA-N 363127 N-(2-((2-((3,4-difluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1059 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363127&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434616 401958588 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719208 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(F)ccc1F InChI=1S/C32H32F2N2O3/c1-22-26(9-6-10-30(22)24-7-4-3-5-8-24)20-38-29-13-11-25(19-35-15-16-36-23(2)37)32(18-29)39-21-27-17-28(33)12-14-31(27)34/h3-14,17-18,35H,15-16,19-21H2,1-2H3,(H,36,37) RDEOIVWDOQULJD-UHFFFAOYSA-N 363128 N-(2-((2-((2,5-difluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1060 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363128&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434948 401958589 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719209 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C34H32F6N2O3/c1-22-27(9-6-10-31(22)25-7-4-3-5-8-25)21-44-30-12-11-26(19-41-13-14-42-23(2)43)32(18-30)45-20-24-15-28(33(35,36)37)17-29(16-24)34(38,39)40/h3-12,15-18,41H,13-14,19-21H2,1-2H3,(H,42,43) WAEODEBPNGNSIX-UHFFFAOYSA-N 363129 N-(2-((2-((3,5-bis(trifluoromethyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1061 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363129&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434603 401958590 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719210 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(F)cc(F)c1 InChI=1S/C32H32F2N2O3/c1-22-27(9-6-10-31(22)25-7-4-3-5-8-25)21-38-30-12-11-26(19-35-13-14-36-23(2)37)32(18-30)39-20-24-15-28(33)17-29(34)16-24/h3-12,15-18,35H,13-14,19-21H2,1-2H3,(H,36,37) OAHJCLACCXHERC-UHFFFAOYSA-N 363130 N-(2-((2-((3,5-difluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1062 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363130&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435000 401958591 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719211 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc2ccccc12 InChI=1S/C36H36N2O3/c1-26-31(14-9-17-34(26)28-10-4-3-5-11-28)24-40-33-19-18-30(23-37-20-21-38-27(2)39)36(22-33)41-25-32-15-8-13-29-12-6-7-16-35(29)32/h3-19,22,37H,20-21,23-25H2,1-2H3,(H,38,39) XFLQIZVNYKHRNY-UHFFFAOYSA-N 363131 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(naphthalen-1-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1063 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363131&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434651 401958592 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719212 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(F)cc1F InChI=1S/C32H32F2N2O3/c1-22-26(9-6-10-30(22)24-7-4-3-5-8-24)20-38-29-14-12-25(19-35-15-16-36-23(2)37)32(18-29)39-21-27-11-13-28(33)17-31(27)34/h3-14,17-18,35H,15-16,19-21H2,1-2H3,(H,36,37) LAUQOZIYNZDBLY-UHFFFAOYSA-N 363132 N-(2-((2-((2,4-difluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1064 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363132&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434827 401958593 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719213 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(C)cc(C)c1 InChI=1S/C34H38N2O3/c1-24-17-25(2)19-28(18-24)22-39-34-20-32(14-13-30(34)21-35-15-16-36-27(4)37)38-23-31-11-8-12-33(26(31)3)29-9-6-5-7-10-29/h5-14,17-20,35H,15-16,21-23H2,1-4H3,(H,36,37) IDPVLLDUJMEBDX-UHFFFAOYSA-N 363133 N-(2-((2-((3,5-dimethylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1065 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363133&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434641 401958594 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719214 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1C(F)(F)F InChI=1S/C33H33F3N2O3/c1-23-27(12-8-13-30(23)25-9-4-3-5-10-25)21-40-29-16-15-26(20-37-17-18-38-24(2)39)32(19-29)41-22-28-11-6-7-14-31(28)33(34,35)36/h3-16,19,37H,17-18,20-22H2,1-2H3,(H,38,39) NZTBDWBOGIBWJG-UHFFFAOYSA-N 363134 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((2-(trifluoromethyl)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1066 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363134&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434841 401958595 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719215 COC(=O)c1ccc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)cc1 InChI=1S/C34H36N2O5/c1-24-30(10-7-11-32(24)27-8-5-4-6-9-27)23-40-31-17-16-29(21-35-18-19-36-25(2)37)33(20-31)41-22-26-12-14-28(15-13-26)34(38)39-3/h4-17,20,35H,18-19,21-23H2,1-3H3,(H,36,37) CVUFWVJMAGBHPN-UHFFFAOYSA-N 363135 US9850225, Example 1067::methyl 4-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenoxy)methyl)benzoate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363135&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434725 401958596 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719216 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(Cl)cc1 InChI=1S/C32H33ClN2O3/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-37-30-16-13-27(20-34-17-18-35-24(2)36)32(19-30)38-21-25-11-14-29(33)15-12-25/h3-16,19,34H,17-18,20-22H2,1-2H3,(H,35,36) TWHPAIHCZSPWOJ-UHFFFAOYSA-N 363136 N-(2-((2-((4-chlorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1068 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363136&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435163 401958597 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719217 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(Cl)c(Cl)c1 InChI=1S/C32H32Cl2N2O3/c1-22-27(9-6-10-29(22)25-7-4-3-5-8-25)21-38-28-13-12-26(19-35-15-16-36-23(2)37)32(18-28)39-20-24-11-14-30(33)31(34)17-24/h3-14,17-18,35H,15-16,19-21H2,1-2H3,(H,36,37) ZSYCZDSMQAJXQQ-UHFFFAOYSA-N 363137 N-(2-((2-((3,4-dichlorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1069 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363137&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434854 401958598 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719218 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(C)c1F InChI=1S/C33H35FN2O3/c1-23-9-7-13-29(33(23)34)22-39-32-19-30(16-15-27(32)20-35-17-18-36-25(3)37)38-21-28-12-8-14-31(24(28)2)26-10-5-4-6-11-26/h4-16,19,35H,17-18,20-22H2,1-3H3,(H,36,37) NCIUVLVMNXATBE-UHFFFAOYSA-N 363138 N-(2-((2-((2-fluoro-3-methylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1070 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363138&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434640 401958599 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719219 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(F)c1F InChI=1S/C32H32F2N2O3/c1-22-26(10-6-12-29(22)24-8-4-3-5-9-24)20-38-28-15-14-25(19-35-16-17-36-23(2)37)31(18-28)39-21-27-11-7-13-30(33)32(27)34/h3-15,18,35H,16-17,19-21H2,1-2H3,(H,36,37) CWEWNOOYIBAAIE-UHFFFAOYSA-N 363139 N-(2-((2-((2,3-difluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1071 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363139&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434779 401958600 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719220 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(Cl)c1F InChI=1S/C32H32ClFN2O3/c1-22-26(10-6-12-29(22)24-8-4-3-5-9-24)20-38-28-15-14-25(19-35-16-17-36-23(2)37)31(18-28)39-21-27-11-7-13-30(33)32(27)34/h3-15,18,35H,16-17,19-21H2,1-2H3,(H,36,37) RJORFZPFCXDOFG-UHFFFAOYSA-N 363140 N-(2-((2-((3-chloro-2-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1072 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363140&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435153 401958601 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719221 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C(=O)c1ccccc1 InChI=1S/C39H38N2O4/c1-28-35(17-10-18-37(28)31-12-5-3-6-13-31)27-44-36-20-19-34(25-40-21-22-41-29(2)42)38(24-36)45-26-30-11-9-16-33(23-30)39(43)32-14-7-4-8-15-32/h3-20,23-24,40H,21-22,25-27H2,1-2H3,(H,41,42) ZIVKDJUVHAOKIE-UHFFFAOYSA-N 363141 N-(2-((2-((3-benzoylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1073 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363141&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434638 401958602 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719222 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc2cccnc12 InChI=1S/C35H35N3O3/c1-25-30(12-7-15-33(25)27-9-4-3-5-10-27)23-40-32-17-16-29(22-36-19-20-37-26(2)39)34(21-32)41-24-31-13-6-11-28-14-8-18-38-35(28)31/h3-18,21,36H,19-20,22-24H2,1-2H3,(H,37,39) AFMLNEYUEVBVEC-UHFFFAOYSA-N 363142 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(quinolin-8-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1074 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363142&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434811 401958603 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719223 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(F)cc1 InChI=1S/C32H33FN2O3/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-37-30-16-13-27(20-34-17-18-35-24(2)36)32(19-30)38-21-25-11-14-29(33)15-12-25/h3-16,19,34H,17-18,20-22H2,1-2H3,(H,35,36) OUQWJRLSRXSJIE-UHFFFAOYSA-N 363143 N-(2-((2-((4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1075 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363143&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435175 401958604 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719224 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)[N+]([O-])=O InChI=1S/C32H33N3O5/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-39-30-15-14-27(20-33-16-17-34-24(2)36)32(19-30)40-21-25-8-6-12-29(18-25)35(37)38/h3-15,18-19,33H,16-17,20-22H2,1-2H3,(H,34,36) NHBHWBXXXHLNJC-UHFFFAOYSA-N 363144 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(3-nitrobenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1076 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363144&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434976 401958605 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719225 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(Oc2ccccc2F)c1 InChI=1S/C38H37FN2O4/c1-27-32(13-9-15-35(27)30-11-4-3-5-12-30)26-43-33-19-18-31(24-40-20-21-41-28(2)42)38(23-33)44-25-29-10-8-14-34(22-29)45-37-17-7-6-16-36(37)39/h3-19,22-23,40H,20-21,24-26H2,1-2H3,(H,41,42) QRYQMLVDDDFMNI-UHFFFAOYSA-N 363145 N-(2-((2-((3-(2-fluorophenoxyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1077 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363145&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434778 401958606 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719226 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(Oc2ccc(F)cc2)c1 InChI=1S/C38H37FN2O4/c1-27-32(11-7-13-37(27)30-9-4-3-5-10-30)26-43-35-17-14-31(24-40-20-21-41-28(2)42)38(23-35)44-25-29-8-6-12-36(22-29)45-34-18-15-33(39)16-19-34/h3-19,22-23,40H,20-21,24-26H2,1-2H3,(H,41,42) VSYQCMILBWUSLY-UHFFFAOYSA-N 363146 N-(2-((2-((3-(4-fluorophenoxyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1078 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363146&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435059 401958607 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719227 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C(F)(F)F InChI=1S/C33H33F3N2O3/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-40-30-15-14-27(20-37-16-17-38-24(2)39)32(19-30)41-21-25-8-6-12-29(18-25)33(34,35)36/h3-15,18-19,37H,16-17,20-22H2,1-2H3,(H,38,39) IQWRNVMSTQMKEW-UHFFFAOYSA-N 363119 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((3-(trifluoromethyl)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1051::US9850225, Example 1079 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363119&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435103 401958580 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719228 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(ccc1F)C(F)(F)F InChI=1S/C33H32F4N2O3/c1-22-26(9-6-10-30(22)24-7-4-3-5-8-24)20-41-29-13-11-25(19-38-15-16-39-23(2)40)32(18-29)42-21-27-17-28(33(35,36)37)12-14-31(27)34/h3-14,17-18,38H,15-16,19-21H2,1-2H3,(H,39,40) GFKPZTVXKNNZAV-UHFFFAOYSA-N 363148 N-(2-((2-((2-fluoro-5-(trifluoromethyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1080 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363148&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434625 401958608 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719229 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(F)cc(c1)C(F)(F)F InChI=1S/C33H32F4N2O3/c1-22-27(9-6-10-31(22)25-7-4-3-5-8-25)21-41-30-12-11-26(19-38-13-14-39-23(2)40)32(18-30)42-20-24-15-28(33(35,36)37)17-29(34)16-24/h3-12,15-18,38H,13-14,19-21H2,1-2H3,(H,39,40) ZCPCFSNKEFFTAY-UHFFFAOYSA-N 363149 N-(2-((2-((3-fluoro-5-(trifluoromethyl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1081 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363149&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434959 401958609 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719230 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(OC(F)(F)F)c1 InChI=1S/C33H33F3N2O4/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-40-29-15-14-27(20-37-16-17-38-24(2)39)32(19-29)41-21-25-8-6-12-30(18-25)42-33(34,35)36/h3-15,18-19,37H,16-17,20-22H2,1-2H3,(H,38,39) CKBXTSHHVBMSGJ-UHFFFAOYSA-N 363150 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((3-(trifluoromethoxy)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1082 Programmed cell death 1 ligand 1 Human 828 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363150&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434586 401958610 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719231 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc2nc(cc(Cl)c2c1)C(F)(F)F InChI=1S/C36H33ClF3N3O3/c1-23-28(9-6-10-30(23)26-7-4-3-5-8-26)22-45-29-13-12-27(20-41-15-16-42-24(2)44)34(18-29)46-21-25-11-14-33-31(17-25)32(37)19-35(43-33)36(38,39)40/h3-14,17-19,41H,15-16,20-22H2,1-2H3,(H,42,44) HEHQIVMEFNFPSB-UHFFFAOYSA-N 363151 N-(2-((2-((4-chloro-2-(trifluoromethyl)quinolin-6-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1083 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363151&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435105 401958611 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719232 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)S(C)(=O)=O InChI=1S/C33H36N2O5S/c1-24-29(10-7-11-32(24)27-8-5-4-6-9-27)23-39-30-15-14-28(21-34-18-19-35-25(2)36)33(20-30)40-22-26-12-16-31(17-13-26)41(3,37)38/h4-17,20,34H,18-19,21-23H2,1-3H3,(H,35,36) GUULFLILYNFJRL-UHFFFAOYSA-N 363152 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((4-(methylsulfonyl)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1084 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363152&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435142 401958612 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719233 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1OC(F)F InChI=1S/C33H34F2N2O4/c1-23-27(12-8-13-30(23)25-9-4-3-5-10-25)21-39-29-16-15-26(20-36-17-18-37-24(2)38)32(19-29)40-22-28-11-6-7-14-31(28)41-33(34)35/h3-16,19,33,36H,17-18,20-22H2,1-2H3,(H,37,38) AYOIIIDKVDBIAI-UHFFFAOYSA-N 363153 N-(2-((2-((2-(difluoromethoxy)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1085 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363153&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434665 401958613 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719234 COc1cccc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)c1 InChI=1S/C33H36N2O4/c1-24-29(12-8-14-32(24)27-10-5-4-6-11-27)23-38-31-16-15-28(21-34-17-18-35-25(2)36)33(20-31)39-22-26-9-7-13-30(19-26)37-3/h4-16,19-20,34H,17-18,21-23H2,1-3H3,(H,35,36) OSWXJOXSWJTPES-UHFFFAOYSA-N 363155 N-(2-((2-((3-methoxybenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1086 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363155&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435202 401958615 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719235 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccccc1OC(F)(F)F InChI=1S/C33H33F3N2O4/c1-23-27(12-8-13-30(23)25-9-4-3-5-10-25)21-40-29-16-15-26(20-37-17-18-38-24(2)39)32(19-29)41-22-28-11-6-7-14-31(28)42-33(34,35)36/h3-16,19,37H,17-18,20-22H2,1-2H3,(H,38,39) BRTRYYZOTIDGPJ-UHFFFAOYSA-N 363156 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((2-(trifluoromethoxy)benzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1087 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363156&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435191 401958616 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719236 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(OC(F)F)cc1 InChI=1S/C33H34F2N2O4/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-16-13-27(20-36-17-18-37-24(2)38)32(19-30)40-21-25-11-14-29(15-12-25)41-33(34)35/h3-16,19,33,36H,17-18,20-22H2,1-2H3,(H,37,38) HOZXGOWDMUTSCY-UHFFFAOYSA-N 363157 N-(2-((2-((4-(difluoromethoxy)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1088 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363157&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435206 401958617 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719237 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(cc1)-c1ccccc1C#N InChI=1S/C39H37N3O3/c1-28-35(12-8-14-37(28)31-9-4-3-5-10-31)27-44-36-20-19-34(25-41-21-22-42-29(2)43)39(23-36)45-26-30-15-17-32(18-16-30)38-13-7-6-11-33(38)24-40/h3-20,23,41H,21-22,25-27H2,1-2H3,(H,42,43) MHMSJHONTCFGDQ-UHFFFAOYSA-N 363158 N-(2-((2-((2′-cyano-[1,1′-biphenyl]-4-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1089 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363158&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434981 401958618 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719238 COc1ccc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)cc1 InChI=1S/C33H36N2O4/c1-24-29(10-7-11-32(24)27-8-5-4-6-9-27)23-38-31-17-14-28(21-34-18-19-35-25(2)36)33(20-31)39-22-26-12-15-30(37-3)16-13-26/h4-17,20,34H,18-19,21-23H2,1-3H3,(H,35,36) JIGHGIZDVWFBIL-UHFFFAOYSA-N 363159 N-(2-((2-((4-methoxybenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1090 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363159&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435045 401958619 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719239 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(F)cc(Cl)c1 InChI=1S/C32H32ClFN2O3/c1-22-27(9-6-10-31(22)25-7-4-3-5-8-25)21-38-30-12-11-26(19-35-13-14-36-23(2)37)32(18-30)39-20-24-15-28(33)17-29(34)16-24/h3-12,15-18,35H,13-14,19-21H2,1-2H3,(H,36,37) WAOZWJPFEZYQNI-UHFFFAOYSA-N 363160 N-(2-((2-((3-chloro-5-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1091 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363160&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435173 401958620 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719240 COc1ccc(F)c(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)c1F InChI=1S/C33H34F2N2O4/c1-22-26(10-7-11-28(22)24-8-5-4-6-9-24)20-40-27-13-12-25(19-36-16-17-37-23(2)38)32(18-27)41-21-29-30(34)14-15-31(39-3)33(29)35/h4-15,18,36H,16-17,19-21H2,1-3H3,(H,37,38) UUPQKLGUUOHUDF-UHFFFAOYSA-N 363161 N-(2-((2-((2,6-difluoro-3-methoxybenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1092 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363161&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434600 401958621 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719241 COc1cc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)ccc1F InChI=1S/C33H35FN2O4/c1-23-28(10-7-11-30(23)26-8-5-4-6-9-26)22-39-29-14-13-27(20-35-16-17-36-24(2)37)32(19-29)40-21-25-12-15-31(34)33(18-25)38-3/h4-15,18-19,35H,16-17,20-22H2,1-3H3,(H,36,37) AUWSZAWNAXWDMV-UHFFFAOYSA-N 363162 N-(2-((2-((4-fluoro-3-methoxybenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1093 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363162&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434842 401958622 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719242 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(C)ccc1F InChI=1S/C33H35FN2O3/c1-23-12-15-32(34)29(18-23)22-39-33-19-30(14-13-27(33)20-35-16-17-36-25(3)37)38-21-28-10-7-11-31(24(28)2)26-8-5-4-6-9-26/h4-15,18-19,35H,16-17,20-22H2,1-3H3,(H,36,37) YKWKCEUCDZOXOD-UHFFFAOYSA-N 363163 N-(2-((2-((2-fluoro-5-methylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1094 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363163&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435126 401958623 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719243 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(ccc1F)C#N InChI=1S/C33H32FN3O3/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)21-39-30-13-12-27(20-36-15-16-37-24(2)38)33(18-30)40-22-29-17-25(19-35)11-14-32(29)34/h3-14,17-18,36H,15-16,20-22H2,1-2H3,(H,37,38) HXWGINOTIZXQLF-UHFFFAOYSA-N 363165 N-(2-((2-((5-cyano-2-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1095 Programmed cell death 1 ligand 1 Human 81.2 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363165&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434701 401958625 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719244 COc1cc(F)cc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)c1 InChI=1S/C33H35FN2O4/c1-23-28(10-7-11-32(23)26-8-5-4-6-9-26)22-39-30-13-12-27(20-35-14-15-36-24(2)37)33(19-30)40-21-25-16-29(34)18-31(17-25)38-3/h4-13,16-19,35H,14-15,20-22H2,1-3H3,(H,36,37) CDWIPXCHICZOHS-UHFFFAOYSA-N 363166 N-(2-((2-((3-fluoro-5-methoxybenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1096 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363166&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435192 401958626 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719245 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(Br)cc1C#N InChI=1S/C33H32BrN3O3/c1-23-27(9-6-10-32(23)25-7-4-3-5-8-25)21-39-31-14-12-26(20-36-15-16-37-24(2)38)33(18-31)40-22-28-11-13-30(34)17-29(28)19-35/h3-14,17-18,36H,15-16,20-22H2,1-2H3,(H,37,38) SXWZPLJKDAZMRR-UHFFFAOYSA-N 363167 N-(2-((2-((4-bromo-2-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1097 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363167&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434954 401958627 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719246 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc2[nH]ncc2c1 InChI=1S/C33H34N4O3/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-13-12-27(19-34-15-16-35-24(2)38)33(18-30)40-21-25-11-14-32-29(17-25)20-36-37-32/h3-14,17-18,20,34H,15-16,19,21-22H2,1-2H3,(H,35,38)(H,36,37) SWNSGEXWAORABD-UHFFFAOYSA-N 363168 N-(2-((2-((1H-indazol-5-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1098 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363168&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434644 401958628 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719247 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc2n(ncc2c1)C1CCCCO1 InChI=1S/C38H42N4O4/c1-27-32(11-8-12-35(27)30-9-4-3-5-10-30)26-45-34-16-15-31(23-39-18-19-40-28(2)43)37(22-34)46-25-29-14-17-36-33(21-29)24-41-42(36)38-13-6-7-20-44-38/h3-5,8-12,14-17,21-22,24,38-39H,6-7,13,18-20,23,25-26H2,1-2H3,(H,40,43) WZKULHYRNSVCOF-UHFFFAOYSA-N 363169 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1099 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363169&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435118 401958629 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719248 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccncn1 InChI=1S/C30H32N4O3/c1-22-26(9-6-10-29(22)24-7-4-3-5-8-24)19-36-28-12-11-25(18-31-15-16-33-23(2)35)30(17-28)37-20-27-13-14-32-21-34-27/h3-14,17,21,31H,15-16,18-20H2,1-2H3,(H,33,35) NBBBGSCNQRNZDY-UHFFFAOYSA-N 363170 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(pyrimidin-4-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1100 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363170&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435030 401958630 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719249 COC(=O)Cc1cccc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)c1 InChI=1S/C35H38N2O5/c1-25-31(13-8-14-33(25)29-11-5-4-6-12-29)24-41-32-16-15-30(22-36-17-18-37-26(2)38)34(21-32)42-23-28-10-7-9-27(19-28)20-35(39)40-3/h4-16,19,21,36H,17-18,20,22-24H2,1-3H3,(H,37,38) OQJDHDGKLHDVGJ-UHFFFAOYSA-N 363171 US9850225, Example 1101::methyl 2-(3-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)phenoxy)methyl)phenyl)acetate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363171&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435028 401958631 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719250 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc2cn[nH]c2c1 InChI=1S/C33H34N4O3/c1-23-29(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-14-13-28(19-34-15-16-35-24(2)38)33(18-30)40-21-25-11-12-27-20-36-37-32(27)17-25/h3-14,17-18,20,34H,15-16,19,21-22H2,1-2H3,(H,35,38)(H,36,37) CJNWYQNVWUCPDC-UHFFFAOYSA-N 363172 N-(2-((2-((1H-indazol-6-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1102 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363172&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434894 401958632 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719251 COC(=O)c1ccc(F)c(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)c1 InChI=1S/C34H35FN2O5/c1-23-28(10-7-11-31(23)25-8-5-4-6-9-25)21-41-30-14-12-27(20-36-16-17-37-24(2)38)33(19-30)42-22-29-18-26(34(39)40-3)13-15-32(29)35/h4-15,18-19,36H,16-17,20-22H2,1-3H3,(H,37,38) AFMJWNSKRLXUDC-UHFFFAOYSA-N 363173 US9850225, Example 1103::methyl 3-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)phenoxy)methyl)-4-fluorobenzoate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363173&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435133 401958633 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719252 CC(=O)NCCNCc1ccc(OCc2cccc(-c3ccccc3)c2C)cc1OCc1noc(C)n1 InChI=1S/C29H32N4O4/c1-20-25(10-7-11-27(20)23-8-5-4-6-9-23)18-35-26-13-12-24(17-30-14-15-31-21(2)34)28(16-26)36-19-29-32-22(3)37-33-29/h4-13,16,30H,14-15,17-19H2,1-3H3,(H,31,34) CARFFZOYUWRYRN-UHFFFAOYSA-N 363175 N-(2-((2-((5-methyl-1,2,4-oxadiazol-3-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1104::US9850225, Example 1115 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363175&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435125 401958635 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719253 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)C(=O)OC(C)(C)C InChI=1S/C37H42N2O5/c1-26-32(15-10-16-34(26)29-12-7-6-8-13-29)25-42-33-18-17-31(23-38-19-20-39-27(2)40)35(22-33)43-24-28-11-9-14-30(21-28)36(41)44-37(3,4)5/h6-18,21-22,38H,19-20,23-25H2,1-5H3,(H,39,40) QFUDFLGRWLSCLK-UHFFFAOYSA-N 363176 US9850225, Example 1105::tert-butyl 3-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)phenoxy)methyl)benzoate Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363176&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434643 401958636 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719254 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(F)cc(OC(F)(F)F)c1 InChI=1S/C33H32F4N2O4/c1-22-27(9-6-10-31(22)25-7-4-3-5-8-25)21-41-29-12-11-26(19-38-13-14-39-23(2)40)32(18-29)42-20-24-15-28(34)17-30(16-24)43-33(35,36)37/h3-12,15-18,38H,13-14,19-21H2,1-2H3,(H,39,40) SUFOTEULWPQKSO-UHFFFAOYSA-N 363177 N-(2-((2-((3-fluoro-5-(trifluoromethoxy)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1106 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363177&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434860 401958637 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719255 COc1cc(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CNCCNC(C)=O)cc(OC)c1 InChI=1S/C34H38N2O5/c1-24-29(11-8-12-33(24)27-9-6-5-7-10-27)23-40-30-14-13-28(21-35-15-16-36-25(2)37)34(20-30)41-22-26-17-31(38-3)19-32(18-26)39-4/h5-14,17-20,35H,15-16,21-23H2,1-4H3,(H,36,37) QTCDZVPIKSSXQL-UHFFFAOYSA-N 363178 N-(2-((2-((3,5-dimethoxybenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy benzyl)amino)ethyl)acetamide::US9850225, Example 1107 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363178&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434877 401958638 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719256 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(F)c(C)c1 InChI=1S/C33H35FN2O3/c1-23-18-26(12-15-32(23)34)21-39-33-19-30(14-13-28(33)20-35-16-17-36-25(3)37)38-22-29-10-7-11-31(24(29)2)27-8-5-4-6-9-27/h4-15,18-19,35H,16-17,20-22H2,1-3H3,(H,36,37) SKNDYCBSEKYUKR-UHFFFAOYSA-N 363179 N-(2-((2-((4-fluoro-3-methylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1108 Programmed cell death 1 ligand 1 Human 624 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363179&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435099 401958639 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719257 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(Cl)ccc1F InChI=1S/C32H32ClFN2O3/c1-22-26(9-6-10-30(22)24-7-4-3-5-8-24)20-38-29-13-11-25(19-35-15-16-36-23(2)37)32(18-29)39-21-27-17-28(33)12-14-31(27)34/h3-14,17-18,35H,15-16,19-21H2,1-2H3,(H,36,37) GVVBOQYZIZXGDH-UHFFFAOYSA-N 363180 N-(2-((2-((5-chloro-2-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy benzyl)amino)ethyl)acetamide::US9850225, Example 1109 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363180&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435186 401958640 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719258 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(F)c(Cl)c1 InChI=1S/C32H32ClFN2O3/c1-22-27(9-6-10-29(22)25-7-4-3-5-8-25)21-38-28-13-12-26(19-35-15-16-36-23(2)37)32(18-28)39-20-24-11-14-31(34)30(33)17-24/h3-14,17-18,35H,15-16,19-21H2,1-2H3,(H,36,37) JKGOQGOSOQLOST-UHFFFAOYSA-N 363181 N-(2-((2-((3-chloro-4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1110 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363181&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434784 401958641 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719259 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccncc1 InChI=1S/C31H33N3O3/c1-23-28(9-6-10-30(23)26-7-4-3-5-8-26)22-36-29-12-11-27(20-33-17-18-34-24(2)35)31(19-29)37-21-25-13-15-32-16-14-25/h3-16,19,33H,17-18,20-22H2,1-2H3,(H,34,35) YAKGGFKSZZHAFG-UHFFFAOYSA-N 363182 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(pyridin-4-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1111 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363182&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435174 401958642 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719260 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(c1)-n1cccc1 InChI=1S/C36H37N3O3/c1-27-32(13-9-15-35(27)30-11-4-3-5-12-30)26-41-34-17-16-31(24-37-18-19-38-28(2)40)36(23-34)42-25-29-10-8-14-33(22-29)39-20-6-7-21-39/h3-17,20-23,37H,18-19,24-26H2,1-2H3,(H,38,40) HYJMNHDJXNEGPM-UHFFFAOYSA-N 363183 N-(2-((2-((3-(1H-pyrrol-1-yl)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1112 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363183&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435207 401958643 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719261 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cc(C)cc(F)c1 InChI=1S/C33H35FN2O3/c1-23-16-26(18-30(34)17-23)21-39-33-19-31(13-12-28(33)20-35-14-15-36-25(3)37)38-22-29-10-7-11-32(24(29)2)27-8-5-4-6-9-27/h4-13,16-19,35H,14-15,20-22H2,1-3H3,(H,36,37) SISXNNMAKOWTMO-UHFFFAOYSA-N 363184 N-(2-((2-((3-fluoro-5-methylbenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1113 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363184&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434956 401958644 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719262 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1ccc(F)c(c1)C#N InChI=1S/C33H32FN3O3/c1-23-28(9-6-10-31(23)26-7-4-3-5-8-26)22-39-30-13-12-27(20-36-15-16-37-24(2)38)33(18-30)40-21-25-11-14-32(34)29(17-25)19-35/h3-14,17-18,36H,15-16,20-22H2,1-2H3,(H,37,38) FMKLYRXQXGEBPC-UHFFFAOYSA-N 363185 N-(2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1114 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363185&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434998 401958645 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719263 CC(=O)NCCNCc1ccc(OCc2cccc(-c3ccccc3)c2C)cc1OCc1noc(C)n1 InChI=1S/C29H32N4O4/c1-20-25(10-7-11-27(20)23-8-5-4-6-9-23)18-35-26-13-12-24(17-30-14-15-31-21(2)34)28(16-26)36-19-29-32-22(3)37-33-29/h4-13,16,30H,14-15,17-19H2,1-3H3,(H,31,34) CARFFZOYUWRYRN-UHFFFAOYSA-N 363175 N-(2-((2-((5-methyl-1,2,4-oxadiazol-3-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1104::US9850225, Example 1115 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363175&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435125 401958635 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719264 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(OC(F)F)c1 InChI=1S/C33H34F2N2O4/c1-23-28(11-7-13-31(23)26-9-4-3-5-10-26)22-39-29-15-14-27(20-36-16-17-37-24(2)38)32(19-29)40-21-25-8-6-12-30(18-25)41-33(34)35/h3-15,18-19,33,36H,16-17,20-22H2,1-2H3,(H,37,38) LXOXJNFPVXQOEH-UHFFFAOYSA-N 363187 N-(2-((2-((3-(difluoromethoxy)benzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1116 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363187&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434716 401958646 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719265 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccnc1 InChI=1S/C31H33N3O3/c1-23-28(11-6-12-30(23)26-9-4-3-5-10-26)22-36-29-14-13-27(20-33-16-17-34-24(2)35)31(18-29)37-21-25-8-7-15-32-19-25/h3-15,18-19,33H,16-17,20-22H2,1-2H3,(H,34,35) JIUFAZPXZJZKRP-UHFFFAOYSA-N 363188 N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-(pyridin-3-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1117 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363188&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435158 401958647 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719266 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1nccc2ccccc12 InChI=1S/C35H35N3O3/c1-25-30(12-8-14-32(25)27-9-4-3-5-10-27)23-40-31-16-15-29(22-36-19-20-37-26(2)39)35(21-31)41-24-34-33-13-7-6-11-28(33)17-18-38-34/h3-18,21,36H,19-20,22-24H2,1-2H3,(H,37,39) PUEFACRXJRVXSI-UHFFFAOYSA-N 363189 N-(2-((2-(isoquinolin-1-ylmethoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1118 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363189&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434873 401958648 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719267 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OCc1cccc(NC(=O)OC(C)(C)C)c1 InChI=1S/C37H43N3O5/c1-26-31(14-10-16-34(26)29-12-7-6-8-13-29)25-43-33-18-17-30(23-38-19-20-39-27(2)41)35(22-33)44-24-28-11-9-15-32(21-28)40-36(42)45-37(3,4)5/h6-18,21-22,38H,19-20,23-25H2,1-5H3,(H,39,41)(H,40,42) UZNMYQNLLPGZLO-UHFFFAOYSA-N 363190 US9850225, Example 1119::tert-butyl (3-((2-(((2-acetamidoethyl)amino)methyl)-5-((2-methyl-[1,1′-biphenyl]-3-yl) methoxy)phenoxy)methyl)phenyl)carbamate Programmed cell death 1 ligand 1 Human 14250 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363190&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118445916 401958649 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719268 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)cc1OC[C@@H]1CCC(=O)N1 InChI=1S/C30H35N3O4/c1-21-25(9-6-10-28(21)23-7-4-3-5-8-23)19-36-27-13-11-24(18-31-15-16-32-22(2)34)29(17-27)37-20-26-12-14-30(35)33-26/h3-11,13,17,26,31H,12,14-16,18-20H2,1-2H3,(H,32,34)(H,33,35)/t26-/m0/s1 NWOUVWYQHYZUBR-SANMLTNESA-N 363191 (S)—N-(2-((4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)-2-((5-oxopyrrolidin-2-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1120 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363191&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434672 401958650 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719269 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-23-28(6-3-7-31(23)26-9-11-32-34(15-26)42-13-12-41-32)22-43-30-10-8-27(19-37-20-29(38)16-35(39)40)33(17-30)44-21-25-5-2-4-24(14-25)18-36/h2-11,14-15,17,29,37-38H,12-13,16,19-22H2,1H3,(H,39,40)/t29-/m0/s1 QFGUWQVTCLTWGU-LJAQVGFWSA-N 363192 (S)-4-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxybutanoic acid::US9850225, Example 1121 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363192&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435165 401958651 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719270 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32N2O7/c1-22-27(6-3-7-29(22)25-9-11-31-33(15-25)41-13-12-40-31)21-42-28-10-8-26(18-36-30(19-37)34(38)39)32(16-28)43-20-24-5-2-4-23(14-24)17-35/h2-11,14-16,30,36-37H,12-13,18-21H2,1H3,(H,38,39)/t30-/m1/s1 SLWLHSUYZWZGEI-SSEXGKCCSA-N 363193 (R)-2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxypropanoic acid::US9850225, Example 1122 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363193&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434913 401958652 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719271 C[C@H](O)[C@@H](NCc1ccc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H34N2O7/c1-22-28(7-4-8-30(22)26-10-12-31-33(16-26)42-14-13-41-31)21-43-29-11-9-27(19-37-34(23(2)38)35(39)40)32(17-29)44-20-25-6-3-5-24(15-25)18-36/h3-12,15-17,23,34,37-38H,13-14,19-21H2,1-2H3,(H,39,40)/t23-,34+/m0/s1 UQCBMFZPPQHVKT-OHWKKVTOSA-N 363194 (2R,3S)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1123 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363194&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434995 401958653 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719272 Cc1c(COc2ccc(CNC(C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-23-28(7-4-8-30(23)26-10-12-31-33(16-26)42-14-13-41-31)21-43-29-11-9-27(19-37-35(2,22-38)34(39)40)32(17-29)44-20-25-6-3-5-24(15-25)18-36/h3-12,15-17,37-38H,13-14,19-22H2,1-2H3,(H,39,40) MBMGJDWMBQZWSP-UHFFFAOYSA-N 363195 2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1124 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363195&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434912 401958654 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719273 C[C@@H](O)[C@@H](NCc1ccc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H34N2O7/c1-22-28(7-4-8-30(22)26-10-12-31-33(16-26)42-14-13-41-31)21-43-29-11-9-27(19-37-34(23(2)38)35(39)40)32(17-29)44-20-25-6-3-5-24(15-25)18-36/h3-12,15-17,23,34,37-38H,13-14,19-21H2,1-2H3,(H,39,40)/t23-,34-/m1/s1 UQCBMFZPPQHVKT-GRMGDBHTSA-N 363196 (2R,3R)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1125 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363196&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435115 401958655 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719274 Cc1c(COc2ccc(CN[C@H](CO)CC(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-23-28(6-3-7-31(23)26-9-11-32-34(15-26)42-13-12-41-32)22-43-30-10-8-27(19-37-29(20-38)16-35(39)40)33(17-30)44-21-25-5-2-4-24(14-25)18-36/h2-11,14-15,17,29,37-38H,12-13,16,19-22H2,1H3,(H,39,40)/t29-/m0/s1 TXOABIOSPWSONH-LJAQVGFWSA-N 363202 (S)-3-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-hydroxybutanoic acid::US9850225, Example 1126 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363202&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434963 401958661 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719275 Cc1c(COc2ccc(CN[C@](C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-23-28(7-4-8-30(23)26-10-12-31-33(16-26)42-14-13-41-31)21-43-29-11-9-27(19-37-35(2,22-38)34(39)40)32(17-29)44-20-25-6-3-5-24(15-25)18-36/h3-12,15-17,37-38H,13-14,19-22H2,1-2H3,(H,39,40)/t35-/m1/s1 MBMGJDWMBQZWSP-PGUFJCEWSA-N 363203 (R)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1127 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363203&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434958 401958662 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719276 Cc1c(COc2ccc(CN[C@@](C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-23-28(7-4-8-30(23)26-10-12-31-33(16-26)42-14-13-41-31)21-43-29-11-9-27(19-37-35(2,22-38)34(39)40)32(17-29)44-20-25-6-3-5-24(15-25)18-36/h3-12,15-17,37-38H,13-14,19-22H2,1-2H3,(H,39,40)/t35-/m0/s1 MBMGJDWMBQZWSP-DHUJRADRSA-N 363204 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1128 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363204&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434909 401958663 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719277 Cc1c(COc2ccc(CN[C@@H](CO)CC(O)=O)c(OCc3cccc(c3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-23-28(6-3-7-31(23)26-9-11-32-34(15-26)42-13-12-41-32)22-43-30-10-8-27(19-37-29(20-38)16-35(39)40)33(17-30)44-21-25-5-2-4-24(14-25)18-36/h2-11,14-15,17,29,37-38H,12-13,16,19-22H2,1H3,(H,39,40)/t29-/m1/s1 TXOABIOSPWSONH-GDLZYMKVSA-N 363206 (R)-3-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-hydroxybutanoic acid::US9850225, Example 1129 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363206&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434871 401958665 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719278 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cc(ccn1)C#N InChI=1S/C34H34N4O5/c1-23-28(4-3-5-31(23)26-7-9-32-34(17-26)41-15-14-40-32)21-42-30-8-6-27(20-36-12-13-37-24(2)39)33(18-30)43-22-29-16-25(19-35)10-11-38-29/h3-11,16-18,36H,12-15,20-22H2,1-2H3,(H,37,39) KMVUYPMHPZZKBY-UHFFFAOYSA-N 363207 N-(2-(2-((4-cyanopyridin-2-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)ethyl)acetamide::US9850225, Example 1130 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363207&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434706 401958666 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719279 Cc1c(COc2ccc(CN[C@](C)(CO)C(O)=O)c(OCc3cc(ccn3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H33N3O7/c1-22-26(4-3-5-29(22)24-7-9-30-32(15-24)42-13-12-41-30)19-43-28-8-6-25(18-37-34(2,21-38)33(39)40)31(16-28)44-20-27-14-23(17-35)10-11-36-27/h3-11,14-16,37-38H,12-13,18-21H2,1-2H3,(H,39,40)/t34-/m1/s1 SWXSBIUFGOIARY-UUWRZZSWSA-N 363208 (R)-2-(2-((4-cyanopyridin-2-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1131 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363208&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434585 401958667 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719280 Cc1c(COc2ccc(CN3CCCC[C@H]3C(O)=O)c(OCc3cc(ccn3)C#N)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H35N3O6/c1-24-28(5-4-6-31(24)26-9-11-33-35(18-26)43-16-15-42-33)22-44-30-10-8-27(21-39-14-3-2-7-32(39)36(40)41)34(19-30)45-23-29-17-25(20-37)12-13-38-29/h4-6,8-13,17-19,32H,2-3,7,14-16,21-23H2,1H3,(H,40,41)/t32-/m0/s1 UEOHLPCNXHEVPN-YTTGMZPUSA-N 363209 (S)-1-(2-((4-cyanopyridin-2-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1132 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363209&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435010 401958668 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719281 COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CNC[C@@H](O)CC(O)=O InChI=1S/C34H34N2O6/c1-23-27(12-7-13-30(23)26-10-4-3-5-11-26)22-41-29-16-32(40-2)31(20-36-19-28(37)15-34(38)39)33(17-29)42-21-25-9-6-8-24(14-25)18-35/h3-14,16-17,28,36-37H,15,19-22H2,1-2H3,(H,38,39)/t28-/m0/s1 OFRBPFBHSOVQFL-NDEPHWFRSA-N 363210 (S)-4-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1133 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363210&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434696 401958669 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719282 COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CN[C@H](CO)C(O)=O InChI=1S/C33H32N2O6/c1-22-26(12-7-13-28(22)25-10-4-3-5-11-25)21-40-27-15-31(39-2)29(18-35-30(19-36)33(37)38)32(16-27)41-20-24-9-6-8-23(14-24)17-34/h3-16,30,35-36H,18-21H2,1-2H3,(H,37,38)/t30-/m1/s1 RVUZVLLMSICCEW-SSEXGKCCSA-N 363211 (R)-2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1134 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363211&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435013 401958670 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719283 COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CN[C@H]([C@H](C)O)C(O)=O InChI=1S/C34H34N2O6/c1-22-27(13-8-14-29(22)26-11-5-4-6-12-26)21-41-28-16-31(40-3)30(19-36-33(23(2)37)34(38)39)32(17-28)42-20-25-10-7-9-24(15-25)18-35/h4-17,23,33,36-37H,19-21H2,1-3H3,(H,38,39)/t23-,33+/m0/s1 MWGTVYDWJRCRQT-FLASPHMUSA-N 363212 (2R,3S)-2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1135 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363212&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434985 401958671 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719284 COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CN[C@@H]([C@H](C)O)C(O)=O InChI=1S/C34H34N2O6/c1-22-27(13-8-14-29(22)26-11-5-4-6-12-26)21-41-28-16-31(40-3)30(19-36-33(23(2)37)34(38)39)32(17-28)42-20-25-10-7-9-24(15-25)18-35/h4-17,23,33,36-37H,19-21H2,1-3H3,(H,38,39)/t23-,33-/m0/s1 MWGTVYDWJRCRQT-WYOOIXGGSA-N 363213 (2S,3S)-2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1136 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363213&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434862 401958672 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719285 COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CNC(C)(CO)C(O)=O InChI=1S/C34H34N2O6/c1-23-27(13-8-14-29(23)26-11-5-4-6-12-26)21-41-28-16-31(40-3)30(19-36-34(2,22-37)33(38)39)32(17-28)42-20-25-10-7-9-24(15-25)18-35/h4-17,36-37H,19-22H2,1-3H3,(H,38,39) KRFPWDMSJMARBJ-UHFFFAOYSA-N 363214 2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1137 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363214&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434597 401958673 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719286 COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CN[C@H]([C@@H](C)O)C(O)=O InChI=1S/C34H34N2O6/c1-22-27(13-8-14-29(22)26-11-5-4-6-12-26)21-41-28-16-31(40-3)30(19-36-33(23(2)37)34(38)39)32(17-28)42-20-25-10-7-9-24(15-25)18-35/h4-17,23,33,36-37H,19-21H2,1-3H3,(H,38,39)/t23-,33-/m1/s1 MWGTVYDWJRCRQT-PVAZPRTOSA-N 363215 (2R,3R)-2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1138 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363215&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434765 401958674 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719287 COc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CN[C@H](CO)C(O)=O InChI=1S/C35H34N2O8/c1-22-26(7-4-8-28(22)25-9-10-31-34(14-25)43-12-11-42-31)21-44-27-15-32(41-2)29(18-37-30(19-38)35(39)40)33(16-27)45-20-24-6-3-5-23(13-24)17-36/h3-10,13-16,30,37-38H,11-12,18-21H2,1-2H3,(H,39,40)/t30-/m1/s1 JBPWOBBETPBFIL-SSEXGKCCSA-N 363216 (R)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-6-methoxybenzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1139 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363216&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435085 401958675 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719288 COc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CNC[C@@H](O)CC(O)=O InChI=1S/C36H36N2O8/c1-23-27(7-4-8-30(23)26-9-10-32-35(14-26)44-12-11-43-32)22-45-29-16-33(42-2)31(20-38-19-28(39)15-36(40)41)34(17-29)46-21-25-6-3-5-24(13-25)18-37/h3-10,13-14,16-17,28,38-39H,11-12,15,19-22H2,1-2H3,(H,40,41)/t28-/m0/s1 GYGYSETYDZXZRD-NDEPHWFRSA-N 363217 (S)-4-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-6-methoxybenzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1140 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363217&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434695 401958676 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719289 COc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CN[C@@H](CO)C(O)=O InChI=1S/C35H34N2O8/c1-22-26(7-4-8-28(22)25-9-10-31-34(14-25)43-12-11-42-31)21-44-27-15-32(41-2)29(18-37-30(19-38)35(39)40)33(16-27)45-20-24-6-3-5-23(13-24)17-36/h3-10,13-16,30,37-38H,11-12,18-21H2,1-2H3,(H,39,40)/t30-/m0/s1 JBPWOBBETPBFIL-PMERELPUSA-N 363218 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-6-methoxybenzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1141 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363218&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435197 401958677 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719290 COc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc(OCc2cccc(c2)C#N)c1CN[C@@](C)(CO)C(O)=O InChI=1S/C36H36N2O8/c1-23-27(8-5-9-29(23)26-10-11-31-34(15-26)44-13-12-43-31)21-45-28-16-32(42-3)30(19-38-36(2,22-39)35(40)41)33(17-28)46-20-25-7-4-6-24(14-25)18-37/h4-11,14-17,38-39H,12-13,19-22H2,1-3H3,(H,40,41)/t36-/m0/s1 KWVPTKRSPPBZEJ-BHVANESWSA-N 363219 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-6-methoxybenzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1142 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363219&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434749 401958678 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719291 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCCCCC#N)c2)cccc1-c1ccccc1 InChI=1S/C29H32N2O5/c1-21-24(11-8-12-26(21)22-9-4-2-5-10-22)20-36-25-14-13-23(18-31-27(19-32)29(33)34)28(17-25)35-16-7-3-6-15-30/h2,4-5,8-14,17,27,31-32H,3,6-7,16,18-20H2,1H3,(H,33,34)/t27-/m1/s1 KCIPOQCKWMIDJI-HHHXNRCGSA-N 363220 (R)-2-((2-(4-cyanobutoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1143 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363220&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434633 401958679 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719292 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCCCCC#N)c2)cccc1-c1ccccc1 InChI=1S/C30H34N2O5/c1-22-25(11-8-12-28(22)23-9-4-2-5-10-23)21-37-27-14-13-24(19-32-20-26(33)17-30(34)35)29(18-27)36-16-7-3-6-15-31/h2,4-5,8-14,18,26,32-33H,3,6-7,16-17,19-21H2,1H3,(H,34,35)/t26-/m0/s1 PFTOXGQKQWUHGD-SANMLTNESA-N 363221 (S)-4-((2-(4-cyanobutoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1144 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363221&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434856 401958680 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719293 OC(=O)[C@@H]1CCCCN1Cc1ccc(OCc2cccc(c2Cl)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C36H33ClN2O6/c37-35-28(7-4-8-30(35)26-11-13-32-34(18-26)43-16-15-42-32)23-44-29-12-10-27(21-39-14-2-1-9-31(39)36(40)41)33(19-29)45-22-25-6-3-5-24(17-25)20-38/h3-8,10-13,17-19,31H,1-2,9,14-16,21-23H2,(H,40,41)/t31-/m0/s1 PXUDPHSIMYUFNT-HKBQPEDESA-N 363222 (S)-1-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-(3-cyanobenzyloxyl)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1145 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363222&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434822 401958681 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719294 OC[C@@H](NCc1ccc(OCc2cccc(c2Cl)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C33H29ClN2O7/c34-32-25(5-2-6-27(32)23-8-10-29-31(14-23)41-12-11-40-29)20-42-26-9-7-24(17-36-28(18-37)33(38)39)30(15-26)43-19-22-4-1-3-21(13-22)16-35/h1-10,13-15,28,36-37H,11-12,17-20H2,(H,38,39)/t28-/m1/s1 LAJFPYWWLUHYEA-MUUNZHRXSA-N 363223 (R)-2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-(3-cyanobenzyloxy)benzylamino)-3-hydroxypropanoic acid::US9850225, Example 1146 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363223&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434889 401958682 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719295 O[C@H](CNCc1ccc(OCc2cccc(c2Cl)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)CC(O)=O InChI=1S/C34H31ClN2O7/c35-34-26(5-2-6-29(34)24-8-10-30-32(14-24)42-12-11-41-30)21-43-28-9-7-25(18-37-19-27(38)15-33(39)40)31(16-28)44-20-23-4-1-3-22(13-23)17-36/h1-10,13-14,16,27,37-38H,11-12,15,18-21H2,(H,39,40)/t27-/m0/s1 IUZNQSQFZZQRBZ-MHZLTWQESA-N 363224 (S)-4-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-(3-cyanobenzyloxy)benzylamino)-3-hydroxybutanoic acid::US9850225, Example 1147 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363224&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434694 401958683 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719296 C[C@](CO)(NCc1ccc(OCc2cccc(c2Cl)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C34H31ClN2O7/c1-34(21-38,33(39)40)37-18-25-8-10-27(16-30(25)44-19-23-5-2-4-22(14-23)17-36)43-20-26-6-3-7-28(32(26)35)24-9-11-29-31(15-24)42-13-12-41-29/h2-11,14-16,37-38H,12-13,18-21H2,1H3,(H,39,40)/t34-/m1/s1 XDXZNQOPTDGREL-UUWRZZSWSA-N 363225 (R)-2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-(3-cyanobenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1148 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363225&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434829 401958684 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719297 C[C@@](CO)(NCc1ccc(OCc2cccc(c2Cl)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C34H31ClN2O7/c1-34(21-38,33(39)40)37-18-25-8-10-27(16-30(25)44-19-23-5-2-4-22(14-23)17-36)43-20-26-6-3-7-28(32(26)35)24-9-11-29-31(15-24)42-13-12-41-29/h2-11,14-16,37-38H,12-13,18-21H2,1H3,(H,39,40)/t34-/m0/s1 XDXZNQOPTDGREL-UMSFTDKQSA-N 363226 (S)-2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-(3-cyanobenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1149 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363226&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434580 401958685 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719298 CC(=O)NCCNCc1ccc(OCc2cccc(c2Cl)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C34H32ClN3O5/c1-23(39)38-13-12-37-20-27-8-10-29(18-32(27)43-21-25-5-2-4-24(16-25)19-36)42-22-28-6-3-7-30(34(28)35)26-9-11-31-33(17-26)41-15-14-40-31/h2-11,16-18,37H,12-15,20-22H2,1H3,(H,38,39) SYUKKGYZUADDAP-UHFFFAOYSA-N 363227 N-(2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-(3-cyanobenzyloxy)benzylamino)ethyl)acetamide::US9850225, Example 1150 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363227&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434897 401958686 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719299 Cc1cc(CNCCO)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1Cl)-c1ccc2OCCOc2c1 InChI=1S/C32H30ClN3O5/c1-21-11-26(18-35-7-8-37)30(40-19-23-12-22(15-34)16-36-17-23)14-29(21)41-20-25-3-2-4-27(32(25)33)24-5-6-28-31(13-24)39-10-9-38-28/h2-6,11-14,16-17,35,37H,7-10,18-20H2,1H3 BFHUVOKFJFSOPW-UHFFFAOYSA-N 363228 5-((5-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((2-hydroxyethylamino)methyl)-4-methylphenoxy)methyl)nicotinonitrile::US9850225, Example 1151 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363228&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434748 401958687 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719300 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1Cl)-c1ccc2OCCOc2c1 InChI=1S/C36H34ClN3O6/c1-23-13-28(20-40-10-3-2-7-30(40)36(41)42)33(45-21-25-14-24(17-38)18-39-19-25)16-32(23)46-22-27-5-4-6-29(35(27)37)26-8-9-31-34(15-26)44-12-11-43-31/h4-6,8-9,13-16,18-19,30H,2-3,7,10-12,20-22H2,1H3,(H,41,42)/t30-/m0/s1 ISKGSKOUFJODPP-PMERELPUSA-N 363229 (S)-1-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1152 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363229&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435050 401958688 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719301 Cc1cc(CN[C@H](CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1Cl)-c1ccc2OCCOc2c1 InChI=1S/C33H30ClN3O7/c1-20-9-25(16-37-27(17-38)33(39)40)30(43-18-22-10-21(13-35)14-36-15-22)12-29(20)44-19-24-3-2-4-26(32(24)34)23-5-6-28-31(11-23)42-8-7-41-28/h2-6,9-12,14-15,27,37-38H,7-8,16-19H2,1H3,(H,39,40)/t27-/m1/s1 XUHRDJHZYFULNG-HHHXNRCGSA-N 363230 (R)-2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxypropanoic acid::US9850225, Example 1153 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363230&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435120 401958689 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719302 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1Cl)-c1ccc2OCCOc2c1 InChI=1S/C34H32ClN3O7/c1-21-10-26(17-38-34(2,20-39)33(40)41)30(44-18-23-11-22(14-36)15-37-16-23)13-29(21)45-19-25-4-3-5-27(32(25)35)24-6-7-28-31(12-24)43-9-8-42-28/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m0/s1 DCMRPQIGXVSUNH-UMSFTDKQSA-N 363231 (S)-2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1154 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363231&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434966 401958690 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719303 Cc1cc(CN2CCCC[C@@H]2C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1Cl)-c1ccc2OCCOc2c1 InChI=1S/C36H34ClN3O6/c1-23-13-28(20-40-10-3-2-7-30(40)36(41)42)33(45-21-25-14-24(17-38)18-39-19-25)16-32(23)46-22-27-5-4-6-29(35(27)37)26-8-9-31-34(15-26)44-12-11-43-31/h4-6,8-9,13-16,18-19,30H,2-3,7,10-12,20-22H2,1H3,(H,41,42)/t30-/m1/s1 ISKGSKOUFJODPP-SSEXGKCCSA-N 363232 (R)-1-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1155 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363232&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434941 401958691 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719304 Cc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1Cl)-c1ccc2OCCOc2c1 InChI=1S/C34H32ClN3O7/c1-21-10-26(17-38-34(2,20-39)33(40)41)30(44-18-23-11-22(14-36)15-37-16-23)13-29(21)45-19-25-4-3-5-27(32(25)35)24-6-7-28-31(12-24)43-9-8-42-28/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m1/s1 DCMRPQIGXVSUNH-UUWRZZSWSA-N 363233 (R)-2-(4-(2-chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1156 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363233&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434610 401958692 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719305 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@H](CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H31ClN2O7/c1-21-25(6-3-7-27(21)24-8-9-30-33(14-24)42-11-10-41-30)20-44-32-15-31(43-19-23-5-2-4-22(12-23)16-36)26(13-28(32)35)17-37-29(18-38)34(39)40/h2-9,12-15,29,37-38H,10-11,17-20H2,1H3,(H,39,40)/t29-/m1/s1 FKSRHTZIZOREHT-GDLZYMKVSA-N 363235 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1157 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363235&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435200 401958694 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719306 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](CC(O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H31ClN2O8/c1-21-25(6-3-7-27(21)24-8-9-30-33(14-24)44-11-10-43-30)20-46-32-16-31(45-19-23-5-2-4-22(12-23)17-37)26(13-28(32)36)18-38-29(35(41)42)15-34(39)40/h2-9,12-14,16,29,38H,10-11,15,18-20H2,1H3,(H,39,40)(H,41,42)/t29-/m0/s1 QNMAWGNKUXCOKZ-LJAQVGFWSA-N 363236 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)succinic acid::US9850225, Example 1158 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363236&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434803 401958695 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719307 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3cccc(O)c3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C40H35ClN2O7/c1-25-30(8-4-10-33(25)29-11-12-36-39(19-29)48-14-13-47-36)24-50-38-20-37(49-23-28-7-2-6-27(15-28)21-42)31(18-34(38)41)22-43-35(40(45)46)17-26-5-3-9-32(44)16-26/h2-12,15-16,18-20,35,43-44H,13-14,17,22-24H2,1H3,(H,45,46) RZMONMBZAUEYBX-UHFFFAOYSA-N 363237 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(3-hydroxyphenyl)propanoic acid::US9850225, Example 1159 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363237&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435068 401958696 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719308 CSC[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O6S/c1-22-26(7-4-8-28(22)25-9-10-31-34(15-25)42-12-11-41-31)20-44-33-16-32(43-19-24-6-3-5-23(13-24)17-37)27(14-29(33)36)18-38-30(21-45-2)35(39)40/h3-10,13-16,30,38H,11-12,18-21H2,1-2H3,(H,39,40)/t30-/m0/s1 SNCNCQGCXQGGEE-PMERELPUSA-N 363238 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(methylthio)propanoic acid::US9850225, Example 1160 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363238&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435140 401958697 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719309 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](C(O)=O)c3ccc(O)cc3)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C39H33ClN2O7/c1-24-29(6-3-7-32(24)28-10-13-34-37(18-28)47-15-14-46-34)23-49-36-19-35(48-22-26-5-2-4-25(16-26)20-41)30(17-33(36)40)21-42-38(39(44)45)27-8-11-31(43)12-9-27/h2-13,16-19,38,42-43H,14-15,21-23H2,1H3,(H,44,45)/t38-/m1/s1 HZGLMXUEUOBCGO-KXQOOQHDSA-N 363239 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-2-(4-hydroxyphenyl)acetic acid::US9850225, Example 1161 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363239&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434602 401958698 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719310 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(C(O)=O)C(F)(F)F)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H28ClF3N2O6/c1-20-24(6-3-7-26(20)23-8-9-28-31(14-23)44-11-10-43-28)19-46-30-15-29(45-18-22-5-2-4-21(12-22)16-39)25(13-27(30)35)17-40-32(33(41)42)34(36,37)38/h2-9,12-15,32,40H,10-11,17-19H2,1H3,(H,41,42) CONVOOOGBBLXFA-UHFFFAOYSA-N 363240 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3,3,3-trifluoropropanoic acid::US9850225, Example 1162 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363240&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434744 401958699 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719311 C[C@@H](O)[C@@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O7/c1-21-26(7-4-8-28(21)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-34(22(2)39)35(40)41/h3-10,13-16,22,34,38-39H,11-12,18-20H2,1-2H3,(H,40,41)/t22-,34-/m1/s1 ZAAUQIRMFVXHBM-GMWXTNTRSA-N 363241 (2R,3R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1163 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363241&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434627 401958700 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719312 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3c[nH]cn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 363242 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1H-imidazol-4-yl)propanoic acid::US9850225, Example 1164 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363242&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434879 401958701 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719313 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCCC3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O6/c1-23-27(7-3-8-29(23)26-10-11-32-35(17-26)43-14-13-42-32)22-45-34-18-33(44-21-25-6-2-5-24(15-25)19-38)28(16-30(34)37)20-39-12-4-9-31(39)36(40)41/h2-3,5-8,10-11,15-18,31H,4,9,12-14,20-22H2,1H3,(H,40,41) BNMPOUDRIMSXDA-UHFFFAOYSA-N 363244 1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)pyrrolidine-2-carboxylic acid::US9850225, Example 1165 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363244&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434768 401958703 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719314 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3C[C@H](O)C[C@@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-29(22)25-8-9-32-35(14-25)44-11-10-43-32)21-46-34-16-33(45-20-24-5-2-4-23(12-24)17-38)27(13-30(34)37)18-39-19-28(40)15-31(39)36(41)42/h2-9,12-14,16,28,31,40H,10-11,15,18-21H2,1H3,(H,41,42)/t28-,31-/m1/s1 QBXVXKRWOVBUDB-GRKNLSHJSA-N 50239948 CHEMBL4071326::US9850225, Example 1166 Programmed cell death 1 ligand 1 Human 1.40 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239948&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 11713221 85715678 CHEMBL4071326 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719315 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3c[nH]c4ccc(O)cc34)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 363246 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid::US9850225, Example 1167 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363246&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434795 401958705 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719316 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3cn(C)c4ccccc34)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C43H38ClN3O6/c1-27-31(9-6-11-34(27)30-13-14-39-42(20-30)51-16-15-50-39)26-53-41-21-40(52-25-29-8-5-7-28(17-29)22-45)32(18-36(41)44)23-46-37(43(48)49)19-33-24-47(2)38-12-4-3-10-35(33)38/h3-14,17-18,20-21,24,37,46H,15-16,19,23,25-26H2,1-2H3,(H,48,49) HCQOFFLSYODAHT-UHFFFAOYSA-N 363247 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1-methyl-1H-indol-3-yl)propanoic acid::US9850225, Example 1168 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363247&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435033 401958706 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719317 C[C@@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C34H31ClN2O6/c1-21-26(7-4-8-28(21)25-9-10-30-33(15-25)41-12-11-40-30)20-43-32-16-31(42-19-24-6-3-5-23(13-24)17-36)27(14-29(32)35)18-37-22(2)34(38)39/h3-10,13-16,22,37H,11-12,18-20H2,1-2H3,(H,38,39)/t22-/m1/s1 NOJBXBUROWNRFY-JOCHJYFZSA-N 363248 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)propanoic acid::US9850225, Example 1169 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363248&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434818 401958707 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719318 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNCCO)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C33H31ClN2O5/c1-22-26(6-3-7-28(22)25-8-9-30-33(16-25)39-13-12-38-30)21-41-32-17-31(27(15-29(32)34)19-36-10-11-37)40-20-24-5-2-4-23(14-24)18-35/h2-9,14-17,36-37H,10-13,19-21H2,1H3 XFJYWIDIGLRVOI-UHFFFAOYSA-N 363249 3-((4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-(((2-hydroxyethyl)amino)methyl)phenoxy)methyl)benzonitrile::US9850225, Example 1170 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363249&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435007 401958708 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719319 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN(Cc3ccccc3)[C@@H](CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C41H37ClN2O7/c1-27-32(11-6-12-34(27)31-13-14-37-40(19-31)49-16-15-48-37)26-51-39-20-38(50-25-30-10-5-9-29(17-30)21-43)33(18-35(39)42)23-44(36(24-45)41(46)47)22-28-7-3-2-4-8-28/h2-14,17-20,36,45H,15-16,22-26H2,1H3,(H,46,47)/t36-/m0/s1 FEJDJXGETFQWAO-BHVANESWSA-N 363250 (S)-2-(benzyl(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1171 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363250&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435067 401958709 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719320 CN(C)CC(NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C36H36ClN3O6/c1-23-27(8-5-9-29(23)26-10-11-32-35(16-26)44-13-12-43-32)22-46-34-17-33(45-21-25-7-4-6-24(14-25)18-38)28(15-30(34)37)19-39-31(36(41)42)20-40(2)3/h4-11,14-17,31,39H,12-13,19-22H2,1-3H3,(H,41,42) XBTYJJVHUVZQMA-UHFFFAOYSA-N 363251 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(dimethylamino)propanoic acid::US9850225, Example 1172 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363251&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434844 401958710 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719321 CN(C)CCCC[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C39H42ClN3O6/c1-26-30(10-7-11-32(26)29-13-14-35-38(20-29)47-17-16-46-35)25-49-37-21-36(48-24-28-9-6-8-27(18-28)22-41)31(19-33(37)40)23-42-34(39(44)45)12-4-5-15-43(2)3/h6-11,13-14,18-21,34,42H,4-5,12,15-17,23-25H2,1-3H3,(H,44,45)/t34-/m0/s1 FKVMKDUEJWTUIF-UMSFTDKQSA-N 363252 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-6-(dimethylamino)hexanoic acid::US9850225, Example 1173 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363252&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435138 401958711 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719322 C[S+]([O-])CC[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C36H35ClN2O7S/c1-23-27(7-4-8-29(23)26-9-10-32-35(17-26)44-13-12-43-32)22-46-34-18-33(45-21-25-6-3-5-24(15-25)19-38)28(16-30(34)37)20-39-31(36(40)41)11-14-47(2)42/h3-10,15-18,31,39H,11-14,20-22H2,1-2H3,(H,40,41)/t31-,47?/m0/s1 OMRMTJIGBXXQAU-QXWMRTDYSA-N 363253 (2S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-(methylsulfinyl)butanoic acid::US9850225, Example 1174 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363253&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435121 401958712 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719323 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@H](CC(O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H31ClN2O8/c1-21-25(6-3-7-27(21)24-8-9-30-33(14-24)44-11-10-43-30)20-46-32-16-31(45-19-23-5-2-4-22(12-23)17-37)26(13-28(32)36)18-38-29(35(41)42)15-34(39)40/h2-9,12-14,16,29,38H,10-11,15,18-20H2,1H3,(H,39,40)(H,41,42)/t29-/m1/s1 QNMAWGNKUXCOKZ-GDLZYMKVSA-N 363254 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)succinic acid::US9850225, Example 1175 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363254&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434729 401958713 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719324 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cc3cn(C)cn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H35ClN4O6/c1-24-28(7-4-8-31(24)27-9-10-34-37(15-27)47-12-11-46-34)22-49-36-17-35(48-21-26-6-3-5-25(13-26)18-40)29(14-32(36)39)19-41-33(38(44)45)16-30-20-43(2)23-42-30/h3-10,13-15,17,20,23,33,41H,11-12,16,19,21-22H2,1-2H3,(H,44,45)/t33-/m0/s1 GBHASVREQYIAPN-XIFFEERXSA-N 363255 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1-methyl-1H-imidazol-4-yl)propanoic acid::US9850225, Example 1176 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363255&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434989 401958714 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719325 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC3(CC3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H31ClN2O6/c1-22-26(6-3-7-28(22)25-8-9-30-33(16-25)42-13-12-41-30)21-44-32-17-31(43-20-24-5-2-4-23(14-24)18-37)27(15-29(32)36)19-38-35(10-11-35)34(39)40/h2-9,14-17,38H,10-13,19-21H2,1H3,(H,39,40) KCZSKZAMJUVHNL-UHFFFAOYSA-N 363256 1-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)cyclopropanecarboxylic acid::US9850225, Example 1177 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363256&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434669 401958715 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719326 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3nccs3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H32ClN3O6S/c1-23-27(6-3-7-29(23)26-8-9-32-35(16-26)45-12-11-44-32)22-47-34-18-33(46-21-25-5-2-4-24(14-25)19-39)28(15-30(34)38)20-41-31(37(42)43)17-36-40-10-13-48-36/h2-10,13-16,18,31,41H,11-12,17,20-22H2,1H3,(H,42,43) BBVPJTABGBUFAX-UHFFFAOYSA-N 363257 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(thiazol-2-yl)propanoic acid::US9850225, Example 1178 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363257&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434631 401958716 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719327 COC(C)(C)C(NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C37H37ClN2O7/c1-23-27(9-6-10-29(23)26-11-12-31-34(17-26)45-14-13-44-31)22-47-33-18-32(46-21-25-8-5-7-24(15-25)19-39)28(16-30(33)38)20-40-35(36(41)42)37(2,3)43-4/h5-12,15-18,35,40H,13-14,20-22H2,1-4H3,(H,41,42) KEHYRMHISJTJFT-UHFFFAOYSA-N 363258 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-methoxy-3-methylbutanoic acid::US9850225, Example 1179 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363258&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435154 401958717 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719328 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](CC#N)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H30ClN3O6/c1-22-26(6-3-7-28(22)25-8-9-31-34(16-25)43-13-12-42-31)21-45-33-17-32(44-20-24-5-2-4-23(14-24)18-38)27(15-29(33)36)19-39-30(10-11-37)35(40)41/h2-9,14-17,30,39H,10,12-13,19-21H2,1H3,(H,40,41)/t30-/m0/s1 VYSMNPCHUMHOMC-PMERELPUSA-N 363259 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-cyanopropanoic acid::US9850225, Example 1180 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363259&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434775 401958718 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719329 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3ccccc3O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C40H35ClN2O7/c1-25-30(9-5-10-32(25)28-12-13-36-39(19-28)48-15-14-47-36)24-50-38-20-37(49-23-27-7-4-6-26(16-27)21-42)31(17-33(38)41)22-43-34(40(45)46)18-29-8-2-3-11-35(29)44/h2-13,16-17,19-20,34,43-44H,14-15,18,22-24H2,1H3,(H,45,46) HFZNHPJTIWQDOZ-UHFFFAOYSA-N 363260 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(2-hydroxyphenyl)propanoic acid::US9850225, Example 1181 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363260&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434592 401958719 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719330 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(CCS(C)(=O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H35ClN2O8S/c1-23-27(7-4-8-29(23)26-9-10-32-35(17-26)45-13-12-44-32)22-47-34-18-33(46-21-25-6-3-5-24(15-25)19-38)28(16-30(34)37)20-39-31(36(40)41)11-14-48(2,42)43/h3-10,15-18,31,39H,11-14,20-22H2,1-2H3,(H,40,41) ROUILKBAXLKQTH-UHFFFAOYSA-N 363261 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-(methylsulfonyl)butanoic acid::US9850225, Example 1182 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363261&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435065 401958720 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719331 CN(Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)[C@@H](CO)C(O)=O InChI=1S/C35H33ClN2O7/c1-22-26(7-4-8-28(22)25-9-10-31-34(15-25)43-12-11-42-31)21-45-33-16-32(44-20-24-6-3-5-23(13-24)17-37)27(14-29(33)36)18-38(2)30(19-39)35(40)41/h3-10,13-16,30,39H,11-12,18-21H2,1-2H3,(H,40,41)/t30-/m0/s1 XWAYJDCKAOFIEV-PMERELPUSA-N 363262 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)(methyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1183 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363262&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434962 401958721 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719332 COCC(NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O7/c1-22-26(7-4-8-28(22)25-9-10-31-34(15-25)43-12-11-42-31)20-45-33-16-32(44-19-24-6-3-5-23(13-24)17-37)27(14-29(33)36)18-38-30(21-41-2)35(39)40/h3-10,13-16,30,38H,11-12,18-21H2,1-2H3,(H,39,40) SAKDTXDIWIHZPP-UHFFFAOYSA-N 363263 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-methoxypropanoic acid::US9850225, Example 1184 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363263&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434899 401958722 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719333 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3c[nH]c4ncccc34)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 363265 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid::US9850225, Example 1185 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363265&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435106 401958724 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719334 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cc3cn(Cc4ccccc4)cn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C44H39ClN4O6/c1-29-34(11-6-12-37(29)33-13-14-40-43(19-33)53-16-15-52-40)27-55-42-21-41(54-26-32-10-5-9-31(17-32)22-46)35(18-38(42)45)23-47-39(44(50)51)20-36-25-49(28-48-36)24-30-7-3-2-4-8-30/h2-14,17-19,21,25,28,39,47H,15-16,20,23-24,26-27H2,1H3,(H,50,51)/t39-/m0/s1 UIQQWEQJYFELQS-KDXMTYKHSA-N 363266 (S)-3-(1-benzyl-1H-imidazol-4-yl)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)propanoic acid::US9850225, Example 1186 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363266&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434805 401958725 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719335 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3ccc(O)cc3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C40H35ClN2O7/c1-25-30(6-3-7-33(25)29-10-13-36-39(19-29)48-15-14-47-36)24-50-38-20-37(49-23-28-5-2-4-27(16-28)21-42)31(18-34(38)41)22-43-35(40(45)46)17-26-8-11-32(44)12-9-26/h2-13,16,18-20,35,43-44H,14-15,17,22-24H2,1H3,(H,45,46) HQVFFTMHGUHJRA-UHFFFAOYSA-N 363267 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(4-hydroxyphenyl)propanoic acid::US9850225, Example 1187 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363267&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434887 401958726 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719336 CC(N(C)Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O6/c1-22-27(8-5-9-29(22)26-10-11-31-34(16-26)42-13-12-41-31)21-44-33-17-32(43-20-25-7-4-6-24(14-25)18-37)28(15-30(33)36)19-38(3)23(2)35(39)40/h4-11,14-17,23H,12-13,19-21H2,1-3H3,(H,39,40) DQHYRQMTQVZYNR-UHFFFAOYSA-N 363268 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)(methyl)amino)propanoic acid::US9850225, Example 1188 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363268&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434656 401958727 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719337 C[C@H](O)[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O7/c1-21-26(7-4-8-28(21)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-34(22(2)39)35(40)41/h3-10,13-16,22,34,38-39H,11-12,18-20H2,1-2H3,(H,40,41)/t22-,34-/m0/s1 ZAAUQIRMFVXHBM-RIPCNWKXSA-N 363269 (2S,3S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1189 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363269&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434718 401958728 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719338 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCC[C@H]([C@H]3C(O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H35ClN2O8/c1-23-27(7-3-8-29(23)26-10-11-32-35(17-26)47-14-13-46-32)22-49-34-18-33(48-21-25-6-2-5-24(15-25)19-40)28(16-31(34)39)20-41-12-4-9-30(37(42)43)36(41)38(44)45/h2-3,5-8,10-11,15-18,30,36H,4,9,12-14,20-22H2,1H3,(H,42,43)(H,44,45)/t30-,36+/m1/s1 FRWVOFFFRGSHIE-GERKYKROSA-N 363270 (2S,3R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2,3-dicarboxylic acid::US9850225, Example 1190 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363270&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435078 401958729 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719339 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(C)(Cc3c[nH]cn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 363271 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1H-imidazol-4-yl)-2-methylpropanoic acid::US9850225, Example 1191 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363271&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435130 401958730 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719340 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(Cc3c[nH]c4ccccc34)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 363273 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1H-indol-3-yl)propanoic acid::US9850225, Example 1192 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363273&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434646 401958732 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719341 CC[C@@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O6/c1-3-30(35(39)40)38-19-27-15-29(36)33(17-32(27)43-20-24-7-4-6-23(14-24)18-37)44-21-26-8-5-9-28(22(26)2)25-10-11-31-34(16-25)42-13-12-41-31/h4-11,14-17,30,38H,3,12-13,19-21H2,1-2H3,(H,39,40)/t30-/m1/s1 NUCQYWCOOVPGME-SSEXGKCCSA-N 363274 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)butanoic acid::US9850225, Example 1193 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363274&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435189 401958733 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719342 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@H](COCc3ccccc3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C41H37ClN2O7/c1-27-32(11-6-12-34(27)31-13-14-37-40(19-31)49-16-15-48-37)25-51-39-20-38(50-24-30-10-5-9-29(17-30)21-43)33(18-35(39)42)22-44-36(41(45)46)26-47-23-28-7-3-2-4-8-28/h2-14,17-20,36,44H,15-16,22-26H2,1H3,(H,45,46)/t36-/m1/s1 GBNFWRDXTHRDNT-PSXMRANNSA-N 363275 (R)-3-(benzyloxy)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)propanoic acid::US9850225, Example 1194 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363275&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435109 401958734 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719343 C[C@H](O)[C@@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O7/c1-21-26(7-4-8-28(21)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-34(22(2)39)35(40)41/h3-10,13-16,22,34,38-39H,11-12,18-20H2,1-2H3,(H,40,41)/t22-,34+/m0/s1 ZAAUQIRMFVXHBM-XSJBNIOMSA-N 363276 (2R,3S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1195 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363276&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435061 401958735 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719344 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3C[C@@H](O)C[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-29(22)25-8-9-32-35(14-25)44-11-10-43-32)21-46-34-16-33(45-20-24-5-2-4-23(12-24)17-38)27(13-30(34)37)18-39-19-28(40)15-31(39)36(41)42/h2-9,12-14,16,28,31,40H,10-11,15,18-21H2,1H3,(H,41,42)/t28-,31-/m0/s1 QBXVXKRWOVBUDB-IZEXYCQBSA-N 363277 (2S,4S)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypyrrolidine-2-carboxylic acid::US9850225, Example 1196 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363277&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435044 401958736 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719345 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3C[C@H](O)C[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-29(22)25-8-9-32-35(14-25)44-11-10-43-32)21-46-34-16-33(45-20-24-5-2-4-23(12-24)17-38)27(13-30(34)37)18-39-19-28(40)15-31(39)36(41)42/h2-9,12-14,16,28,31,40H,10-11,15,18-21H2,1H3,(H,41,42)/t28-,31+/m1/s1 QBXVXKRWOVBUDB-MVSFAKPFSA-N 363278 (2S,4R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypyrrolidine-2-carboxylic acid::US9850225, Example 1197 Programmed cell death 1 ligand 1 Human 1.85 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363278&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search JQT 6R3K 118434719 401958737 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719346 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCCC[C@@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H35ClN2O6/c1-24-28(8-5-9-30(24)27-11-12-33-36(18-27)44-15-14-43-33)23-46-35-19-34(45-22-26-7-4-6-25(16-26)20-39)29(17-31(35)38)21-40-13-3-2-10-32(40)37(41)42/h4-9,11-12,16-19,32H,2-3,10,13-15,21-23H2,1H3,(H,41,42)/t32-/m1/s1 RELGDHKISWTSBN-JGCGQSQUSA-N 363279 (R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1198 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363279&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434617 401958738 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719347 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3C[C@@H](O)C[C@@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-29(22)25-8-9-32-35(14-25)44-11-10-43-32)21-46-34-16-33(45-20-24-5-2-4-23(12-24)17-38)27(13-30(34)37)18-39-19-28(40)15-31(39)36(41)42/h2-9,12-14,16,28,31,40H,10-11,15,18-21H2,1H3,(H,41,42)/t28-,31+/m0/s1 QBXVXKRWOVBUDB-QCENPCRXSA-N 363280 (2R,4S)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypyrrolidine-2-carboxylic acid::US9850225, Example 1199 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363280&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434678 401958739 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719348 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](CCS(C)(=O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H35ClN2O8S/c1-23-27(7-4-8-29(23)26-9-10-32-35(17-26)45-13-12-44-32)22-47-34-18-33(46-21-25-6-3-5-24(15-25)19-38)28(16-30(34)37)20-39-31(36(40)41)11-14-48(2,42)43/h3-10,15-18,31,39H,11-14,20-22H2,1-2H3,(H,40,41)/t31-/m0/s1 ROUILKBAXLKQTH-HKBQPEDESA-N 363281 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-(methylsulfonyl)butanoic acid::US9850225, Example 1200 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363281&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435063 401958740 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719349 CC[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H33ClN2O6/c1-3-30(35(39)40)38-19-27-15-29(36)33(17-32(27)43-20-24-7-4-6-23(14-24)18-37)44-21-26-8-5-9-28(22(26)2)25-10-11-31-34(16-25)42-13-12-41-31/h4-11,14-17,30,38H,3,12-13,19-21H2,1-2H3,(H,39,40)/t30-/m0/s1 NUCQYWCOOVPGME-PMERELPUSA-N 363282 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)butanoic acid::US9850225, Example 1201 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363282&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434770 401958741 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719350 CSCC[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C36H35ClN2O6S/c1-23-27(7-4-8-29(23)26-9-10-32-35(17-26)43-13-12-42-32)22-45-34-18-33(44-21-25-6-3-5-24(15-25)19-38)28(16-30(34)37)20-39-31(36(40)41)11-14-46-2/h3-10,15-18,31,39H,11-14,20-22H2,1-2H3,(H,40,41)/t31-/m0/s1 ONDOJSWYYLXKBN-HKBQPEDESA-N 363283 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-(methylthio)butanoic acid::US9850225, Example 1202 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363283&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434722 401958742 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719351 CN(Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)[C@@H](CC(O)=O)C(O)=O InChI=1S/C36H33ClN2O8/c1-22-26(7-4-8-28(22)25-9-10-31-34(15-25)45-12-11-44-31)21-47-33-17-32(46-20-24-6-3-5-23(13-24)18-38)27(14-29(33)37)19-39(2)30(36(42)43)16-35(40)41/h3-10,13-15,17,30H,11-12,16,19-21H2,1-2H3,(H,40,41)(H,42,43)/t30-/m0/s1 VCSGTWFUYRDNLI-PMERELPUSA-N 363284 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)(methyl)amino)succinic acid::US9850225, Example 1203 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363284&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434703 401958743 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719352 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CC[C@@H](O)[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-28(22)25-8-9-31-34(16-25)44-13-12-43-31)21-46-33-17-32(45-20-24-5-2-4-23(14-24)18-38)27(15-29(33)37)19-39-11-10-30(40)35(39)36(41)42/h2-9,14-17,30,35,40H,10-13,19-21H2,1H3,(H,41,42)/t30-,35+/m1/s1 DLUOQZNXLIGATQ-BIMVPBQRSA-N 363285 (2S,3R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-3-hydroxypyrrolidine-2-carboxylic acid::US9850225, Example 1204 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363285&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434601 401958744 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719353 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@H](CCO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-26(6-3-7-28(22)25-8-9-31-34(16-25)43-13-12-42-31)21-45-33-17-32(44-20-24-5-2-4-23(14-24)18-37)27(15-29(33)36)19-38-30(10-11-39)35(40)41/h2-9,14-17,30,38-39H,10-13,19-21H2,1H3,(H,40,41)/t30-/m1/s1 QKLLMOGNOMFAFL-SSEXGKCCSA-N 363286 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-hydroxybutanoic acid::US9850225, Example 1205 Programmed cell death 1 ligand 1 Human 2.71 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363286&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434921 401958745 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719354 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@H](Cc3cscn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H32ClN3O6S/c1-23-27(6-3-7-30(23)26-8-9-33-36(14-26)45-11-10-44-33)20-47-35-16-34(46-19-25-5-2-4-24(12-25)17-39)28(13-31(35)38)18-40-32(37(42)43)15-29-21-48-22-41-29/h2-9,12-14,16,21-22,32,40H,10-11,15,18-20H2,1H3,(H,42,43)/t32-/m1/s1 VCSPNHIEPIAAIU-JGCGQSQUSA-N 363287 (R)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(thiazol-4-yl)propanoic acid::US9850225, Example 1206 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363287&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434882 401958746 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719355 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cc3cncn3C)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H35ClN4O6/c1-24-28(7-4-8-31(24)27-9-10-34-37(15-27)47-12-11-46-34)22-49-36-17-35(48-21-26-6-3-5-25(13-26)18-40)29(14-32(36)39)19-42-33(38(44)45)16-30-20-41-23-43(30)2/h3-10,13-15,17,20,23,33,42H,11-12,16,19,21-22H2,1-2H3,(H,44,45)/t33-/m0/s1 CBTGIJSFSZCNFF-XIFFEERXSA-N 363288 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(1-methyl-1H-imidazol-5-yl)propanoic acid::US9850225, Example 1207 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363288&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434992 401958747 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719356 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cc3cscn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H32ClN3O6S/c1-23-27(6-3-7-30(23)26-8-9-33-36(14-26)45-11-10-44-33)20-47-35-16-34(46-19-25-5-2-4-24(12-25)17-39)28(13-31(35)38)18-40-32(37(42)43)15-29-21-48-22-41-29/h2-9,12-14,16,21-22,32,40H,10-11,15,18-20H2,1H3,(H,42,43)/t32-/m0/s1 VCSPNHIEPIAAIU-YTTGMZPUSA-N 363289 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(thiazol-4-yl)propanoic acid::US9850225, Example 1208 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363289&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434982 401958748 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719357 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(C(O)=O)C(C)(C)O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H35ClN2O7/c1-22-26(8-5-9-28(22)25-10-11-30-33(16-25)44-13-12-43-30)21-46-32-17-31(45-20-24-7-4-6-23(14-24)18-38)27(15-29(32)37)19-39-34(35(40)41)36(2,3)42/h4-11,14-17,34,39,42H,12-13,19-21H2,1-3H3,(H,40,41) KUCOOJKSPRAGMN-UHFFFAOYSA-N 363290 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-3-methylbutanoic acid::US9850225, Example 1210 Programmed cell death 1 ligand 1 Human 12.7 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363290&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434673 401958749 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719358 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(C(O)=O)c3c[nH]c4ccccc34)cc2Cl)cccc1-c1ccc2OCCOc2c1 363291 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-2-(1H-indol-3-yl)acetic acid::US9850225, Example 1211 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363291&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434750 401958750 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719359 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNCC(O)CN3CCOCC3)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H40ClN3O6/c1-26-30(6-3-7-33(26)29-8-9-35-38(18-29)46-15-14-45-35)25-48-37-19-36(47-24-28-5-2-4-27(16-28)20-40)31(17-34(37)39)21-41-22-32(43)23-42-10-12-44-13-11-42/h2-9,16-19,32,41,43H,10-15,21-25H2,1H3 NSRCGMJSSNCAPQ-UHFFFAOYSA-N 363292 3-((4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-(((2-hydroxy-3-morpholinopropyl)amino)methyl)phenoxy)methyl)benzonitrile::US9850225, Example 1212 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363292&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435092 401958751 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719360 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCOCC3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-23-27(6-3-7-29(23)26-8-9-32-35(16-26)44-13-12-43-32)21-46-34-17-33(45-20-25-5-2-4-24(14-25)18-38)28(15-30(34)37)19-39-10-11-42-22-31(39)36(40)41/h2-9,14-17,31H,10-13,19-22H2,1H3,(H,40,41) KTNVNPDIFJHIHF-UHFFFAOYSA-N 363293 4-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)morpholine-3-carboxylic acid::US9850225, Example 1213 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363293&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434767 401958752 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719361 CC(C)C(CO)(NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C37H37ClN2O7/c1-23(2)37(22-41,36(42)43)40-19-29-15-31(38)34(17-33(29)46-20-26-7-4-6-25(14-26)18-39)47-21-28-8-5-9-30(24(28)3)27-10-11-32-35(16-27)45-13-12-44-32/h4-11,14-17,23,40-41H,12-13,19-22H2,1-3H3,(H,42,43) CVHGHMZHRJMKGP-UHFFFAOYSA-N 363294 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-2-(hydroxymethyl)-3-methylbutanoic acid::US9850225, Example 1214 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363294&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434753 401958753 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719362 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3C[C@H](F)C[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H32ClFN2O6/c1-22-26(6-3-7-29(22)25-8-9-32-35(14-25)44-11-10-43-32)21-46-34-16-33(45-20-24-5-2-4-23(12-24)17-39)27(13-30(34)37)18-40-19-28(38)15-31(40)36(41)42/h2-9,12-14,16,28,31H,10-11,15,18-21H2,1H3,(H,41,42)/t28-,31+/m1/s1 AUMBLLOUWYMBSQ-MVSFAKPFSA-N 363295 (2S,4R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-fluoropyrrolidine-2-carboxylic acid::US9850225, Example 1215 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363295&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435102 401958754 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719363 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(CC(F)(F)F)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H30ClF3N2O6/c1-21-25(6-3-7-27(21)24-8-9-30-33(14-24)45-11-10-44-30)20-47-32-15-31(46-19-23-5-2-4-22(12-23)17-40)26(13-28(32)36)18-41-29(34(42)43)16-35(37,38)39/h2-9,12-15,29,41H,10-11,16,18-20H2,1H3,(H,42,43) LQISAZLFWHDQSJ-UHFFFAOYSA-N 363296 2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4,4,4-trifluorobutanoic acid::US9850225, Example 1216 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363296&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435152 401958755 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719364 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cc3cccc(c3)C#N)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C41H34ClN3O6/c1-26-32(9-4-10-34(26)31-11-12-37-40(19-31)49-14-13-48-37)25-51-39-20-38(50-24-30-8-3-7-29(16-30)22-44)33(18-35(39)42)23-45-36(41(46)47)17-27-5-2-6-28(15-27)21-43/h2-12,15-16,18-20,36,45H,13-14,17,23-25H2,1H3,(H,46,47)/t36-/m0/s1 CTTOWBORSWWUOU-BHVANESWSA-N 363297 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(3-cyanophenyl)propanoic acid::US9850225, Example 1217 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363297&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435110 401958756 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719365 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC(CO)(Cc3ccccc3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C41H37ClN2O7/c1-27-32(11-6-12-34(27)31-13-14-36-39(19-31)49-16-15-48-36)25-51-38-20-37(50-24-30-10-5-9-29(17-30)22-43)33(18-35(38)42)23-44-41(26-45,40(46)47)21-28-7-3-2-4-8-28/h2-14,17-20,44-45H,15-16,21,23-26H2,1H3,(H,46,47) AIDZUGZIDYDNMZ-UHFFFAOYSA-N 363298 2-benzyl-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1218 Programmed cell death 1 ligand 1 Human 10.1 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363298&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434902 401958757 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719366 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CC[C@H](O)[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-28(22)25-8-9-31-34(16-25)44-13-12-43-31)21-46-33-17-32(45-20-24-5-2-4-23(14-24)18-38)27(15-29(33)37)19-39-11-10-30(40)35(39)36(41)42/h2-9,14-17,30,35,40H,10-13,19-21H2,1H3,(H,41,42)/t30-,35-/m0/s1 DLUOQZNXLIGATQ-QGRQJHSQSA-N 363299 (2S,3S)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-3-hydroxypyrrolidine-2-carboxylic acid::US9850225, Example 1219 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363299&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434880 401958758 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719367 CN1CCC(CC1)(NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C38H38ClN3O6/c1-25-29(7-4-8-31(25)28-9-10-33-36(19-28)46-16-15-45-33)24-48-35-20-34(47-23-27-6-3-5-26(17-27)21-40)30(18-32(35)39)22-41-38(37(43)44)11-13-42(2)14-12-38/h3-10,17-20,41H,11-16,22-24H2,1-2H3,(H,43,44) SSTQOQXCFHOONT-UHFFFAOYSA-N 363300 4-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-1-methylpiperidine-4-carboxylic acid::US9850225, Example 1220 Programmed cell death 1 ligand 1 Human 6.07 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363300&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435107 401958759 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719368 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cc3ccccn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C39H34ClN3O6/c1-25-29(8-5-10-32(25)28-11-12-35-38(18-28)47-15-14-46-35)24-49-37-20-36(48-23-27-7-4-6-26(16-27)21-41)30(17-33(37)40)22-43-34(39(44)45)19-31-9-2-3-13-42-31/h2-13,16-18,20,34,43H,14-15,19,22-24H2,1H3,(H,44,45)/t34-/m0/s1 XKUDOMLJQJEOOF-UMSFTDKQSA-N 363301 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(pyridin-2-yl)propanoic acid::US9850225, Example 1221 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363301&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435004 401958760 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719369 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCSC[C@@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H33ClN2O6S/c1-23-27(6-3-7-29(23)26-8-9-32-35(16-26)43-12-11-42-32)21-45-34-17-33(44-20-25-5-2-4-24(14-25)18-38)28(15-30(34)37)19-39-10-13-46-22-31(39)36(40)41/h2-9,14-17,31H,10-13,19-22H2,1H3,(H,40,41)/t31-/m1/s1 SQBNTSHKDPDVNS-WJOKGBTCSA-N 363302 (S)-4-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)thiomorpholine-3-carboxylic acid::US9850225, Example 1222 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363302&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435017 401958761 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719370 CN1CCN(CC(C)(C)NCc2cc(Cl)c(OCc3cccc(c3C)-c3ccc4OCCOc4c3)cc2OCc2cccc(c2)C#N)CC1 InChI=1S/C40H45ClN4O4/c1-28-32(9-6-10-34(28)31-11-12-36-39(21-31)47-18-17-46-36)26-49-38-22-37(48-25-30-8-5-7-29(19-30)23-42)33(20-35(38)41)24-43-40(2,3)27-45-15-13-44(4)14-16-45/h5-12,19-22,43H,13-18,24-27H2,1-4H3 HUVQINOJVKDICI-UHFFFAOYSA-N 363303 3-((4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-(((2-methyl-1-(4-methylpiperazin-1-yl)propan-2-yl)amino)methyl)phenoxy)methyl)benzonitrile::US9850225, Example 1223 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363303&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435204 401958762 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719371 CN1CCN(Cc2cc(Cl)c(OCc3cccc(c3C)-c3ccc4OCCOc4c3)cc2OCc2cccc(c2)C#N)C(C1)C(O)=O InChI=1S/C37H36ClN3O6/c1-24-28(7-4-8-30(24)27-9-10-33-36(17-27)45-14-13-44-33)23-47-35-18-34(46-22-26-6-3-5-25(15-26)19-39)29(16-31(35)38)20-41-12-11-40(2)21-32(41)37(42)43/h3-10,15-18,32H,11-14,20-23H2,1-2H3,(H,42,43) CBMLPBINKYLQQZ-UHFFFAOYSA-N 363304 1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-methylpiperazine-2-carboxylic acid::US9850225, Example 1224 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363304&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434686 401958763 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719372 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNCC(O)CN3CCCC3=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H38ClN3O6/c1-25-29(7-3-8-32(25)28-10-11-34-37(17-28)46-14-13-45-34)24-48-36-18-35(47-23-27-6-2-5-26(15-27)19-40)30(16-33(36)39)20-41-21-31(43)22-42-12-4-9-38(42)44/h2-3,5-8,10-11,15-18,31,41,43H,4,9,12-14,20-24H2,1H3 XMKXPTDLYYVFBV-UHFFFAOYSA-N 363305 3-((4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((2-hydroxy-3-(2-oxopyrrolidin-1-yl)propyl)amino)methyl)phenoxy)methyl)benzonitrile::US9850225, Example 1225 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363305&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435116 401958764 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719373 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCc4nc[nH]c4C3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 363306 5-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-4-carboxylic acid::US9850225, Example 1226 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363306&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434814 401958765 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719374 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](Cn3ncnn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H31ClN6O6/c1-22-26(6-3-7-28(22)25-8-9-31-34(14-25)46-11-10-45-31)20-48-33-15-32(47-19-24-5-2-4-23(12-24)16-37)27(13-29(33)36)17-38-30(35(43)44)18-42-40-21-39-41-42/h2-9,12-15,21,30,38H,10-11,17-20H2,1H3,(H,43,44)/t30-/m0/s1 IJPAWEZVVBDJFO-PMERELPUSA-N 363308 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(2H-tetrazol-2-yl)propanoic acid::US9850225, Example 1227 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363308&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434609 401958767 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719375 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@H](Cc3cn(Cc4ccccc4)cn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C44H39ClN4O6/c1-29-34(11-6-12-37(29)33-13-14-40-43(19-33)53-16-15-52-40)27-55-42-21-41(54-26-32-10-5-9-31(17-32)22-46)35(18-38(42)45)23-47-39(44(50)51)20-36-25-49(28-48-36)24-30-7-3-2-4-8-30/h2-14,17-19,21,25,28,39,47H,15-16,20,23-24,26-27H2,1H3,(H,50,51)/t39-/m1/s1 UIQQWEQJYFELQS-LDLOPFEMSA-N 363309 (R)-3-(1-benzyl-1H-imidazol-4-yl)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)propanoic acid::US9850225, Example 1228 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363309&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434777 401958768 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719376 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNCc3nnn[nH]3)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C33H29ClN6O4/c1-21-25(6-3-7-27(21)24-8-9-29-32(14-24)42-11-10-41-29)20-44-31-15-30(43-19-23-5-2-4-22(12-23)16-35)26(13-28(31)34)17-36-18-33-37-39-40-38-33/h2-9,12-15,36H,10-11,17-20H2,1H3,(H,37,38,39,40) KVFHAKCLKXRXSS-UHFFFAOYSA-N 363310 3-((2-((((1H-tetrazol-5-yl)methyl)amino)methyl)-4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)phenoxy)methyl)benzonitrile::US9850225, Example 1229 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363310&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434685 401958769 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719377 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H35ClN2O6/c1-24-28(8-5-9-30(24)27-11-12-33-36(18-27)44-15-14-43-33)23-46-35-19-34(45-22-26-7-4-6-25(16-26)20-39)29(17-31(35)38)21-40-13-3-2-10-32(40)37(41)42/h4-9,11-12,16-19,32H,2-3,10,13-15,21-23H2,1H3,(H,41,42)/t32-/m0/s1 RELGDHKISWTSBN-YTTGMZPUSA-N 363311 (S)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1230 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363311&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435046 401958770 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719378 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccccc1 InChI=1S/C32H29ClN2O5/c1-21-26(11-6-12-27(21)24-9-3-2-4-10-24)20-39-29-14-13-25(17-35-28(18-36)32(37)38)31(30(29)33)40-19-23-8-5-7-22(15-23)16-34/h2-15,28,35-36H,17-20H2,1H3,(H,37,38)/t28-/m1/s1 AEZSNGNHHGSNOX-MUUNZHRXSA-N 363312 (R)-2-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1231 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363312&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434891 401958771 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719379 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccccc1 InChI=1S/C33H31ClN2O5/c1-22-27(11-6-12-29(22)25-9-3-2-4-10-25)21-40-30-14-13-26(18-36-19-28(37)16-31(38)39)33(32(30)34)41-20-24-8-5-7-23(15-24)17-35/h2-15,28,36-37H,16,18-21H2,1H3,(H,38,39)/t28-/m0/s1 NBNSYDVPJKERSX-NDEPHWFRSA-N 363313 (S)-4-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1232 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363313&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434999 401958772 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719380 Cc1c(COc2ccc(CN3CCCC[C@H]3C(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccccc1 InChI=1S/C35H33ClN2O4/c1-24-29(13-8-14-30(24)27-11-3-2-4-12-27)23-41-32-17-16-28(21-38-18-6-5-15-31(38)35(39)40)34(33(32)36)42-22-26-10-7-9-25(19-26)20-37/h2-4,7-14,16-17,19,31H,5-6,15,18,21-23H2,1H3,(H,39,40)/t31-/m0/s1 JKKDGWNYBQRAAD-HKBQPEDESA-N 363314 (S)-1-(3-chloro-2-(3-cyanobenzyloxy)-4-((2-methylbiphenyl-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1233 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363314&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434972 401958773 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719381 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccccc2)c(Cl)c1OCc1cccc(c1)C#N InChI=1S/C33H32ClN3O3/c1-23-29(12-7-13-30(23)27-10-4-3-5-11-27)22-39-31-15-14-28(20-36-16-17-37-24(2)38)33(32(31)34)40-21-26-9-6-8-25(18-26)19-35/h3-15,18,36H,16-17,20-22H2,1-2H3,(H,37,38) HUGUSGGCINLMGQ-UHFFFAOYSA-N 363315 N-(2-(3-chloro-2-(3-cyanobenzyloxy)-4-((2-methylbiphenyl-3-yl)methoxy)benzylamino)ethyl)acetamide::US9850225, Example 1234 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363315&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435002 401958774 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719382 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H31ClN2O7/c1-21-26(6-3-7-27(21)24-8-10-29-31(15-24)42-13-12-41-29)20-43-30-11-9-25(17-37-28(18-38)34(39)40)33(32(30)35)44-19-23-5-2-4-22(14-23)16-36/h2-11,14-15,28,37-38H,12-13,17-20H2,1H3,(H,39,40)/t28-/m1/s1 RHYSPVUVXCZVIV-MUUNZHRXSA-N 363316 (R)-2-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1235 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363316&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434769 401958775 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719383 Cc1c(COc2ccc(CN3CCCCC3)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H35ClN2O4/c1-25-30(9-6-10-31(25)28-11-13-32-34(20-28)41-18-17-40-32)24-42-33-14-12-29(22-39-15-3-2-4-16-39)36(35(33)37)43-23-27-8-5-7-26(19-27)21-38/h5-14,19-20H,2-4,15-18,22-24H2,1H3 RLOOAUHOZWSXEY-UHFFFAOYSA-N 363317 (S)-1-(3-chloro-2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1236 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363317&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118441453 401958776 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719384 CC(=O)NCCNCc1ccc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)c(Cl)c1OCc1cccc(c1)C#N InChI=1S/C35H34ClN3O5/c1-23-29(7-4-8-30(23)27-9-11-31-33(18-27)42-16-15-41-31)22-43-32-12-10-28(20-38-13-14-39-24(2)40)35(34(32)36)44-21-26-6-3-5-25(17-26)19-37/h3-12,17-18,38H,13-16,20-22H2,1-2H3,(H,39,40) WVLGQTAYZUCCLP-UHFFFAOYSA-N 363318 N-(2-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1237 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363318&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434594 401958777 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719385 Cc1c(COc2ccc(CN[C@@](C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-27(7-4-8-28(22)25-9-11-29-31(16-25)43-14-13-42-29)20-44-30-12-10-26(18-38-35(2,21-39)34(40)41)33(32(30)36)45-19-24-6-3-5-23(15-24)17-37/h3-12,15-16,38-39H,13-14,18-21H2,1-2H3,(H,40,41)/t35-/m0/s1 IVWMGSHTQSFQLH-DHUJRADRSA-N 363319 (S)-2-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1238 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363319&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434971 401958778 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719386 Cc1c(COc2ccc(CN[C@](C)(CO)C(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-27(7-4-8-28(22)25-9-11-29-31(16-25)43-14-13-42-29)20-44-30-12-10-26(18-38-35(2,21-39)34(40)41)33(32(30)36)45-19-24-6-3-5-23(15-24)17-37/h3-12,15-16,38-39H,13-14,18-21H2,1-2H3,(H,40,41)/t35-/m1/s1 IVWMGSHTQSFQLH-PGUFJCEWSA-N 363320 (R)-2-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1239 Programmed cell death 1 ligand 1 Human 149 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363320&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434809 401958779 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719387 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCc3cccc(c3)C#N)c2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-27(6-3-7-29(22)25-8-10-30-32(15-25)43-13-12-42-30)21-44-31-11-9-26(18-38-19-28(39)16-33(40)41)35(34(31)36)45-20-24-5-2-4-23(14-24)17-37/h2-11,14-15,28,38-39H,12-13,16,18-21H2,1H3,(H,40,41)/t28-/m0/s1 LFWYGRMVNAPSER-NDEPHWFRSA-N 363321 (S)-4-((3-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1240 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363321&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435079 401958780 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719388 C[C@](CO)(NCc1cc(Cl)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C35H30ClN3O7/c1-35(21-40,34(41)42)39-18-26-13-29(36)32(15-31(26)45-19-23-5-2-4-22(12-23)16-37)46-20-25-6-3-7-27(28(25)17-38)24-8-9-30-33(14-24)44-11-10-43-30/h2-9,12-15,39-40H,10-11,18-21H2,1H3,(H,41,42)/t35-/m1/s1 YOVCNLCBKCEIJP-PGUFJCEWSA-N 363322 (R)-2-((5-chloro-4-((2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)oxy)-2-((3-cyanobenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1241 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363322&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434893 401958781 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719389 OC[C@@H](NCc1cc(Cl)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C34H28ClN3O7/c35-28-12-25(17-38-29(18-39)34(40)41)31(44-19-22-4-1-3-21(11-22)15-36)14-32(28)45-20-24-5-2-6-26(27(24)16-37)23-7-8-30-33(13-23)43-10-9-42-30/h1-8,11-14,29,38-39H,9-10,17-20H2,(H,40,41)/t29-/m1/s1 TWANQEJZCRZYJW-GDLZYMKVSA-N 363323 (R)-2-((5-chloro-4-((2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)oxy)-2-((3-cyanobenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1242 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363323&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435144 401958782 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719390 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC3(COC3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H31ClN2O7/c1-22-26(6-3-7-28(22)25-8-9-30-33(14-25)43-11-10-42-30)19-45-32-15-31(44-18-24-5-2-4-23(12-24)16-37)27(13-29(32)36)17-38-35(34(39)40)20-41-21-35/h2-9,12-15,38H,10-11,17-21H2,1H3,(H,39,40) DJXRTOIVNOXSFL-UHFFFAOYSA-N 363324 3-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)oxetane-3-carboxylic acid::US9850225, Example 1243 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363324&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435155 401958783 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719391 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-26(7-4-8-28(22)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-35(2,21-39)34(40)41/h3-10,13-16,38-39H,11-12,18-21H2,1-2H3,(H,40,41)/t35-/m1/s1 CPEOJEYQTDEPQL-PGUFJCEWSA-N 363325 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1244 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363325&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435194 401958784 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719392 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-26(7-4-8-28(22)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-35(2,21-39)34(40)41/h3-10,13-16,38-39H,11-12,18-21H2,1-2H3,(H,40,41)/t35-/m0/s1 CPEOJEYQTDEPQL-DHUJRADRSA-N 363326 (S)-2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1245 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363326&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434764 401958785 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719393 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC[C@@H](O)CC(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33ClN2O7/c1-22-26(6-3-7-29(22)25-8-9-31-34(14-25)43-11-10-42-31)21-45-33-16-32(44-20-24-5-2-4-23(12-24)17-37)27(13-30(33)36)18-38-19-28(39)15-35(40)41/h2-9,12-14,16,28,38-39H,10-11,15,18-21H2,1H3,(H,40,41)/t28-/m0/s1 NBXSTEOUTRKTCC-NDEPHWFRSA-N 363327 (S)-4-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1246 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363327&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435071 401958786 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719394 CC(=O)NCCNCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C35H34ClN3O5/c1-23-28(7-4-8-30(23)27-9-10-32-35(17-27)42-14-13-41-32)22-44-34-18-33(43-21-26-6-3-5-25(15-26)19-37)29(16-31(34)36)20-38-11-12-39-24(2)40/h3-10,15-18,38H,11-14,20-22H2,1-2H3,(H,39,40) UYQDGSZLEYFTTB-UHFFFAOYSA-N 363328 N-(2-((5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1247 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363328&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434667 401958787 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719395 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32ClN3O7/c1-21-25(4-3-5-27(21)24-6-7-29-32(12-24)43-9-8-42-29)19-45-31-13-30(44-18-23-10-22(14-36)15-37-16-23)26(11-28(31)35)17-38-34(2,20-39)33(40)41/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m1/s1 AORMRAFXDZAYIV-UUWRZZSWSA-N 363329 (R)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1248 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363329&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435027 401958788 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719396 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@H](CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C33H30ClN3O7/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)42-8-7-41-29)19-44-31-12-30(43-18-22-9-21(13-35)14-36-15-22)25(10-27(31)34)16-37-28(17-38)33(39)40/h2-6,9-12,14-15,28,37-38H,7-8,16-19H2,1H3,(H,39,40)/t28-/m1/s1 ZIMVINCYEODYQW-MUUNZHRXSA-N 363330 (R)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1249 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363330&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435185 401958789 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719397 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC[C@@H](O)CC(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32ClN3O7/c1-21-25(3-2-4-28(21)24-5-6-30-33(11-24)43-8-7-42-30)20-45-32-13-31(44-19-23-9-22(14-36)15-37-16-23)26(10-29(32)35)17-38-18-27(39)12-34(40)41/h2-6,9-11,13,15-16,27,38-39H,7-8,12,17-20H2,1H3,(H,40,41)/t27-/m0/s1 RCZXCVYMDZXDEX-MHZLTWQESA-N 363331 (S)-4-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1250 Programmed cell death 1 ligand 1 Human 1.19 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363331&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435160 401958790 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719398 CC(=O)NCCNCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C34H33ClN4O5/c1-22-27(4-3-5-29(22)26-6-7-31-34(14-26)42-11-10-41-31)21-44-33-15-32(43-20-25-12-24(16-36)17-38-18-25)28(13-30(33)35)19-37-8-9-39-23(2)40/h3-7,12-15,17-18,37H,8-11,19-21H2,1-2H3,(H,39,40) VYPKWHJCYAIWSA-UHFFFAOYSA-N 363332 N-(2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1251 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363332&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434986 401958791 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719399 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32ClN3O7/c1-21-25(4-3-5-27(21)24-6-7-29-32(12-24)43-9-8-42-29)19-45-31-13-30(44-18-23-10-22(14-36)15-37-16-23)26(11-28(31)35)17-38-34(2,20-39)33(40)41/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m0/s1 AORMRAFXDZAYIV-UMSFTDKQSA-N 363333 (S)-2-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1252 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363333&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434993 401958792 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719400 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H34ClN3O6/c1-23-27(5-4-6-29(23)26-8-9-32-35(15-26)44-12-11-43-32)22-46-34-16-33(45-21-25-13-24(17-38)18-39-19-25)28(14-30(34)37)20-40-10-3-2-7-31(40)36(41)42/h4-6,8-9,13-16,18-19,31H,2-3,7,10-12,20-22H2,1H3,(H,41,42)/t31-/m0/s1 JZRQGULNPQIOSX-HKBQPEDESA-N 363334 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid, TFA salt::US9850225, Example 1253 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363334&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434724 401958793 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719401 Cc1c(COc2cc(OCc3cncc(Br)c3)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C33H32BrClN2O7/c1-20-23(4-3-5-26(20)22-6-7-28-31(12-22)42-9-8-41-28)18-44-30-13-29(43-17-21-10-25(34)16-36-14-21)24(11-27(30)35)15-37-33(2,19-38)32(39)40/h3-7,10-14,16,37-38H,8-9,15,17-19H2,1-2H3,(H,39,40)/t33-/m1/s1 WQZAVOCQWIMWJG-MGBGTMOVSA-N 363335 (R)-2-(2-((5-bromopyridin-3-yl)methoxy)-5-chloro-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1254 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363335&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434751 401958794 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719402 CC(=O)NCCNCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(Br)c1 InChI=1S/C33H33BrClN3O5/c1-21-25(4-3-5-28(21)24-6-7-30-33(14-24)41-11-10-40-30)20-43-32-15-31(42-19-23-12-27(34)18-37-16-23)26(13-29(32)35)17-36-8-9-38-22(2)39/h3-7,12-16,18,36H,8-11,17,19-20H2,1-2H3,(H,38,39) WPKOJUXMMFDBIP-UHFFFAOYSA-N 363336 N-(2-(2-((5-bromopyridin-3-yl)methoxy)-5-chloro-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)ethyl)acetamide::US9850225, Example 1255 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363336&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434721 401958795 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719403 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(=O)NS(C)(=O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H37ClN4O7S/c1-24-28(6-5-7-30(24)27-9-10-33-36(16-27)47-13-12-46-33)23-49-35-17-34(48-22-26-14-25(18-39)19-40-20-26)29(15-31(35)38)21-42-11-4-3-8-32(42)37(43)41-50(2,44)45/h5-7,9-10,14-17,19-20,32H,3-4,8,11-13,21-23H2,1-2H3,(H,41,43)/t32-/m0/s1 ZVGJNVQAMABRKD-YTTGMZPUSA-N 363337 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-(methylsulfonyl)piperidine-2-carboxamide::US9850225, Example 1256 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363337&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434791 401958796 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719404 CN(C)S(=O)(=O)NC(=O)[C@@H]1CCCCN1Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C38H40ClN5O7S/c1-25-29(7-6-8-31(25)28-10-11-34-37(17-28)49-14-13-48-34)24-51-36-18-35(50-23-27-15-26(19-40)20-41-21-27)30(16-32(36)39)22-44-12-5-4-9-33(44)38(45)42-52(46,47)43(2)3/h6-8,10-11,15-18,20-21,33H,4-5,9,12-14,22-24H2,1-3H3,(H,42,45)/t33-/m0/s1 QTHKUZFLXDYYJR-XIFFEERXSA-N 363338 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N—(N,N-dimethylsulfamoyl)piperidine-2-carboxamide::US9850225, Example 1257 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363338&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435098 401958797 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719405 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(=O)NS(=O)(=O)C(F)(F)F)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H34ClF3N4O7S/c1-23-27(5-4-6-29(23)26-8-9-32-35(15-26)50-12-11-49-32)22-52-34-16-33(51-21-25-13-24(17-42)18-43-19-25)28(14-30(34)38)20-45-10-3-2-7-31(45)36(46)44-53(47,48)37(39,40)41/h4-6,8-9,13-16,18-19,31H,2-3,7,10-12,20-22H2,1H3,(H,44,46)/t31-/m0/s1 CHQZIRLDHUWQQQ-HKBQPEDESA-N 363339 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-((trifluoromethyl)sulfonyl)piperidine-2-carboxamide::US9850225, Example 1258 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363339&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434863 401958798 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719406 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(=O)NS(=O)(=O)C3CC3)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C39H39ClN4O7S/c1-25-29(5-4-6-32(25)28-8-11-35-38(17-28)49-14-13-48-35)24-51-37-18-36(50-23-27-15-26(19-41)20-42-21-27)30(16-33(37)40)22-44-12-3-2-7-34(44)39(45)43-52(46,47)31-9-10-31/h4-6,8,11,15-18,20-21,31,34H,2-3,7,9-10,12-14,22-24H2,1H3,(H,43,45)/t34-/m0/s1 KYJUXUZZFPJQIQ-UMSFTDKQSA-N 363340 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-(cyclopropylsulfonyl)piperidine-2-carboxamide::US9850225, Example 1259 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363340&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435008 401958799 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719407 CC(C)S(=O)(=O)NC(=O)[C@@H]1CCCCN1Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C39H41ClN4O7S/c1-25(2)52(46,47)43-39(45)34-9-4-5-12-44(34)22-31-16-33(40)37(18-36(31)50-23-28-15-27(19-41)20-42-21-28)51-24-30-7-6-8-32(26(30)3)29-10-11-35-38(17-29)49-14-13-48-35/h6-8,10-11,15-18,20-21,25,34H,4-5,9,12-14,22-24H2,1-3H3,(H,43,45)/t34-/m0/s1 RSGYKXSOYFKZGB-UMSFTDKQSA-N 363341 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-(isopropylsulfonyl)piperidine-2-carboxamide::US9850225, Example 1260 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363341&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434689 401958800 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719408 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(=O)NS(=O)(=O)c3cn(C)cn3)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C40H39ClN6O7S/c1-26-30(6-5-7-32(26)29-9-10-35-38(16-29)52-13-12-51-35)24-54-37-17-36(53-23-28-14-27(18-42)19-43-20-28)31(15-33(37)41)21-47-11-4-3-8-34(47)40(48)45-55(49,50)39-22-46(2)25-44-39/h5-7,9-10,14-17,19-20,22,25,34H,3-4,8,11-13,21,23-24H2,1-2H3,(H,45,48)/t34-/m0/s1 NZYBNHSYIYOVDJ-UMSFTDKQSA-N 363342 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-((1-methyl-1H-imidazol-4-yl)sulfonyl)piperidine-2-carboxamide::US9850225, Example 1261 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363342&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435053 401958801 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719409 CN1CCN(CC1)S(=O)(=O)NC(=O)[C@@H]1CCCCN1Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C41H45ClN6O7S/c1-28-32(6-5-7-34(28)31-9-10-37-40(20-31)53-17-16-52-37)27-55-39-21-38(54-26-30-18-29(22-43)23-44-24-30)33(19-35(39)42)25-47-11-4-3-8-36(47)41(49)45-56(50,51)48-14-12-46(2)13-15-48/h5-7,9-10,18-21,23-24,36H,3-4,8,11-17,25-27H2,1-2H3,(H,45,49)/t36-/m0/s1 VJLPIFODDVSKRQ-BHVANESWSA-N 363343 (S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-((4-methylpiperazin-1-yl)sulfonyl)piperidine-2-carboxamide::US9850225, Example 1262 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363343&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435054 401958802 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719410 Cc1c(COc2cc(O)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C27H28ClNO7/c1-16-18(4-3-5-20(16)17-6-7-23-25(11-17)35-9-8-34-23)14-36-24-12-22(31)19(10-21(24)28)13-29-27(2,15-30)26(32)33/h3-7,10-12,29-31H,8-9,13-15H2,1-2H3,(H,32,33)/t27-/m1/s1 DPQCAJBZMLUEIE-HHHXNRCGSA-N 363344 (R)-2-((5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-hydroxybenzyl)amino)-3-hydroxy-2-methylpropanoic acid, TFA::US9850225, Example 1263 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363344&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434785 401958803 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719411 CC(=O)NCCNCc1cc(C)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C36H37N3O5/c1-24-16-31(21-38-12-13-39-26(3)40)35(43-22-28-7-4-6-27(17-28)20-37)19-34(24)44-23-30-8-5-9-32(25(30)2)29-10-11-33-36(18-29)42-15-14-41-33/h4-11,16-19,38H,12-15,21-23H2,1-3H3,(H,39,40) GLMJUECYXOBRDU-UHFFFAOYSA-N 363345 N-(2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)ethyl)acetamide::US9850225, Example 1264 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363345&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434807 401958804 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719412 Cc1cc(CNC[C@@H](O)CC(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H36N2O7/c1-23-13-29(19-38-20-30(39)16-36(40)41)34(44-21-26-6-3-5-25(14-26)18-37)17-33(23)45-22-28-7-4-8-31(24(28)2)27-9-10-32-35(15-27)43-12-11-42-32/h3-10,13-15,17,30,38-39H,11-12,16,19-22H2,1-2H3,(H,40,41)/t30-/m0/s1 DYVLJKKUSCDKRZ-PMERELPUSA-N 363346 (S)-4-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1265 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363346&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434845 401958805 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719413 Cc1cc(CN[C@@H](CO)C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C35H34N2O7/c1-22-13-28(18-37-30(19-38)35(39)40)33(43-20-25-6-3-5-24(14-25)17-36)16-32(22)44-21-27-7-4-8-29(23(27)2)26-9-10-31-34(15-26)42-12-11-41-31/h3-10,13-16,30,37-38H,11-12,18-21H2,1-2H3,(H,39,40)/t30-/m0/s1 UWNXGZKSIKQKAH-PMERELPUSA-N 363347 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1266 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363347&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434702 401958806 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719414 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H36N2O7/c1-23-14-29(19-38-36(3,22-39)35(40)41)33(44-20-26-7-4-6-25(15-26)18-37)17-32(23)45-21-28-8-5-9-30(24(28)2)27-10-11-31-34(16-27)43-13-12-42-31/h4-11,14-17,38-39H,12-13,19-22H2,1-3H3,(H,40,41)/t36-/m0/s1 HKLSFZJCUUNJRX-BHVANESWSA-N 363348 (S)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1267 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363348&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435057 401958807 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719415 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C38H38N2O6/c1-25-17-31(22-40-14-4-3-11-33(40)38(41)42)36(45-23-28-8-5-7-27(18-28)21-39)20-35(25)46-24-30-9-6-10-32(26(30)2)29-12-13-34-37(19-29)44-16-15-43-34/h5-10,12-13,17-20,33H,3-4,11,14-16,22-24H2,1-2H3,(H,41,42)/t33-/m0/s1 YOJUYVRTOWKADA-XIFFEERXSA-N 363349 (S)-1-(2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1268 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363349&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435208 401958808 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719416 Cc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H36N2O7/c1-23-14-29(19-38-36(3,22-39)35(40)41)33(44-20-26-7-4-6-25(15-26)18-37)17-32(23)45-21-28-8-5-9-30(24(28)2)27-10-11-31-34(16-27)43-13-12-42-31/h4-11,14-17,38-39H,12-13,19-22H2,1-3H3,(H,40,41)/t36-/m1/s1 HKLSFZJCUUNJRX-PSXMRANNSA-N 363350 (R)-2-((2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1269 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363350&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434855 401958809 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719417 Cc1cc(CNC[C@@H](O)CC(O)=O)c(OCc2ccc(F)c(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H35FN2O7/c1-22-12-28(18-39-19-29(40)15-36(41)42)34(45-20-24-6-8-31(37)27(13-24)17-38)16-33(22)46-21-26-4-3-5-30(23(26)2)25-7-9-32-35(14-25)44-11-10-43-32/h3-9,12-14,16,29,39-40H,10-11,15,18-21H2,1-2H3,(H,41,42)/t29-/m0/s1 BMVKWRCPNMQQOQ-LJAQVGFWSA-N 363351 (S)-4-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1270 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363351&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434788 401958810 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719418 CC(=O)NCCNCc1cc(C)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1ccc(F)c(c1)C#N InChI=1S/C36H36FN3O5/c1-23-15-30(20-39-11-12-40-25(3)41)35(44-21-26-7-9-32(37)29(16-26)19-38)18-34(23)45-22-28-5-4-6-31(24(28)2)27-8-10-33-36(17-27)43-14-13-42-33/h4-10,15-18,39H,11-14,20-22H2,1-3H3,(H,40,41) AFPMNGVRDIGLRJ-UHFFFAOYSA-N 363352 N-(2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)ethyl)acetamide::US9850225, Example 1271 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363352&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435019 401958811 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719419 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2ccc(F)c(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C38H37FN2O6/c1-24-16-30(21-41-13-4-3-8-33(41)38(42)43)36(46-22-26-9-11-32(39)29(17-26)20-40)19-35(24)47-23-28-6-5-7-31(25(28)2)27-10-12-34-37(18-27)45-15-14-44-34/h5-7,9-12,16-19,33H,3-4,8,13-15,21-23H2,1-2H3,(H,42,43)/t33-/m0/s1 ODKHJSFCXLLUME-XIFFEERXSA-N 363355 (S)-1-(2-((3-cyano-4-fluorobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1272 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363355&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434590 401958813 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719420 Cc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2ccc(F)c(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H35FN2O7/c1-22-13-28(18-39-36(3,21-40)35(41)42)33(45-19-24-7-9-30(37)27(14-24)17-38)16-32(22)46-20-26-5-4-6-29(23(26)2)25-8-10-31-34(15-25)44-12-11-43-31/h4-10,13-16,39-40H,11-12,18-21H2,1-3H3,(H,41,42)/t36-/m1/s1 FKHUMYGCRJKTHQ-PSXMRANNSA-N 363356 (R)-2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1273 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363356&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434867 401958814 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719421 Cc1cc(CN[C@@H](CO)C(O)=O)c(OCc2ccc(F)c(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C35H33FN2O7/c1-21-12-27(17-38-30(18-39)35(40)41)33(44-19-23-6-8-29(36)26(13-23)16-37)15-32(21)45-20-25-4-3-5-28(22(25)2)24-7-9-31-34(14-24)43-11-10-42-31/h3-9,12-15,30,38-39H,10-11,17-20H2,1-2H3,(H,40,41)/t30-/m0/s1 GREHIZYCYGNCIS-PMERELPUSA-N 363357 (S)-2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1274 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363357&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434961 401958815 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719422 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2ccc(F)c(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H35FN2O7/c1-22-13-28(18-39-36(3,21-40)35(41)42)33(45-19-24-7-9-30(37)27(14-24)17-38)16-32(22)46-20-26-5-4-6-29(23(26)2)25-8-10-31-34(15-25)44-12-11-43-31/h4-10,13-16,39-40H,11-12,18-21H2,1-3H3,(H,41,42)/t36-/m0/s1 FKHUMYGCRJKTHQ-BHVANESWSA-N 363358 (S)-2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1275 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363358&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435199 401958816 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719423 CC(=O)NCCNCc1cc(C)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccnc1 InChI=1S/C34H37N3O5/c1-23-16-29(20-36-12-13-37-25(3)38)33(41-21-26-6-5-11-35-19-26)18-32(23)42-22-28-7-4-8-30(24(28)2)27-9-10-31-34(17-27)40-15-14-39-31/h4-11,16-19,36H,12-15,20-22H2,1-3H3,(H,37,38) OLPQHGVNFHEYER-UHFFFAOYSA-N 363359 N-(2-((4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methyl-2-(pyridin-3-ylmethoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1276 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363359&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435134 401958817 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719424 Cc1cc(CN[C@@H](CO)C(O)=O)c(OCc2cccnc2)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C33H34N2O7/c1-21-13-26(17-35-28(18-36)33(37)38)31(41-19-23-5-4-10-34-16-23)15-30(21)42-20-25-6-3-7-27(22(25)2)24-8-9-29-32(14-24)40-12-11-39-29/h3-10,13-16,28,35-36H,11-12,17-20H2,1-2H3,(H,37,38)/t28-/m0/s1 LNLGFDBFVZZLEW-NDEPHWFRSA-N 363360 (S)-2-((4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methyl-2-(pyridin-3-ylmethoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1277 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363360&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434846 401958818 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719425 Cc1cc(CNC[C@@H](O)CC(O)=O)c(OCc2cccnc2)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C34H36N2O7/c1-22-13-27(18-36-19-28(37)15-34(38)39)32(42-20-24-5-4-10-35-17-24)16-31(22)43-21-26-6-3-7-29(23(26)2)25-8-9-30-33(14-25)41-12-11-40-30/h3-10,13-14,16-17,28,36-37H,11-12,15,18-21H2,1-2H3,(H,38,39)/t28-/m0/s1 ABWCQDDZIYNWBW-NDEPHWFRSA-N 363361 (S)-4-((4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methyl-2-(pyridin-3-ylmethoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1278 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363361&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434662 401958819 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719426 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cccnc2)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C36H38N2O6/c1-24-17-29(21-38-14-4-3-10-31(38)36(39)40)34(43-22-26-7-6-13-37-20-26)19-33(24)44-23-28-8-5-9-30(25(28)2)27-11-12-32-35(18-27)42-16-15-41-32/h5-9,11-13,17-20,31H,3-4,10,14-16,21-23H2,1-2H3,(H,39,40)/t31-/m0/s1 WACOYVLHVAVSNK-HKBQPEDESA-N 363362 (S)-1-(4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methyl-2-(pyridin-3-ylmethoxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1279 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363362&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434661 401958820 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719427 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2cccnc2)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C34H36N2O7/c1-22-14-27(18-36-34(3,21-37)33(38)39)31(42-19-24-6-5-11-35-17-24)16-30(22)43-20-26-7-4-8-28(23(26)2)25-9-10-29-32(15-25)41-13-12-40-29/h4-11,14-17,36-37H,12-13,18-21H2,1-3H3,(H,38,39)/t34-/m0/s1 RFIXBDLGNKLEDK-UMSFTDKQSA-N 363363 (S)-2-((4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methyl-2-(pyridin-3-ylmethoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1280 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363363&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434717 401958821 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719428 Cc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2cccnc2)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C34H36N2O7/c1-22-14-27(18-36-34(3,21-37)33(38)39)31(42-19-24-6-5-11-35-17-24)16-30(22)43-20-26-7-4-8-28(23(26)2)25-9-10-29-32(15-25)41-13-12-40-29/h4-11,14-17,36-37H,12-13,18-21H2,1-3H3,(H,38,39)/t34-/m1/s1 RFIXBDLGNKLEDK-UUWRZZSWSA-N 363366 (R)-2-((4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methyl-2-(pyridin-3-ylmethoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1281 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363366&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434618 401958823 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719429 CC(=O)NCCNCc1cc(C)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C35H36N4O5/c1-23-13-30(20-37-9-10-39-25(3)40)34(43-21-27-14-26(17-36)18-38-19-27)16-33(23)44-22-29-5-4-6-31(24(29)2)28-7-8-32-35(15-28)42-12-11-41-32/h4-8,13-16,18-19,37H,9-12,20-22H2,1-3H3,(H,39,40) AUQQACYTJFRTIL-UHFFFAOYSA-N 363367 N-(2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)ethyl)acetamide::US9850225, Example 1282 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363367&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434720 401958824 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719430 Cc1cc(CNC[C@@H](O)CC(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C35H35N3O7/c1-22-10-28(18-38-19-29(39)13-35(40)41)33(44-20-25-11-24(15-36)16-37-17-25)14-32(22)45-21-27-4-3-5-30(23(27)2)26-6-7-31-34(12-26)43-9-8-42-31/h3-7,10-12,14,16-17,29,38-39H,8-9,13,18-21H2,1-2H3,(H,40,41)/t29-/m0/s1 KNHZRYHBJBCWCI-LJAQVGFWSA-N 363368 (S)-4-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)-3-hydroxybutanoic acid::US9850225, Example 1283 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363368&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434834 401958825 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719431 Cc1cc(CN[C@@H](CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C34H33N3O7/c1-21-10-27(17-37-29(18-38)34(39)40)32(43-19-24-11-23(14-35)15-36-16-24)13-31(21)44-20-26-4-3-5-28(22(26)2)25-6-7-30-33(12-25)42-9-8-41-30/h3-7,10-13,15-16,29,37-38H,8-9,17-20H2,1-2H3,(H,39,40)/t29-/m0/s1 YRACWCUSAGLZCG-LJAQVGFWSA-N 363369 (S)-2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)-3-hydroxypropanoic acid::US9850225, Example 1284 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363369&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435038 401958826 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719432 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C37H37N3O6/c1-24-14-30(21-40-11-4-3-8-32(40)37(41)42)35(45-22-27-15-26(18-38)19-39-20-27)17-34(24)46-23-29-6-5-7-31(25(29)2)28-9-10-33-36(16-28)44-13-12-43-33/h5-7,9-10,14-17,19-20,32H,3-4,8,11-13,21-23H2,1-2H3,(H,41,42)/t32-/m0/s1 NITFZQZWGZBIIX-YTTGMZPUSA-N 363370 (S)-1-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1285 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363370&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434759 401958827 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719433 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C35H35N3O7/c1-22-11-28(18-38-35(3,21-39)34(40)41)32(44-19-25-12-24(15-36)16-37-17-25)14-31(22)45-20-27-5-4-6-29(23(27)2)26-7-8-30-33(13-26)43-10-9-42-30/h4-8,11-14,16-17,38-39H,9-10,18-21H2,1-3H3,(H,40,41)/t35-/m0/s1 RJKHYQLXAJIFMD-DHUJRADRSA-N 363371 (S)-2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1286 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363371&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435205 401958828 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719434 Cc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C35H35N3O7/c1-22-11-28(18-38-35(3,21-39)34(40)41)32(44-19-25-12-24(15-36)16-37-17-25)14-31(22)45-20-27-5-4-6-29(23(27)2)26-7-8-30-33(13-26)43-10-9-42-30/h4-8,11-14,16-17,38-39H,9-10,18-21H2,1-3H3,(H,40,41)/t35-/m1/s1 RJKHYQLXAJIFMD-PGUFJCEWSA-N 363372 (R)-2-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1287 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363372&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434645 401958829 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719435 Cc1cc(CN2CCCC[C@@H]2C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C37H37N3O6/c1-24-14-30(21-40-11-4-3-8-32(40)37(41)42)35(45-22-27-15-26(18-38)19-39-20-27)17-34(24)46-23-29-6-5-7-31(25(29)2)28-9-10-33-36(16-28)44-13-12-43-33/h5-7,9-10,14-17,19-20,32H,3-4,8,11-13,21-23H2,1-2H3,(H,41,42)/t32-/m1/s1 NITFZQZWGZBIIX-JGCGQSQUSA-N 363373 (R)-1-(2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1288 Programmed cell death 1 ligand 1 Human 1.88 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363373&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434904 401958830 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719436 CCc1cc(CNCCNC(C)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C37H39N3O5/c1-4-29-18-32(22-39-13-14-40-26(3)41)36(44-23-28-8-5-7-27(17-28)21-38)20-35(29)45-24-31-9-6-10-33(25(31)2)30-11-12-34-37(19-30)43-16-15-42-34/h5-12,17-20,39H,4,13-16,22-24H2,1-3H3,(H,40,41) LPDVXTCQFCMDPN-UHFFFAOYSA-N 363374 N-(2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-ethylbenzylamino)ethyl)acetamide::US9850225, Example 1289 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363374&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435026 401958831 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719437 CCc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C37H38N2O7/c1-4-27-16-30(20-39-37(3,23-40)36(41)42)34(45-21-26-8-5-7-25(15-26)19-38)18-33(27)46-22-29-9-6-10-31(24(29)2)28-11-12-32-35(17-28)44-14-13-43-32/h5-12,15-18,39-40H,4,13-14,20-23H2,1-3H3,(H,41,42)/t37-/m0/s1 SVWOVLOGUCOWKY-QNGWXLTQSA-N 363375 (S)-2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl) -2-methylbenzyloxy)-5-ethylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1290 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363375&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434910 401958832 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719438 CCc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2cccc(c2)C#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C37H38N2O7/c1-4-27-16-30(20-39-37(3,23-40)36(41)42)34(45-21-26-8-5-7-25(15-26)19-38)18-33(27)46-22-29-9-6-10-31(24(29)2)28-11-12-32-35(17-28)44-14-13-43-32/h5-12,15-18,39-40H,4,13-14,20-23H2,1-3H3,(H,41,42)/t37-/m1/s1 SVWOVLOGUCOWKY-DIPNUNPCSA-N 363376 (R)-2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-ethylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1291 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363376&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434743 401958833 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719439 CC(=O)NCCNCc1cc(C=C)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C37H37N3O5/c1-4-29-18-32(22-39-13-14-40-26(3)41)36(44-23-28-8-5-7-27(17-28)21-38)20-35(29)45-24-31-9-6-10-33(25(31)2)30-11-12-34-37(19-30)43-16-15-42-34/h4-12,17-20,39H,1,13-16,22-24H2,2-3H3,(H,40,41) KEQFBUFSKVDVKG-UHFFFAOYSA-N 363377 N-(2-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-vinylbenzylamino)ethyl)acetamide::US9850225, Example 1292 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363377&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435181 401958834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719440 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2C=C)cccc1-c1ccc2OCCOc2c1 InChI=1S/C39H38N2O6/c1-3-29-19-32(23-41-15-5-4-12-34(41)39(42)43)37(46-24-28-9-6-8-27(18-28)22-40)21-36(29)47-25-31-10-7-11-33(26(31)2)30-13-14-35-38(20-30)45-17-16-44-35/h3,6-11,13-14,18-21,34H,1,4-5,12,15-17,23-25H2,2H3,(H,42,43)/t34-/m0/s1 TXGFFSPUIIFJPN-UMSFTDKQSA-N 363378 (S)-1-(2-(3-cyanobenzyloxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl) -2-methylbenzyloxy)-5-vinylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1293 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363378&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434754 401958835 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719441 CC(=O)NCCNCc1cc(C)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCCCCC#N InChI=1S/C33H39N3O5/c1-23-18-28(21-35-13-14-36-25(3)37)32(38-15-6-4-5-12-34)20-31(23)41-22-27-8-7-9-29(24(27)2)26-10-11-30-33(19-26)40-17-16-39-30/h7-11,18-20,35H,4-6,13-17,21-22H2,1-3H3,(H,36,37) GTTKBCFWBPJSCH-UHFFFAOYSA-N 363379 N-(2-(2-(4-cyanobutoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)ethyl)acetamide::US9850225, Example 1294 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363379&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434872 401958836 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719442 Cc1cc(CNC[C@@H](O)CC(O)=O)c(OCCCCC#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C33H38N2O7/c1-22-15-26(19-35-20-27(36)17-33(37)38)31(39-12-5-3-4-11-34)18-30(22)42-21-25-7-6-8-28(23(25)2)24-9-10-29-32(16-24)41-14-13-40-29/h6-10,15-16,18,27,35-36H,3-5,12-14,17,19-21H2,1-2H3,(H,37,38)/t27-/m0/s1 FEBFWIQHHVWJPM-MHZLTWQESA-N 363382 (S)-4-(2-(4-cyanobutoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)-3-hydroxybutanoic acid::US9850225, Example 1295 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363382&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434741 401958839 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719443 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCCCCC#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C35H40N2O6/c1-24-19-28(22-37-15-6-4-11-30(37)35(38)39)33(40-16-7-3-5-14-36)21-32(24)43-23-27-9-8-10-29(25(27)2)26-12-13-31-34(20-26)42-18-17-41-31/h8-10,12-13,19-21,30H,3-7,11,15-18,22-23H2,1-2H3,(H,38,39)/t30-/m0/s1 AFJIJRGBVWOZIU-PMERELPUSA-N 363383 (S)-1-(2-(4-cyanobutoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1296 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363383&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434916 401958840 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719444 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCCCCC#N)cc1OCc1cccc(c1C)-c1ccc2OCCOc2c1 InChI=1S/C33H38N2O7/c1-22-16-26(19-35-33(3,21-36)32(37)38)30(39-13-6-4-5-12-34)18-29(22)42-20-25-8-7-9-27(23(25)2)24-10-11-28-31(17-24)41-15-14-40-28/h7-11,16-18,35-36H,4-6,13-15,19-21H2,1-3H3,(H,37,38)/t33-/m0/s1 XYLZPOHRYJTOON-XIFFEERXSA-N 363384 (S)-2-(2-(4-cyanobutoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1297 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363384&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434988 401958841 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719445 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Br)cccc1-c1ccccc1 InChI=1S/C34H32BrN3O4/c1-23-27(10-7-11-29(23)26-8-3-2-4-9-26)22-42-33-16-32(41-21-25-14-24(17-36)18-37-19-25)28(15-30(33)35)20-38-13-6-5-12-31(38)34(39)40/h2-4,7-11,14-16,18-19,31H,5-6,12-13,20-22H2,1H3,(H,39,40)/t31-/m0/s1 IWSHPAFBIFAYNV-HKBQPEDESA-N 363385 (S)-1-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-((2-methylbiphenyl-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1298 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363385&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434620 401958842 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719446 CC(=O)NCCNCc1cc(Br)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cccc(c1)C#N InChI=1S/C35H34BrN3O5/c1-23-28(7-4-8-30(23)27-9-10-32-35(17-27)42-14-13-41-32)22-44-34-18-33(43-21-26-6-3-5-25(15-26)19-37)29(16-31(34)36)20-38-11-12-39-24(2)40/h3-10,15-18,38H,11-14,20-22H2,1-2H3,(H,39,40) ZJMRDMXXHNPVID-UHFFFAOYSA-N 363386 N-(2-((5-bromo-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1299 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363386&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434908 401958843 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719447 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CNC[C@@H](O)CC(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33BrN2O7/c1-22-26(6-3-7-29(22)25-8-9-31-34(14-25)43-11-10-42-31)21-45-33-16-32(44-20-24-5-2-4-23(12-24)17-37)27(13-30(33)36)18-38-19-28(39)15-35(40)41/h2-9,12-14,16,28,38-39H,10-11,15,18-21H2,1H3,(H,40,41)/t28-/m0/s1 HDLZBRJSTJBMBE-NDEPHWFRSA-N 363387 (S)-4-((5-bromo-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1300 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363387&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434815 401958844 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719448 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@H](CO)C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H31BrN2O7/c1-21-25(6-3-7-27(21)24-8-9-30-33(14-24)42-11-10-41-30)20-44-32-15-31(43-19-23-5-2-4-22(12-23)16-36)26(13-28(32)35)17-37-29(18-38)34(39)40/h2-9,12-15,29,37-38H,10-11,17-20H2,1H3,(H,39,40)/t29-/m0/s1 IKPFKGCPHQAIFU-LJAQVGFWSA-N 363388 (S)-2-((5-bromo-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1301 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363388&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434824 401958845 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719449 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C37H35BrN2O6/c1-24-28(8-5-9-30(24)27-11-12-33-36(18-27)44-15-14-43-33)23-46-35-19-34(45-22-26-7-4-6-25(16-26)20-39)29(17-31(35)38)21-40-13-3-2-10-32(40)37(41)42/h4-9,11-12,16-19,32H,2-3,10,13-15,21-23H2,1H3,(H,41,42)/t32-/m0/s1 HMPBAHKGBGJLPU-YTTGMZPUSA-N 363389 (S)-1-(5-bromo-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1302 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363389&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435111 401958846 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719450 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33BrN2O7/c1-22-26(7-4-8-28(22)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-35(2,21-39)34(40)41/h3-10,13-16,38-39H,11-12,18-21H2,1-2H3,(H,40,41)/t35-/m1/s1 SIRHWYRCEWTBSE-PGUFJCEWSA-N 363390 (R)-2-((5-bromo-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1303 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363390&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435179 401958847 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719451 Cc1c(COc2cc(OCc3cccc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H33BrN2O7/c1-22-26(7-4-8-28(22)25-9-10-30-33(15-25)43-12-11-42-30)20-45-32-16-31(44-19-24-6-3-5-23(13-24)17-37)27(14-29(32)36)18-38-35(2,21-39)34(40)41/h3-10,13-16,38-39H,11-12,18-21H2,1-2H3,(H,40,41)/t35-/m0/s1 SIRHWYRCEWTBSE-DHUJRADRSA-N 363391 (S)-2-((5-bromo-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1304 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363391&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434668 401958848 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719452 CC(=O)NCCNCc1cc(C)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cncc(c1)C#N InChI=1S/C35H33N5O5/c1-23-12-29(20-38-8-9-40-24(2)41)34(44-21-26-13-25(16-36)18-39-19-26)15-33(23)45-22-28-4-3-5-30(31(28)17-37)27-6-7-32-35(14-27)43-11-10-42-32/h3-7,12-15,18-19,38H,8-11,20-22H2,1-2H3,(H,40,41) DGATVRFUXLVEIL-UHFFFAOYSA-N 363393 N-(2-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)ethyl)acetamide::US9850225, Example 1305 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363393&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435037 401958850 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719453 CC(=O)NCCNCc1cc(C)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cncc(c1)C#N InChI=1S/C35H33N5O5/c1-23-12-29(20-38-8-9-40-24(2)41)34(44-21-26-13-25(16-36)18-39-19-26)15-33(23)45-22-28-4-3-5-30(31(28)17-37)27-6-7-32-35(14-27)43-11-10-42-32/h3-7,12-15,18-19,38H,8-11,20-22H2,1-2H3,(H,40,41) DGATVRFUXLVEIL-UHFFFAOYSA-N 363393 N-(2-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)ethyl)acetamide::US9850225, Example 1305 Programmed cell death 1 ligand 1 Human 0.920 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363393&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435037 401958850 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719454 Cc1cc(CNC[C@@H](O)CC(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(-c2ccc3OCCOc3c2)c1C#N InChI=1S/C35H32N4O7/c1-22-9-27(18-39-19-28(40)12-35(41)42)33(45-20-24-10-23(14-36)16-38-17-24)13-32(22)46-21-26-3-2-4-29(30(26)15-37)25-5-6-31-34(11-25)44-8-7-43-31/h2-6,9-11,13,16-17,28,39-40H,7-8,12,18-21H2,1H3,(H,41,42)/t28-/m0/s1 CQTODQLEFAZBTQ-NDEPHWFRSA-N 363394 (S)-4-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxybutanoic acid::US9850225, Example 1307 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363394&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434979 401958851 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719455 Cc1cc(CN[C@@](C)(CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(-c2ccc3OCCOc3c2)c1C#N InChI=1S/C35H32N4O7/c1-22-10-27(18-39-35(2,21-40)34(41)42)32(45-19-24-11-23(14-36)16-38-17-24)13-31(22)46-20-26-4-3-5-28(29(26)15-37)25-6-7-30-33(12-25)44-9-8-43-30/h3-7,10-13,16-17,39-40H,8-9,18-21H2,1-2H3,(H,41,42)/t35-/m0/s1 HIJXRNYXGUDWBH-DHUJRADRSA-N 363395 (S)-2-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1308 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363395&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434918 401958852 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719456 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(-c2ccc3OCCOc3c2)c1C#N InChI=1S/C37H34N4O6/c1-24-13-29(21-41-10-3-2-7-32(41)37(42)43)35(46-22-26-14-25(17-38)19-40-20-26)16-34(24)47-23-28-5-4-6-30(31(28)18-39)27-8-9-33-36(15-27)45-12-11-44-33/h4-6,8-9,13-16,19-20,32H,2-3,7,10-12,21-23H2,1H3,(H,42,43)/t32-/m0/s1 NSAZPJPBTFONPP-YTTGMZPUSA-N 363396 (S)-1-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US9850225, Example 1309 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363396&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434680 401958853 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719457 Cc1cc(CN[C@H](CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(-c2ccc3OCCOc3c2)c1C#N InChI=1S/C34H30N4O7/c1-21-9-26(17-38-29(18-39)34(40)41)32(44-19-23-10-22(13-35)15-37-16-23)12-31(21)45-20-25-3-2-4-27(28(25)14-36)24-5-6-30-33(11-24)43-8-7-42-30/h2-6,9-12,15-16,29,38-39H,7-8,17-20H2,1H3,(H,40,41)/t29-/m1/s1 GHFCJNWWVKFMNL-GDLZYMKVSA-N 363397 (R)-2-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxypropanoic acid::US9850225, Example 1310 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363397&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435088 401958854 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719458 Cc1cc(CN[C@](C)(CO)C(O)=O)c(OCc2cncc(c2)C#N)cc1OCc1cccc(-c2ccc3OCCOc3c2)c1C#N InChI=1S/C35H32N4O7/c1-22-10-27(18-39-35(2,21-40)34(41)42)32(45-19-24-11-23(14-36)16-38-17-24)13-31(22)46-20-26-4-3-5-28(29(26)15-37)25-6-7-30-33(12-25)44-9-8-43-30/h3-7,10-13,16-17,39-40H,8-9,18-21H2,1-2H3,(H,41,42)/t35-/m1/s1 HIJXRNYXGUDWBH-PGUFJCEWSA-N 363398 (R)-2-(4-(2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyloxy)-2-((5-cyanopyridin-3-yl)methoxy)-5-methylbenzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1311 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363398&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434652 401958855 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719459 OC[C@H](NCc1cc(Br)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cccc(c1)C#N)C(O)=O InChI=1S/C34H28BrN3O7/c35-28-12-25(17-38-29(18-39)34(40)41)31(44-19-22-4-1-3-21(11-22)15-36)14-32(28)45-20-24-5-2-6-26(27(24)16-37)23-7-8-30-33(13-23)43-10-9-42-30/h1-8,11-14,29,38-39H,9-10,17-20H2,(H,40,41)/t29-/m0/s1 SDFGMBXEMPWJHT-LJAQVGFWSA-N 363399 (S)-2-((5-bromo-4-((2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)oxy)-2-((3-cyanobenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1312 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363399&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435018 401958856 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719460 OC(=O)[C@@H]1CCCCN1Cc1cc(Br)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cccc(c1)C#N InChI=1S/C37H32BrN3O6/c38-31-16-28(21-41-12-2-1-9-32(41)37(42)43)34(46-22-25-6-3-5-24(15-25)19-39)18-35(31)47-23-27-7-4-8-29(30(27)20-40)26-10-11-33-36(17-26)45-14-13-44-33/h3-8,10-11,15-18,32H,1-2,9,12-14,21-23H2,(H,42,43)/t32-/m0/s1 FIGDDEFZKIEMPU-YTTGMZPUSA-N 363400 (S)-1-(5-bromo-4-((2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)oxy)-2-((3-cyanobenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1313 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363400&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434922 401958857 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719461 O[C@H](CNCc1cc(Br)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cccc(c1)C#N)CC(O)=O InChI=1S/C35H30BrN3O7/c36-30-12-26(18-39-19-27(40)14-35(41)42)32(45-20-23-4-1-3-22(11-23)16-37)15-33(30)46-21-25-5-2-6-28(29(25)17-38)24-7-8-31-34(13-24)44-10-9-43-31/h1-8,11-13,15,27,39-40H,9-10,14,18-21H2,(H,41,42)/t27-/m0/s1 WCQRFVWNVPNFQT-MHZLTWQESA-N 363401 (S)-4-((5-bromo-4-((2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)oxy)-2-((3-cyanobenzyl)oxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1314 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363401&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434881 401958858 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719462 CC(=O)NCCNCc1cc(Br)c(OCc2cccc(-c3ccc4OCCOc4c3)c2C#N)cc1OCc1cccc(c1)C#N InChI=1S/C35H31BrN4O5/c1-23(41)40-11-10-39-20-28-15-31(36)34(17-33(28)44-21-25-5-2-4-24(14-25)18-37)45-22-27-6-3-7-29(30(27)19-38)26-8-9-32-35(16-26)43-13-12-42-32/h2-9,14-17,39H,10-13,20-22H2,1H3,(H,40,41) OOQBRRLRXWBSIG-UHFFFAOYSA-N 363402 N-(2-((5-bromo-4-((2-cyano-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)oxy)-2-((3-cyanobenzyl)oxy)benzyl)amino)ethyl)acetamide::US10815208, Example 8::US9850225, Example 1315 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363402&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435178 401958859 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719463 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC[C@@H](O)CC(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32BrN3O7/c1-21-25(3-2-4-28(21)24-5-6-30-33(11-24)43-8-7-42-30)20-45-32-13-31(44-19-23-9-22(14-36)15-37-16-23)26(10-29(32)35)17-38-18-27(39)12-34(40)41/h2-6,9-11,13,15-16,27,38-39H,7-8,12,17-20H2,1H3,(H,40,41)/t27-/m0/s1 LHZDWJSQSPEZFZ-MHZLTWQESA-N 363403 (S)-4-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxybutanoic acid::US9850225, Example 1316 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363403&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434951 401958860 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719464 CC(=O)NCCNCc1cc(Br)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C34H33BrN4O5/c1-22-27(4-3-5-29(22)26-6-7-31-34(14-26)42-11-10-41-31)21-44-33-15-32(43-20-25-12-24(16-36)17-38-18-25)28(13-30(33)35)19-37-8-9-39-23(2)40/h3-7,12-15,17-18,37H,8-11,19-21H2,1-2H3,(H,39,40) OGKWCZSSKAICFQ-UHFFFAOYSA-N 363404 N-(2-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)ethyl)acetamide::US9850225, Example 1317 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363404&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434579 401958861 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719465 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CO)C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C33H30BrN3O7/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)42-8-7-41-29)19-44-31-12-30(43-18-22-9-21(13-35)14-36-15-22)25(10-27(31)34)16-37-28(17-38)33(39)40/h2-6,9-12,14-15,28,37-38H,7-8,16-19H2,1H3,(H,39,40)/t28-/m0/s1 WNYYJIUJMBIELW-NDEPHWFRSA-N 363405 (S)-2-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxypropanoic acid::US9850225, Example 1318 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363405&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434940 401958862 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719466 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H34BrN3O6/c1-23-27(5-4-6-29(23)26-8-9-32-35(15-26)44-12-11-43-32)22-46-34-16-33(45-21-25-13-24(17-38)18-39-19-25)28(14-30(34)37)20-40-10-3-2-7-31(40)36(41)42/h4-6,8-9,13-16,18-19,31H,2-3,7,10-12,20-22H2,1H3,(H,41,42)/t31-/m0/s1 FKHBHFXNNBCRCQ-HKBQPEDESA-N 363406 (S)-1-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1319 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363406&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434710 401958863 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719467 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32BrN3O7/c1-21-25(4-3-5-27(21)24-6-7-29-32(12-24)43-9-8-42-29)19-45-31-13-30(44-18-23-10-22(14-36)15-37-16-23)26(11-28(31)35)17-38-34(2,20-39)33(40)41/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m1/s1 KAZHPUZHQBTIRT-UUWRZZSWSA-N 363407 (R)-2-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1320 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363407&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434853 401958864 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719468 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32BrN3O7/c1-21-25(4-3-5-27(21)24-6-7-29-32(12-24)43-9-8-42-29)19-45-31-13-30(44-18-23-10-22(14-36)15-37-16-23)26(11-28(31)35)17-38-34(2,20-39)33(40)41/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m0/s1 KAZHPUZHQBTIRT-UMSFTDKQSA-N 363408 (S)-2-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzylamino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1321 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363408&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434932 401958865 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719469 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNCCO)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C32H30BrN3O5/c1-21-25(3-2-4-27(21)24-5-6-29-32(13-24)39-10-9-38-29)20-41-31-14-30(26(12-28(31)33)18-35-7-8-37)40-19-23-11-22(15-34)16-36-17-23/h2-6,11-14,16-17,35,37H,7-10,18-20H2,1H3 QRFZGYMIMILCRD-UHFFFAOYSA-N 363409 5-((4-bromo-5-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)-2-((2-hydroxyethylamino)methyl)phenoxy)methyl)nicotinonitrile::US9850225, Example 1322 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363409&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435066 401958866 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719470 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@@H]3C(O)=O)cc2Br)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H34BrN3O6/c1-23-27(5-4-6-29(23)26-8-9-32-35(15-26)44-12-11-43-32)22-46-34-16-33(45-21-25-13-24(17-38)18-39-19-25)28(14-30(34)37)20-40-10-3-2-7-31(40)36(41)42/h4-6,8-9,13-16,18-19,31H,2-3,7,10-12,20-22H2,1H3,(H,41,42)/t31-/m1/s1 FKHBHFXNNBCRCQ-WJOKGBTCSA-N 363410 (R)-1-(5-bromo-2-((5-cyanopyridin-3-yl)methoxy)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyloxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1323 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363410&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435058 401958867 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719471 Cc1c(COc2cc(OCc3cccc(c3C)-c3ccccc3)ccc2CN[C@H](CO)C(O)=O)cncc1C#N InChI=1S/C32H31N3O5/c1-21-26(14-33)15-34-16-27(21)20-40-31-13-28(12-11-24(31)17-35-30(18-36)32(37)38)39-19-25-9-6-10-29(22(25)2)23-7-4-3-5-8-23/h3-13,15-16,30,35-36H,17-20H2,1-2H3,(H,37,38)/t30-/m1/s1 WFQSEFASXCLFAJ-SSEXGKCCSA-N 363411 (R)-2-(2-((5-cyano-4-methylpyridin-3-yl)methoxy)-4-((2-methylbiphenyl-3-yl)methoxy)benzylamino)-3-hydroxypropanoic acid::US9850225, Example 1324 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363411&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434942 401958868 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719472 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3cccc(c3)C(N)=O)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H34N2O8/c1-21-26(6-3-7-28(21)23-9-11-30-32(15-23)42-13-12-41-30)20-43-27-10-8-25(17-36-29(18-37)34(39)40)31(16-27)44-19-22-4-2-5-24(14-22)33(35)38/h2-11,14-16,29,36-37H,12-13,17-20H2,1H3,(H2,35,38)(H,39,40)/t29-/m1/s1 AWPWRNVPVAWJOT-GDLZYMKVSA-N 363412 (R)-2-((2-((3-carbamoylbenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1325 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363412&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435095 401958869 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719473 Cc1c(COc2ccc(CN[C@](C)(CO)C(O)=O)c(OCc3cccc(c3)C(N)=O)c2)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H36N2O8/c1-22-27(7-4-8-29(22)24-10-12-30-32(16-24)43-14-13-42-30)20-44-28-11-9-26(18-37-35(2,21-38)34(40)41)31(17-28)45-19-23-5-3-6-25(15-23)33(36)39/h3-12,15-17,37-38H,13-14,18-21H2,1-2H3,(H2,36,39)(H,40,41)/t35-/m1/s1 GJJDLEQPJDVOLD-PGUFJCEWSA-N 363413 (R)-2-((2-((3-carbamoylbenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1326 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363413&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434920 401958870 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719474 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3cncc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C31H29N3O5/c1-21-26(8-5-9-28(21)24-6-3-2-4-7-24)20-38-27-11-10-25(17-34-29(18-35)31(36)37)30(13-27)39-19-23-12-22(14-32)15-33-16-23/h2-13,15-16,29,34-35H,17-20H2,1H3,(H,36,37)/t29-/m1/s1 NBAJSHKXFFMTLV-GDLZYMKVSA-N 363414 (R)-2-((2-((5-cyanopyridin-3-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1327 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363414&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434832 401958871 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719475 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCc3cncc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C32H31N3O5/c1-22-27(8-5-9-30(22)25-6-3-2-4-7-25)21-39-29-11-10-26(18-35-19-28(36)13-32(37)38)31(14-29)40-20-24-12-23(15-33)16-34-17-24/h2-12,14,16-17,28,35-36H,13,18-21H2,1H3,(H,37,38)/t28-/m0/s1 XZMNKQYPVLZAGS-NDEPHWFRSA-N 363415 (S)-4-((2-((5-cyanopyridin-3-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1328 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363415&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434823 401958872 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719476 Cc1c(COc2ccc(CN3CCCC[C@H]3C(O)=O)c(OCc3cncc(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C34H33N3O4/c1-24-29(10-7-11-31(24)27-8-3-2-4-9-27)23-40-30-14-13-28(21-37-15-6-5-12-32(37)34(38)39)33(17-30)41-22-26-16-25(18-35)19-36-20-26/h2-4,7-11,13-14,16-17,19-20,32H,5-6,12,15,21-23H2,1H3,(H,38,39)/t32-/m0/s1 BYWZKMDEXCIARL-YTTGMZPUSA-N 363416 (S)-1-(2-((5-cyanopyridin-3-yl)methoxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1329 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363416&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435091 401958873 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719477 Cc1c(COc2ccc(CNC[C@@H](O)CC(O)=O)c(OCc3ccc(F)c(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H31FN2O5/c1-22-26(8-5-9-30(22)24-6-3-2-4-7-24)21-40-29-12-11-25(18-36-19-28(37)15-33(38)39)32(16-29)41-20-23-10-13-31(34)27(14-23)17-35/h2-14,16,28,36-37H,15,18-21H2,1H3,(H,38,39)/t28-/m0/s1 HGBPOZBSUHQJFK-NDEPHWFRSA-N 363417 (S)-4-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid::US9850225, Example 1331 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363417&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434728 401958874 C03834 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719478 Cc1c(COc2ccc(CN[C@H](CO)C(O)=O)c(OCc3ccc(F)c(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C32H29FN2O5/c1-21-25(8-5-9-28(21)23-6-3-2-4-7-23)20-39-27-12-11-24(17-35-30(18-36)32(37)38)31(15-27)40-19-22-10-13-29(33)26(14-22)16-34/h2-15,30,35-36H,17-20H2,1H3,(H,37,38)/t30-/m1/s1 QFDOFJLJBNGGRZ-SSEXGKCCSA-N 363418 (R)-2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 1332 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363418&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434898 401958875 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719479 Cc1c(COc2ccc(CN[C@](C)(CO)C(O)=O)c(OCc3ccc(F)c(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C33H31FN2O5/c1-22-26(9-6-10-29(22)24-7-4-3-5-8-24)20-40-28-13-12-25(18-36-33(2,21-37)32(38)39)31(16-28)41-19-23-11-14-30(34)27(15-23)17-35/h3-16,36-37H,18-21H2,1-2H3,(H,38,39)/t33-/m1/s1 MIBPBLJURGLAMZ-MGBGTMOVSA-N 363419 (R)-2-((2-((3-cyano-4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 1333 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363419&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435176 401958876 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719480 Cc1c(COc2ccc(CN3CCCC[C@H]3C(O)=O)c(OCc3ccc(F)c(c3)C#N)c2)cccc1-c1ccccc1 InChI=1S/C35H33FN2O4/c1-24-28(10-7-11-31(24)26-8-3-2-4-9-26)23-41-30-15-14-27(21-38-17-6-5-12-33(38)35(39)40)34(19-30)42-22-25-13-16-32(36)29(18-25)20-37/h2-4,7-11,13-16,18-19,33H,5-6,12,17,21-23H2,1H3,(H,39,40)/t33-/m0/s1 QCZGULNLBHHRFK-XIFFEERXSA-N 363424 (S)-1-(2-((3-cyano-4-fluorobenzyl)oxy)-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 1334 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363424&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434833 401958881 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719481 COc1cc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O InChI=1S/C26H30N2O3/c1-19-23(10-7-11-25(19)21-8-5-4-6-9-21)18-31-24-13-12-22(26(16-24)30-3)17-27-14-15-28-20(2)29/h4-13,16,27H,14-15,17-18H2,1-3H3,(H,28,29) OKNHSXIGHFKIMY-UHFFFAOYSA-N 363425 N-(2-((2-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)ethyl)acetamide::US9850225, Example 1335::US9872852, Example 68 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363425&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434657 401958882 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719482 CCOC(=O)c1cncc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN[C@@](C)(CO)C(O)=O)c1 InChI=1S/C36H37ClN2O9/c1-4-44-34(41)27-12-23(16-38-17-27)19-47-31-15-32(29(37)13-26(31)18-39-36(3,21-40)35(42)43)48-20-25-6-5-7-28(22(25)2)24-8-9-30-33(14-24)46-11-10-45-30/h5-9,12-17,39-40H,4,10-11,18-21H2,1-3H3,(H,42,43)/t36-/m0/s1 VDOSIXJXJLHODY-BHVANESWSA-N 363426 (S)-2-((5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((5-(ethoxycarbonyl)pyridin-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 2000 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363426&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434634 401958883 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719483 Cc1c(COc2cc(OCc3cncc(c3)C(O)=O)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H33ClN2O9/c1-20-23(4-3-5-26(20)22-6-7-28-31(12-22)44-9-8-43-28)18-46-30-13-29(45-17-21-10-25(32(39)40)15-36-14-21)24(11-27(30)35)16-37-34(2,19-38)33(41)42/h3-7,10-15,37-38H,8-9,16-19H2,1-2H3,(H,39,40)(H,41,42)/t34-/m0/s1 BCUHLFQTUAHXRE-UMSFTDKQSA-N 363427 (S)-5-((2-(((2-carboxy-1-hydroxypropan-2-yl)amino)methyl)-4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)phenoxy)methyl)nicotinic acid::US9850225, Example 2001 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363427&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434911 401958884 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719484 Cc1c(COc2cc(OCc3cncc(c3)C(O)=O)c(CN[C@@H](CCCN)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H36ClN3O8/c1-21-24(4-2-5-27(21)23-7-8-30-33(14-23)45-11-10-44-30)20-47-32-15-31(46-19-22-12-26(34(40)41)17-38-16-22)25(13-28(32)36)18-39-29(35(42)43)6-3-9-37/h2,4-5,7-8,12-17,29,39H,3,6,9-11,18-20,37H2,1H3,(H,40,41)(H,42,43)/t29-/m0/s1 HPOOEZVJLFNHQV-LJAQVGFWSA-N 363428 (S)-5-((2-(((4-amino-1-carboxybutyl)amino)methyl)-4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)phenoxy)methyl)nicotinic acid::US9850225, Example 2002 Programmed cell death 1 ligand 1 Human 10.00 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363428&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435166 401958885 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719485 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CCCN)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H35ClN4O6/c1-22-26(4-2-5-28(22)25-7-8-31-34(14-25)44-11-10-43-31)21-46-33-15-32(45-20-24-12-23(16-38)17-39-18-24)27(13-29(33)36)19-40-30(35(41)42)6-3-9-37/h2,4-5,7-8,12-15,17-18,30,40H,3,6,9-11,19-21,37H2,1H3,(H,41,42)/t30-/m0/s1 RIRINYLYNSLBLV-PMERELPUSA-N 363429 (S)-5-amino-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)pentanoic acid::US9850225, Example 2003 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363429&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434659 401958886 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719486 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CCCCN)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H37ClN4O6/c1-23-27(5-4-6-29(23)26-8-9-32-35(15-26)45-12-11-44-32)22-47-34-16-33(46-21-25-13-24(17-39)18-40-19-25)28(14-30(34)37)20-41-31(36(42)43)7-2-3-10-38/h4-6,8-9,13-16,18-19,31,41H,2-3,7,10-12,20-22,38H2,1H3,(H,42,43)/t31-/m0/s1 MTLMPZDXYBMRRP-HKBQPEDESA-N 363430 (S)-6-amino-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)hexanoic acid::US9850225, Example 2004 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363430&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434975 401958887 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719487 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CCN)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H33ClN4O6/c1-21-25(3-2-4-27(21)24-5-6-30-33(13-24)43-10-9-42-30)20-45-32-14-31(44-19-23-11-22(15-37)16-38-17-23)26(12-28(32)35)18-39-29(7-8-36)34(40)41/h2-6,11-14,16-17,29,39H,7-10,18-20,36H2,1H3,(H,40,41)/t29-/m0/s1 ISCMNJUIOUTZRV-LJAQVGFWSA-N 363431 (S)-4-amino-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)butanoic acid::US9850225, Example 2005 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363431&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434925 401958888 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719488 CN(C)CCCC[C@H](NCc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N)C(O)=O InChI=1S/C38H41ClN4O6/c1-25-29(7-6-8-31(25)28-10-11-34-37(17-28)47-14-13-46-34)24-49-36-18-35(48-23-27-15-26(19-40)20-41-21-27)30(16-32(36)39)22-42-33(38(44)45)9-4-5-12-43(2)3/h6-8,10-11,15-18,20-21,33,42H,4-5,9,12-14,22-24H2,1-3H3,(H,44,45)/t33-/m0/s1 LAEKDIAWUQVGMU-XIFFEERXSA-N 363432 (S)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-6-(dimethylamino)hexanoic acid::US9850225, Example 2006 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363432&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434629 401958889 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719489 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3C[C@@H](O)CC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H34ClN3O7/c1-22-26(3-2-4-29(22)25-5-8-32-35(13-25)45-10-9-44-32)21-47-34-14-33(46-20-24-11-23(15-38)16-39-17-24)27(12-30(34)37)18-40-19-28(41)6-7-31(40)36(42)43/h2-5,8,11-14,16-17,28,31,41H,6-7,9-10,18-21H2,1H3,(H,42,43)/t28-,31-/m0/s1 ZLZSIDVOVQYDHW-IZEXYCQBSA-N 363433 (2S,5S)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-5-hydroxypiperidine-2-carboxylic acid::US9850225, Example 2007 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363433&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435156 401958890 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719490 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CC[C@@H](O)C[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H34ClN3O7/c1-22-26(3-2-4-29(22)25-5-6-32-35(13-25)45-10-9-44-32)21-47-34-15-33(46-20-24-11-23(16-38)17-39-18-24)27(12-30(34)37)19-40-8-7-28(41)14-31(40)36(42)43/h2-6,11-13,15,17-18,28,31,41H,7-10,14,19-21H2,1H3,(H,42,43)/t28-,31+/m1/s1 JJPPTSAHQCHDLJ-MVSFAKPFSA-N 363434 (2S,4R)-1-(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypiperidine-2-carboxylic acid::US9850225, Example 2008 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363434&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435073 401958891 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719491 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](Cc3ccccn3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H33ClN4O6/c1-24-28(5-4-7-31(24)27-8-9-34-37(15-27)47-12-11-46-34)23-49-36-17-35(48-22-26-13-25(18-40)19-41-20-26)29(14-32(36)39)21-43-33(38(44)45)16-30-6-2-3-10-42-30/h2-10,13-15,17,19-20,33,43H,11-12,16,21-23H2,1H3,(H,44,45)/t33-/m0/s1 WFTJIXLGHQMCFJ-XIFFEERXSA-N 363435 (S)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(pyridin-2-yl)propanoic acid::US9850225, Example 2009 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363435&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434642 401958892 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719492 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](Cc3cccnc3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H33ClN4O6/c1-24-29(5-2-6-31(24)28-7-8-34-37(15-28)47-11-10-46-34)23-49-36-16-35(48-22-27-12-26(17-40)19-42-20-27)30(14-32(36)39)21-43-33(38(44)45)13-25-4-3-9-41-18-25/h2-9,12,14-16,18-20,33,43H,10-11,13,21-23H2,1H3,(H,44,45)/t33-/m0/s1 PKBSVBJFSCBSOH-XIFFEERXSA-N 363436 (S)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(pyridin-3-yl)propanoic acid::US10815208, Example 6::US9850225, Example 2010 Programmed cell death 1 ligand 1 Human 50.0 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363436&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435048 401958893 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719493 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](Cc3ccncc3)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C38H33ClN4O6/c1-24-29(3-2-4-31(24)28-5-6-34-37(16-28)47-12-11-46-34)23-49-36-17-35(48-22-27-13-26(18-40)19-42-20-27)30(15-32(36)39)21-43-33(38(44)45)14-25-7-9-41-10-8-25/h2-10,13,15-17,19-20,33,43H,11-12,14,21-23H2,1H3,(H,44,45)/t33-/m0/s1 UGTAVIXXJHTQAJ-XIFFEERXSA-N 363437 (S)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-(pyridin-4-yl)propanoic acid::US9850225, Example 2011 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363437&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435024 401958894 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719494 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CCC(O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H32ClN3O8/c1-21-25(3-2-4-27(21)24-5-7-30-33(13-24)45-10-9-44-30)20-47-32-14-31(46-19-23-11-22(15-37)16-38-17-23)26(12-28(32)36)18-39-29(35(42)43)6-8-34(40)41/h2-5,7,11-14,16-17,29,39H,6,8-10,18-20H2,1H3,(H,40,41)(H,42,43)/t29-/m0/s1 JICYBHYVMRDGHV-LJAQVGFWSA-N 363438 (S)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)pentanedioic acid::US9850225, Example 2012 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363438&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435180 401958895 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719495 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNCC(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C32H28ClN3O6/c1-20-24(3-2-4-26(20)23-5-6-28-31(11-23)40-8-7-39-28)19-42-30-12-29(25(10-27(30)33)16-36-17-32(37)38)41-18-22-9-21(13-34)14-35-15-22/h2-6,9-12,14-15,36H,7-8,16-19H2,1H3,(H,37,38) WUPDVMYQNXHYDI-UHFFFAOYSA-N 363439 2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)acetic acid::US9850225, Example 2013 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363439&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435161 401958896 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719496 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC(CO)C(O)=O)cc2F)cccc1-c1ccc2OCCOc2c1 InChI=1S/C33H30FN3O7/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)42-8-7-41-29)19-44-31-12-30(43-18-22-9-21(13-35)14-36-15-22)25(10-27(31)34)16-37-28(17-38)33(39)40/h2-6,9-12,14-15,28,37-38H,7-8,16-19H2,1H3,(H,39,40) LHGLKYBTQQKCIA-UHFFFAOYSA-N 363440 Step b::US9850225, Example 3000 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363440&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118441455 401958897 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719497 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2F)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H32FN3O7/c1-21-25(4-3-5-27(21)24-6-7-29-32(12-24)43-9-8-42-29)19-45-31-13-30(44-18-23-10-22(14-36)15-37-16-23)26(11-28(31)35)17-38-34(2,20-39)33(40)41/h3-7,10-13,15-16,38-39H,8-9,17-20H2,1-2H3,(H,40,41)/t34-/m1/s1 XXBGJOOWCYCDGR-UUWRZZSWSA-N 363441 US9850225, Example 3001 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363441&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118441458 401958898 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719498 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2F)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H34FN3O6/c1-23-27(5-4-6-29(23)26-8-9-32-35(15-26)44-12-11-43-32)22-46-34-16-33(45-21-25-13-24(17-38)18-39-19-25)28(14-30(34)37)20-40-10-3-2-7-31(40)36(41)42/h4-6,8-9,13-16,18-19,31H,2-3,7,10-12,20-22H2,1H3,(H,41,42)/t31-/m0/s1 YQBLZFGEWIUGLZ-HKBQPEDESA-N 363442 US9850225, Example 3002 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363442&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118441456 401958899 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719499 C[C@H](O)N(CC(O)=O)Cc1cc(F)c(OCc2cccc(c2C)-c2ccc3OCCOc3c2)cc1OCc1cncc(c1)C#N InChI=1S/C34H32FN3O7/c1-21-26(4-3-5-28(21)25-6-7-30-33(12-25)43-9-8-42-30)20-45-32-13-31(44-19-24-10-23(14-36)15-37-16-24)27(11-29(32)35)17-38(22(2)39)18-34(40)41/h3-7,10-13,15-16,22,39H,8-9,17-20H2,1-2H3,(H,40,41)/t22-/m0/s1 KGKZBCGODQTHKA-QFIPXVFZSA-N 363443 US9850225, Example 3003 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363443&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 145452954 401958900 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719500 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3C[C@@H](O)C[C@H]3C(O)=O)cc2F)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H32FN3O7/c1-21-25(3-2-4-28(21)24-5-6-31-34(11-24)44-8-7-43-31)20-46-33-13-32(45-19-23-9-22(14-37)15-38-16-23)26(10-29(33)36)17-39-18-27(40)12-30(39)35(41)42/h2-6,9-11,13,15-16,27,30,40H,7-8,12,17-20H2,1H3,(H,41,42)/t27-,30-/m0/s1 AAQMCCVJORQAKH-FIBWVYCGSA-N 363444 US9850225, Example 3004 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363444&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 145452955 401958901 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719501 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CC[C@H]3C(O)=O)cc2F)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H30FN3O6/c1-21-25(3-2-4-27(21)24-5-6-30-33(13-24)42-10-9-41-30)20-44-32-14-31(43-19-23-11-22(15-36)16-37-17-23)26(12-28(32)35)18-38-8-7-29(38)34(39)40/h2-6,11-14,16-17,29H,7-10,18-20H2,1H3,(H,39,40)/t29-/m0/s1 VWCNFNCPLXFFSQ-LJAQVGFWSA-N 363445 US9850225, Example 3005 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363445&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 145452956 401958902 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719502 C[C@H]1C(O)CN(Cc2cc(F)c(OCc3cccc(c3C)-c3ccc4OCCOc4c3)cc2OCc2cncc(c2)C#N)[C@@H]1C(O)=O InChI=1S/C36H34FN3O7/c1-21-26(4-3-5-28(21)25-6-7-31-34(12-25)45-9-8-44-31)20-47-33-13-32(46-19-24-10-23(14-38)15-39-16-24)27(11-29(33)37)17-40-18-30(41)22(2)35(40)36(42)43/h3-7,10-13,15-16,22,30,35,41H,8-9,17-20H2,1-2H3,(H,42,43)/t22-,30?,35-/m0/s1 XSWIZWBMZAUKOR-QQJNRYKWSA-N 363446 US9850225, Example 3006 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363446&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 145452957 401958903 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719503 CCOC(=O)Nc1cncc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2C=O)c1 InChI=1S/C32H29ClN2O7/c1-3-38-32(37)35-25-11-21(15-34-16-25)18-41-29-14-30(27(33)12-24(29)17-36)42-19-23-5-4-6-26(20(23)2)22-7-8-28-31(13-22)40-10-9-39-28/h4-8,11-17H,3,9-10,18-19H2,1-2H3,(H,35,37) JHCDRFKDKUPEHE-UHFFFAOYSA-N 363447 US9850225, Example 3008::ethyl (5-((4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-formylphenoxy)methyl)pyridin-3-yl)carbamate Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363447&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118445348 401958904 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719504 CCOC(=O)Nc1cncc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN[C@@](C)(CO)C(O)=O)c1 InChI=1S/C36H38ClN3O9/c1-4-45-35(44)40-27-12-23(16-38-18-27)19-48-31-15-32(29(37)13-26(31)17-39-36(3,21-41)34(42)43)49-20-25-6-5-7-28(22(25)2)24-8-9-30-33(14-24)47-11-10-46-30/h5-9,12-16,18,39,41H,4,10-11,17,19-21H2,1-3H3,(H,40,44)(H,42,43)/t36-/m0/s1 NQDDFZIGVCAALU-BHVANESWSA-N 363448 (S)-2-((5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((5-((ethoxycarbonyl)amino)pyridin-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3009 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363448&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435132 401958905 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719505 CC(=O)Nc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2C=O)ccn1 InChI=1S/C31H27ClN2O6/c1-19-23(4-3-5-25(19)22-6-7-27-30(14-22)38-11-10-37-27)18-40-29-15-28(24(16-35)13-26(29)32)39-17-21-8-9-33-31(12-21)34-20(2)36/h3-9,12-16H,10-11,17-18H2,1-2H3,(H,33,34,36) DRGHWXWZAGJFPO-UHFFFAOYSA-N 363449 N-(4-((4-chloro-5-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-formylphenoxy)methyl)pyridin-2-yl)acetamide::US9850225, Example 3010 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363449&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435201 401958906 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719506 CC(=O)Nc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN[C@@](C)(CO)C(O)=O)ccn1 InChI=1S/C35H36ClN3O8/c1-21-25(5-4-6-27(21)24-7-8-29-32(15-24)45-12-11-44-29)19-47-31-16-30(46-18-23-9-10-37-33(13-23)39-22(2)41)26(14-28(31)36)17-38-35(3,20-40)34(42)43/h4-10,13-16,38,40H,11-12,17-20H2,1-3H3,(H,42,43)(H,37,39,41)/t35-/m0/s1 HHRDWSSIPFASJE-DHUJRADRSA-N 363450 (S)-2-((2-((2-acetamidopyridin-4-yl)methoxy)-5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3011 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363450&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434736 401958907 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719507 Cc1c(COc2cc(OCc3cncc(c3)S(C)(=O)=O)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H35ClN2O9S/c1-21-24(5-4-6-27(21)23-7-8-29-32(13-23)44-10-9-43-29)19-46-31-14-30(45-18-22-11-26(17-36-15-22)47(3,41)42)25(12-28(31)35)16-37-34(2,20-38)33(39)40/h4-8,11-15,17,37-38H,9-10,16,18-20H2,1-3H3,(H,39,40)/t34-/m0/s1 ZZPJVPATSXBVNJ-UMSFTDKQSA-N 363451 (S)-2-((5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((5-(methylsulfonyl)pyridin-3-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3012 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363451&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434677 401958908 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719508 Cc1c(COc2cc(OCc3cncc(c3)S(C)(=O)=O)c(CO)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C30H28ClNO7S/c1-19-22(4-3-5-25(19)21-6-7-27-30(12-21)37-9-8-36-27)18-39-29-13-28(23(16-33)11-26(29)31)38-17-20-10-24(15-32-14-20)40(2,34)35/h3-7,10-15,33H,8-9,16-18H2,1-2H3 UKXPEOVFLDPJDV-UHFFFAOYSA-N 363452 (5-chloro-4-{[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy}-2-[(5-methanesulfonylpyridin-3-yl)methoxy]phenyl)methanol::US9850225, Example 3013 Programmed cell death 1 ligand 1 Human 80.0 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363452&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435136 401958909 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719509 COc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN[C@@](C)(CO)C(O)=O)cc(Cl)n1 InChI=1S/C34H34Cl2N2O8/c1-20-23(5-4-6-25(20)22-7-8-27-30(14-22)44-10-9-43-27)18-46-29-15-28(45-17-21-11-31(36)38-32(12-21)42-3)24(13-26(29)35)16-37-34(2,19-39)33(40)41/h4-8,11-15,37,39H,9-10,16-19H2,1-3H3,(H,40,41)/t34-/m0/s1 TZLRGZSSIFWYKK-UMSFTDKQSA-N 363453 (S)-2-((5-chloro-2-((2-chloro-6-methoxypyridin-4-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3014 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363453&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435193 401958910 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719510 COc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN[C@@](C)(CO)C(O)=O)ccn1 InChI=1S/C34H35ClN2O8/c1-21-24(5-4-6-26(21)23-7-8-28-31(15-23)43-12-11-42-28)19-45-30-16-29(44-18-22-9-10-36-32(13-22)41-3)25(14-27(30)35)17-37-34(2,20-38)33(39)40/h4-10,13-16,37-38H,11-12,17-20H2,1-3H3,(H,39,40)/t34-/m0/s1 GGXAYSIMDUBUAC-UMSFTDKQSA-N 363454 (2S)-2-{[(5-chloro-4-{[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy}-2-[(2-methoxypyridin-4-yl)methoxy]phenyl)methyl]amino}-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3015 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363454&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434937 401958911 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719511 COc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CO)ccn1 InChI=1S/C30H28ClNO6/c1-19-22(4-3-5-24(19)21-6-7-26-29(14-21)36-11-10-35-26)18-38-28-15-27(23(16-33)13-25(28)31)37-17-20-8-9-32-30(12-20)34-2/h3-9,12-15,33H,10-11,16-18H2,1-2H3 PFNSYSBKMGVSRX-UHFFFAOYSA-N 363455 (5-chloro-4-{[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy}-2-[(2-methoxypyridin-4-yl)methoxy]phenyl)methanol::US9850225, Example 3016 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363455&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434607 401958912 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719512 COc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN2CCCC[C@H]2C(O)=O)ccn1 InChI=1S/C36H37ClN2O7/c1-23-26(6-5-7-28(23)25-9-10-31-34(18-25)44-15-14-43-31)22-46-33-19-32(45-21-24-11-12-38-35(16-24)42-2)27(17-29(33)37)20-39-13-4-3-8-30(39)36(40)41/h5-7,9-12,16-19,30H,3-4,8,13-15,20-22H2,1-2H3,(H,40,41)/t30-/m0/s1 TUXWVQYJMDFTNE-PMERELPUSA-N 363456 (S)-1-(5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((2-methoxypyridin-4-yl)methoxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 3017 Programmed cell death 1 ligand 1 Human 550 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363456&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434804 401958913 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719513 CN(C)Oc1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN[C@@](C)(CO)C(O)=O)ccn1 InChI=1S/C35H38ClN3O8/c1-22-25(6-5-7-27(22)24-8-9-29-32(16-24)44-13-12-43-29)20-46-31-17-30(45-19-23-10-11-37-33(14-23)47-39(3)4)26(15-28(31)36)18-38-35(2,21-40)34(41)42/h5-11,14-17,38,40H,12-13,18-21H2,1-4H3,(H,41,42)/t35-/m0/s1 KRZLEBKPBJJJRV-DHUJRADRSA-N 363457 (S)-2-((5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((2-(dimethylcarbamoyl)pyridin-4-yl)methoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3018 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363457&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118441460 401958914 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719514 CN(C)C(=O)c1cc(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CO)ccn1 InChI=1S/C32H31ClN2O6/c1-20-23(5-4-6-25(20)22-7-8-28-31(15-22)39-12-11-38-28)19-41-30-16-29(24(17-36)14-26(30)33)40-18-21-9-10-34-27(13-21)32(37)35(2)3/h4-10,13-16,36H,11-12,17-19H2,1-3H3 NQFVDENWYPJNJH-UHFFFAOYSA-N 363458 4-(4-chloro-5-{[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy}-2-(hydroxymethyl)phenoxymethyl)-N,N-dimethylpyridine-2-carboxamide::US9850225, Example 3019 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363458&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434747 401958915 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719515 Cc1c(COc2cc(OCc3cccc(c3)S(C)(=O)=O)c(C=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C31H27ClO7S/c1-20-23(6-4-8-26(20)22-9-10-28-31(15-22)37-12-11-36-28)19-39-30-16-29(24(17-33)14-27(30)32)38-18-21-5-3-7-25(13-21)40(2,34)35/h3-10,13-17H,11-12,18-19H2,1-2H3 OFOVKPJUXRZFJK-UHFFFAOYSA-N 363459 5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((3-(methylsulfonyl)benzyl)oxy)benzaldehyde::US9850225, Example 3020 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363459&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435198 401958916 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719516 Cc1c(COc2cc(OCc3cccc(c3)S(C)(=O)=O)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C35H36ClNO9S/c1-22-25(7-5-9-28(22)24-10-11-30-33(16-24)44-13-12-43-30)20-46-32-17-31(45-19-23-6-4-8-27(14-23)47(3,41)42)26(15-29(32)36)18-37-35(2,21-38)34(39)40/h4-11,14-17,37-38H,12-13,18-21H2,1-3H3,(H,39,40)/t35-/m0/s1 CXSBLOKYJQZLJR-DHUJRADRSA-N 363460 (S)-2-((5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((3-(methylsulfonyl)benzyl)oxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US9850225, Example 3021 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363460&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434933 401958917 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719517 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CC(N)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H31ClN4O7/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)44-8-7-43-29)19-46-31-13-30(45-18-22-9-21(14-36)15-38-16-22)25(10-27(31)35)17-39-28(34(41)42)12-33(37)40/h2-6,9-11,13,15-16,28,39H,7-8,12,17-19H2,1H3,(H2,37,40)(H,41,42)/t28-/m0/s1 NETLWGBGIKNGII-NDEPHWFRSA-N 363461 (S)-4-amino-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-oxobutanoic acid::US9850225, Example 3022 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363461&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434810 401958918 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719518 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@H](CC(O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H30ClN3O8/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)44-8-7-43-29)19-46-31-13-30(45-18-22-9-21(14-36)15-37-16-22)25(10-27(31)35)17-38-28(34(41)42)12-33(39)40/h2-6,9-11,13,15-16,28,38H,7-8,12,17-19H2,1H3,(H,39,40)(H,41,42)/t28-/m0/s1 ZEZNTXBGRSSSEE-NDEPHWFRSA-N 363462 (S)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)succinic acid::US9850225, Example 3023 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363462&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434848 401958919 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719519 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@H](CC(N)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H31ClN4O7/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)44-8-7-43-29)19-46-31-13-30(45-18-22-9-21(14-36)15-38-16-22)25(10-27(31)35)17-39-28(34(41)42)12-33(37)40/h2-6,9-11,13,15-16,28,39H,7-8,12,17-19H2,1H3,(H2,37,40)(H,41,42)/t28-/m1/s1 NETLWGBGIKNGII-MUUNZHRXSA-N 363463 (R)-4-amino-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-4-oxobutanoic acid::US9850225, Example 3024 Programmed cell death 1 ligand 1 Human 5.54 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363463&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434816 401958920 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719520 Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@H](CC(O)=O)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C34H30ClN3O8/c1-20-24(3-2-4-26(20)23-5-6-29-32(11-23)44-8-7-43-29)19-46-31-13-30(45-18-22-9-21(14-36)15-37-16-22)25(10-27(31)35)17-38-28(34(41)42)12-33(39)40/h2-6,9-11,13,15-16,28,38H,7-8,12,17-19H2,1H3,(H,39,40)(H,41,42)/t28-/m1/s1 ZEZNTXBGRSSSEE-MUUNZHRXSA-N 363464 (R)-2-((5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)succinic acid::US9850225, Example 3025 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363464&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434688 401958921 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719521 COC(=O)c1ccc(OC)c(COc2cc(OCc3cccc(c3C)-c3ccc4OCCOc4c3)c(Cl)cc2CN2CCCC[C@H]2C(O)=O)c1 InChI=1S/C39H40ClNO9/c1-24-27(7-6-8-30(24)25-10-13-34-37(19-25)48-16-15-47-34)22-50-36-20-35(49-23-29-17-26(39(44)46-3)11-12-33(29)45-2)28(18-31(36)40)21-41-14-5-4-9-32(41)38(42)43/h6-8,10-13,17-20,32H,4-5,9,14-16,21-23H2,1-3H3,(H,42,43)/t32-/m0/s1 GGPJWTYGNOWAHN-YTTGMZPUSA-N 363465 (S)-1-(5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((2-methoxy-5-(methoxycarbonyl)benzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 3026 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363465&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434890 401958922 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719522 COc1ccc(cc1COc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)c(Cl)cc1CN1CCCC[C@H]1C(O)=O)C(O)=O InChI=1S/C38H38ClNO9/c1-23-26(6-5-7-29(23)24-9-12-33-36(18-24)47-15-14-46-33)21-49-35-19-34(48-22-28-16-25(37(41)42)10-11-32(28)45-2)27(17-30(35)39)20-40-13-4-3-8-31(40)38(43)44/h5-7,9-12,16-19,31H,3-4,8,13-15,20-22H2,1-2H3,(H,41,42)(H,43,44)/t31-/m0/s1 PHJDMVXTMGKWHA-HKBQPEDESA-N 363467 (S)-1-(2-((5-carboxy-2-methoxybenzyl)oxy)-5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 3027 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363467&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435146 401958924 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719523 Cc1c(COc2cc(OCc3ccccc3)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C36H36ClNO6/c1-24-27(10-7-11-29(24)26-13-14-32-35(19-26)42-17-16-41-32)23-44-34-20-33(43-22-25-8-3-2-4-9-25)28(18-30(34)37)21-38-15-6-5-12-31(38)36(39)40/h2-4,7-11,13-14,18-20,31H,5-6,12,15-17,21-23H2,1H3,(H,39,40)/t31-/m0/s1 KEOVHVXVSWTUGJ-HKBQPEDESA-N 363468 (S)-1-(2-(benzyloxy)-5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 3028 Programmed cell death 1 ligand 1 Human 10050 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363468&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434901 401958925 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719524 COc1ccccc1COc1cc(OCc2cccc(c2C)-c2ccc3OCCOc3c2)c(Cl)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C37H38ClNO7/c1-24-26(9-7-10-29(24)25-13-14-33-36(19-25)44-17-16-43-33)22-46-35-20-34(45-23-27-8-3-4-12-32(27)42-2)28(18-30(35)38)21-39-15-6-5-11-31(39)37(40)41/h3-4,7-10,12-14,18-20,31H,5-6,11,15-17,21-23H2,1-2H3,(H,40,41)/t31-/m0/s1 DZUUMJGHXQWGNO-HKBQPEDESA-N 363469 (S)-1-(5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-2-((2-methoxybenzyl)oxy)benzyl)piperidine-2-carboxylic acid::US9850225, Example 3029 Programmed cell death 1 ligand 1 Human 2350 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363469&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118435145 401958926 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 719525 Cc1c(COc2cc(OCC(N)=O)c(CN[C@@H](CO)C(O)=O)cc2Cl)cccc1-c1ccc2OCCOc2c1 InChI=1S/C28H29ClN2O8/c1-16-18(3-2-4-20(16)17-5-6-23-26(10-17)37-8-7-36-23)14-38-25-11-24(39-15-27(30)33)19(9-21(25)29)12-31-22(13-32)28(34)35/h2-6,9-11,22,31-32H,7-8,12-15H2,1H3,(H2,30,33)(H,34,35)/t22-/m0/s1 MBEADHJQDBMFSN-QFIPXVFZSA-N 363470 (S)-2-((2-(2-amino-2-oxoethoxy)-5-chloro-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)amino)-3-hydroxypropanoic acid::US9850225, Example 3030 Programmed cell death 1 ligand 1 Human 5.3 US Patent 10.7270/Q2N018TZ aid1797911 US9850225 Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM 12/26/2017 11/14/2019 Bristol-Myers Squibb Co. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=363470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006891&target=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=363470&enzyme=Programmed+cell+death+1+ligand+1&column=ki&startPg=0&Increment=50&submit=Search 118434588 401958927 1 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 3BIK,3BIS,3FN3,3SBW,4Z18,4ZQK,5GGT,5GRJ,5IUS,5J89,5J8O,5JDR,5JDS,5N2D,5N2F,5NIU,5O45,5XJ4,5XXY,6PV9,6R3K,6RPG,6VQN,6YCR,7BEA,7C88,7CZD,7DCV,7DY7,7NLD,7OUN,7TPS,7UX5,7UXO,7UXP,7UXQ,7VUN,7XYQ,8ALX,8AOM,8OR1 Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5